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Abstract 
Asbestinins are the most complex of the ether bridged 2,11-cyclised cembranoids, isolated 
from the gorgonian octocoral species Briareum asbestinum. They have a complex rigid 
tetracyclic framework with nine or more contiguous stereocentres and a highly substituted 
tetrahydrofuran, for example in 11-acetoxy-4-deoxyasbestinin D and asbestinin 12. The 
asbestinins have been shown to possess significant biological activities including 
antimicrobial and anticancer properties.  
 
The significant synthetic challenge presented by the asbestinins structures combined with 
their biological activity make them an interesting target for total synthesis. There have been 
numerous syntheses of the structurally related cladiellin family but only two previous 
syntheses of the asbestinins which were reported by Crimmins in 2005 and 2008.  
Previous work in the Clark group had established methodology for the synthesis of multiple 
members of the cladiellin family (>10 members synthesised) from a common tricyclic 
intermediate which could be utilised in the synthesis of the asbestinins. This involved a few 
key transformations including a tandem oxonium ylide formation, [2,3]-sigmatropic 
rearrangement to construct the bicyclic core followed by a Stille/Diels–Alder sequence to 
give a common tricyclic intermediate. 
In this thesis, the first total syntheses of five members of the 4-deoxyasbestinin family are 
reported as well as the second total synthesis of 11-acetoxy-4-deoxyasbestinin D. The 
syntheses were completed utilising the common tricyclic intermediate previously reported 
during the synthesis of multiple members of the cladiellin family. The reported total 
syntheses have allowed for confirmation or re-evaluation of the reported revised structures 
of members of the asbestinin family. 
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1. Introduction 
 
1.1 2,11-Cyclised Cembranoid Family of Natural Products 
Since the initial discovery of eunicellin (1) over forty years ago, many members of the 
ether-bridged 2,11-cyclised cembranoids have been isolated from marine invertebrates of 
the octocorallia species such as the asbestinins (2, Figure 1).[1] They have been shown to 
possess various biological activities such as cytotoxic, anti-inflammatory and anti-malarial 
properties.[2] The structural variety of these natural products and the possibility of 
synthesising members of the family from common late-stage intermediates has led to 
considerable interest in the area. 
 
Figure 1: Structure of Eunicellin (1) and Asbestinins Skeleton (2) 
The 2,11-cyclised cembranoids can be split into four main subclasses: cladiellins 
(eunicellins), sarcodictyins, briarellins and asbestinins (Scheme 1).[2] 
 
Scheme 1: Proposed Biosynthesis of the Four Known Families of Oxygenated 2,11-Cyclised Cembranoids 
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The idea that the four subclasses of 2,11-cyclised cembranoids can be biosynthesised from 
the same intermediate was first proposed by Faulkner.[3] He proposed that a 2,11-cyclisation 
(cembrane nomenclature) of the cembrane ring skeleton would result in formation of the 
cladiellins. The briarellins and asbestinins could then be synthesised by formation of a 
seven-membered ether ring between C3 and C16 (asbestinin nomenclature). This proposal 
has yet to be proved, but evidence from isolated metabolites of the three subclasses is 
consistent with the proposed biosynthetic route.[4] 
1.2 Abestinin Family of Natural Products 
In recent years, over 30 members of the asbestinin family of natural products have been 
isolated from the gorgonian octocoral species Briareum asbestinum.[5-10] The first members 
of the family were reported in 1980 by Faulkner, Clardy and co-workers with the isolation 
and characterisation of asbestinins 1−5 (3−7, Figure 2).[6] 
 
Figure 2: Proposed Structures of Asbestinins 1−5 (3−7) 
The structure and relative stereochemistry of each of the isolated asbestinins were 
determined from deductions based on the reduction of asbestinin 1 (3) with lithium 
aluminium hydride to give corresponding diol 7 which was analysed by single X-ray 
crystallography (Scheme 2).  
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Scheme 2: Reduction of Asbestinin 1 (3) with Lithium Aluminium Hydride 
The isolation and characterisation of new asbestinin members stemmed from this initial 
report with Clardy and co-workers reporting the isolation of two new asbestinin diterpenes 
in 1981.[7] This was followed by reports of the isolation and characterisation of multiple 
members of the family by Rodriguez and co-workers in 1991, 1993 and 1994.[8-10]  
Difficulties in determining structures and stereochemical assignments of members of the 
asbestinin family by NMR analysis alone is evident through the isolation publications. For 
example, Rodriguez and co-workers initially proposed the structure of asbestinin 6 (9) in 
1993 but following further analysis of their data as well as new data collected from the 
structurally related natural product asbestinin 11 (11), the structure was revised to be 10 in 
1994 (Figure 3).[9,10] 
 
Figure 3: Revised Structure of Asbestinin 6 (10) 
The structural revision of asbestinin 6 (9) related to positioning of the caprylic and acetyl 
functionality at the C-4 and C-11 positions. Several members of the asbestinin family have 
had their original structures, proposed in the early 1990s, revised as a consequence of the 
use of new NMR techniques and the acquisition of better-quality NMR data.[10,11]  
This can be further seen throughout the 4-deoxyasbestinin series, many members of which 
were originally assumed to have C-4 oxidation but were later found to have C-6 oxidation 
instead. An example of this can be seen in the structurally related asbestinins 10 (12), 20 (13) 
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and 11-acetoxy-4-deoxyasbestinin F (14), which were proposed to have the structures shown 
in Figure 4. 
 
Figure 4: Proposed Structures of Asbestinin 10 (12), 20 (13) and 11-Acetoxy-4-deoxyasbestinin F (14) 
These compounds were first isolated by Rodriguez and co-workers in 1993 and 1994 but 
following re-isolation by the same group in 2006, it became evident that the proposed 
structures were incorrect. Further analysis through chemical interconversions and more 
in-depth NMR analysis led to their revised structures. The key revision was repositioning of 
the ketone in asbestinin 10 (15), previously located at C-4, to the C-6 position. Reduction of 
asbestinin 10 (15) to give asbestinin 20 (14) and 6-epi-asbestinin 20 (16), allowed the 
structure of asbestinin 20 (14) to be revised as well (Scheme 3).[11] 
 
Scheme 3: Revised Structures of Asbestinin 10 (15), 20 (14) and 11-Acetoxy-4-deoxyasbestinin F (17) 
New mass spectrometry data and reassignment of the structure of asbestinin 20 to that first 
reported for 11-acetoxy-4-deoxyasbestinin F allowed Rodriguez and co-workers to propose 
peroxide 17 as the new structure for 11-acetoxy-4-deoxyasbestinin F. To provide additional 
 Introduction 
 
 
5 
 
evidence for this, peroxide 17 was treated with sodium borohydride to reduce the peroxide 
and give asbestinin 20 (14).  
1.2.1 Biological Activity of the Asbestinins 
In 1998, Bernardelli and Paquette described the biological properties of known 2,11-cyclised 
cembranoids, with many being shown to be biologically active by virtue of their cytotoxic, 
anti-inflammatory and anti-malarial properties. [2] An example of this can be seen in the 
4-deoxyasbestinin series, members which were shown to have possess cytotoxicity against 
CHO-K1 cells (Table 1).  
 
Table 1: Cytotoxicity of 4-Deoxyasbestinins Against CHO-K1 Cells 
4-Deoxyasbestinin ED50 (µg/mL) 
11-Acetoxy-4-deoxyasbestinin D 4.82 
4-Deoxyasbestinin C 3.55 
11-Acetoxy-4-deoxyasbestinin B 2.50 
4-Deoxyasbestinin A 3.55 
All four compounds were found to have possess cytotoxicity. The geometry of the double 
bond did not influence cytotoxic activity as can be seen by comparison of data for 
4-deoxyasbestinin A and C. The influence of the ester substituent (acetate or butanoate) is 
also negligible with minor differences in activity. The biological activities of many of the 
asbestinins have not been fully determined but it appears that there is a significant difference 
between the 4-deoxyasbestinins and oxygenated series with the additional oxygenation at 
the C-4 position seeming to reduce their antimicrobial potency.[2] 
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1.2.2 Total Synthesis of 11-Acetoxy-4-deoxyasbestinin D (18) 
It was not until 2005 that the absolute configuration of the asbestinins were confirmed when 
Crimmins and Ellis reported the first total synthesis of 11-acetoxy-4-deoxyasbestinin D (18). 
This synthesis was followed by the synthesis of asbestinin 12 (22) by the same workers in 
2008 (Figure 5). These are the only reported total syntheses for members of the asbestinin 
family to date.[12,13] 
 
Figure 5: Structures of 11-Acetoxy-4-deoxyasbestinin D (18) and Asbestinin 12 (22) 
Crimmins utilised a synthetic strategy for the asbestinins which he had applied to the 
synthesis of numerous members of the cladiellin family previously, for example in ophirin B 
(23) and astrogorgin (24, Figure 6).[14,15] 
 
Figure 6: Examples of the Cladiellin Family Synthesised by the Crimmins Group 
Key disconnections included glycolate alkylation, ring-closing metathesis (RCM) to form 
the nine-membered ring, intramolecular Diels–Alder cycloaddition to form the tricyclic ring 
system and asymmetric hydroboration-etherification to synthesise the tetracyclic core as the 
forward reactions (Figure 7).[12,13] 
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Figure 7: Key Disconnections in the Synthesis of 11-Acetoxy-4-deoxyasbestinin D (18) 
The initial steps in the synthesis of 11-acetoxy-4-deoxyasbestinin D (18) and asbestinin 12 
(22) involved the conversion of R-benzyl glycidyl ether 25 into diene 26 (Scheme 4). This 
sequence was followed by reduction and silyl protection to give diene 27 in order to set up 
the RCM reaction.  
 
Scheme 4: Synthesis of Common Tricyclic Intermediate 33 
With diene 27 in hand, RCM was performed using Grubbs II catalyst to provide the 
corresponding nine-membered cyclic alkene 28 in excellent yield (99%).[16] Cleavage of the 
benzyl ether followed by oxidation and successive Wittig olefinations to install the desired 
diene and subsequent cleavage of primary silyl ether gave diene 29 in five steps.[17]  
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Oxidation of the primary alcohol under Swern conditions gave intermediate aldehyde 30 
which was immediately used in a Wittig olefination reaction to give the corresponding enone 
which underwent immediate intramolecular Diels–Alder cycloaddition to produce tricyclic 
ketone 32 in excellent yield (74% over two steps).[18,19] The final three steps required to 
complete the synthesis of common intermediate 33 involved Wittig olefination of the ketone 
followed by cleavage of the silyl ether and oxidation of the secondary alcohol to give the 
desired  ketone. From here, the syntheses of 11-acetoxy-4-deoxyasbestinin D (18) and 
asbestinin 12 (22) diverge. 
For 11-acetoxy-4-deoxyasbestinin D (18), ketone 33 underwent Grignard addition using 
methyl magnesium chloride followed by hydrolysis of the enol ether to give corresponding 
ketones 34 and 35 (dr 10:1, 34:35, Scheme 5).  
 
Scheme 5: Completion of 11-Acetoxy-4-deoxyasbestinin D (18) 
Enol ether hydrolysis favoured formation of the diastereoisomer with incorrect configuration 
at the C-12 position so ketone 34 had to undergo epimerisation with sodium methoxide 
giving ketones 34 and 35 in a 1:1.2 ratio. This had to be repeated multiple times to produce 
high quantities of ketone 35. The ketone 35 produced by epimerisation was reduced with 
L-Selectride and subsequent acetylation of the secondary alcohol delivered alcohol 36 as a 
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single diastereoisomer. Silyl protection of the tertiary alcohol gave silyl ether 37, the 
precursor to the key asymmetric hydroboration step. Hydroboration of the exo-alkene using 
(+)-diisopinocampheylborane followed by oxidation resulted in highly stereoselective 
creation of the new stereocentre and the resulting single diastereoisomer was subjected to 
deprotection to afford the diol 38.[20,21] The final step in the synthetic route was conversion 
of the diol 38 into the primary triflate, which then underwent ring closure through 
nucleophilic displacement by the tertiary alcohol to give 11-acetoxy-4-deoxyasbestinin D 
(18) in 26 steps and an overall yield of 4%. 
For asbestinin 12 (22), ketone 33 was subjected to the Davis enolate oxidation protocol with 
with oxaziridine 39 to give α-hydroxyketone 340. Grignard addition followed by hydrolysis 
of the enol ether gave ketones 41 and 42 (dr 11:1, 41:42, Scheme 6).[22]  
 
Scheme 6: Completion of Asbestinin 12 (22) 
As before, iterative epimerisations of ketone 41 were required in order to obtain sufficient 
quantities of the intermediate. From this intermediate, the route to asbestinin 12 (22) was 
similar to that for 11-acetoxy-4-deoxyasbestinin D (18). Reduction of ketone 42 followed 
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by treatment with acetic anhydride gave diacetate 43. This intermediate then underwent 
asymmetric hydroboration-oxidation to give diol 44. The diol was treated with triflic 
anhydride to give the primary triflate, which underwent immediate displacement by the 
tertiary alcohol to give asbestinin 12 (22) in 25 steps and an overall yield of 4%. 
1.3 Previous Synthetic Approaches to 2,11-Cyclised Cembranoids 
Since the initial isolation of members of the 2,11-cyclised cembranoids, various approaches 
have been investigated to the form the tricyclic core which is present in the cladiellins, 
briarellins and asbestinins. Strategies utilised for the synthesis of members of these natural 
product families will be discussed in the following section. 
1.3.1 Overman Group Strategy: Prins-pinacol and Nozaki–Hiyama–Kishi 
Cyclisation 
In 1995, Overman and co-workers published the first total synthesis of a 2,11-cyclised 
cembranoid: (−)-7-deacetoxyalcyonin acetate (45, Figure 8).[23] The synthetic strategy was 
based on a stereoselective Prins-pinacol condensation-rearrangement reaction as the key 
transformation to form the bicyclic intermediate.[24,25] The nine-membered ring was later 
installed by a chromium-mediated Nozaki–Hiyama–Kishi cyclisation.[26,27] Following this, 
the Overman group used this key Prins-pinacol rearrangement to synthesise other 
2,11-cyclised cembranoids including briarellin E (46, Figure 3).[28] 
 
Figure 8: Key Disconnections Involved in the Synthesis of (−)-7-Deacetoxyalcyonin Acetate (45) and 
Briarellin E (46) 
The Overman group chose S-hydrocarvone (47) as their starting point for the synthesis of 
(−)-7-deacetoxyalcyonin acetate (45) and this compound was transformed into the 
Prins-pincaol precursor 48 in four steps (Scheme 7). 
 
 Introduction 
 
 
11 
 
 
Scheme 7: Key Reactions Utilised to Form (−)-7-Deacetoxyalcyonin Acetate (45) 
The diol 48 was reacted with enal 49 in the presence of a Lewis acid to form bicyclic 
oxocarbenium intermediate 50 which underwent rearrangement to give bicyclic ether 51 as 
a single diastereoisomer in 79% yield. The Nozaki–Hiyama–Kishi precursor 52 was 
prepared from bicyclic ether 51 in a further 11 steps. This precursor was then used in the 
intramolecular coupling reaction to form tricyclic product 53 with high diastereoselectivity 
(65%, dr >20:1). Finally, acylation followed by cleavage of the silyl ether gave 
(−)-7-deacetoxyalcyonin acetate (45) in 17 linear steps. 
The Overman group used tricyclic alcohol 53 as an advanced intermediate in the synthesis 
of the proposed structure of sclerophytin A (55), a member of the cladiellin family 
(Scheme 8).[29] From the tricyclic alcohol 53, cleavage of the silyl ether and subsequent 
intramolecular oxymercuration using Hg(OAc)2 allowed formation of tetracyclic ether 54. 
 
Scheme 8: Synthesis of Proposed Structure of Sclerophytin A (55) 
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The final step in the synthesis of the proposed structure of sclerophytin A involved 
photoisomerisation of the endocyclic alkene to produce the exo-alkene 55. The spectroscopic 
data and optical rotation from the obtained product did not match the data reported for the 
isolated natural product. 
Based on these results, it was proposed that sclerophytin A could be the epimer of alcohol 55 
so the stereochemistry at the hydroxyl-bearing stereocentre was inverted through an 
oxidation-reduction sequence to give alcohol 56 (Scheme 9). The spectroscopic data for the 
newly-formed compound did not match the data reported for the natural product and so the 
structure had to be revised. Based from these results and further analysis, it was determined 
the structure of sclerophytin A should be revised to triol 59. 
 
Scheme 9: Synthesis of Sclerophytin A (59) 
The revised structure of sclerophytin A (59) was synthesised from intermediate 53 by 
sequential epoxidation of the exocyclic alkene with VO(acac)2 and tert-butylhydroperoxide, 
epoxide opening and deprotection to give triol 58.  The final step was photoisomerisation of 
the endocyclic alkene as before to produce desired product 59. The NMR data and optical 
rotation of the product matched that reported for the isolated natural product, which 
confirmed the structure of sclerophytin A. 
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1.3.2 Paquette Group Strategy: Diels–Alder Cycloaddition and Claisen 
Rearrangement 
The Paquette group was also working on the total synthesis of sclerophytin A at the same 
time as the Overman group. Paquette and co-workers came to the same conclusion as the 
Overman group that the isolated natural product was not compound 55 (Scheme 8).[30,31] 
For their synthetic strategy to prepare the newly proposed structure 59, Paquette and 
co-workers identified disconnections that implied Diels–Alder cycloaddition, Claisen 
rearrangement and conjugate addition reactions as the key transformations in the forward 
direction (Figure 9).[32,33] 
 
Figure 9: Key Disconnections for the Synthesis of Sclerophytin A (59) 
The initial step in their synthesis was an intermolecular Diels–Alder reaction between diene 
61 and dienophile 60 followed by reduction and elimination to form bicyclic lactone 62 
(Scheme 10). Bicyclic lactone 62 was converted into nitrile 63 in nine steps and a subsequent 
three-step procedure gave tricycle 64. This sequence involved formation of the methyl ester 
using sodium methoxide, ester hydrolysis with lithium hydroxide to give the acid and 
lactonisation under Yamaguchi conditions to give tricycle 64 in excellent yield over the three 
steps. The final step required to produce the Claisen rearrangement precursor was 
methenylation of the ketone to give triene 65. 
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Scheme 10: Construction of Tricyclic Ketone 65 
The enol ether 65 was heated in toluene at reflux in the presence of sodium tetrafluoroborate 
to promote Claisen rearrangement to give oxonene 66. Oxonene 66 was converted into enone 
67 over four steps (Scheme 11). From here, enone 67 underwent an aldol condensation 
reaction with formaldehyde mediated by ytterbium triflate and the resulting alcohol was 
protected as a silyl ether to give enone 68.[34]  
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Scheme 11: Completion of Sclerophytin A (59) 
Conjugate addition to enone 68 gave ketone 69 as the sole diastereoisomer and completed 
the three-step procedure in a yield of 25%. The synthesis of sclerophytin A (59) was 
completed in a further four steps resulting in a 35-step total synthesis which helped confirm 
the correct structure of the natural product. 
1.3.3 Molander Group Strategy: Formal [4+3]-Annulation and 
[2+2]-Cycloaddition 
Molander and co-workers developed a very efficient formal [4,3]-annulation method to form 
the tricylic core during their synthesis of (−)-7-deacetoxyalcyonin acetate (45).[20] Other key 
steps included a [2+2]-cycloaddition reaction followed by photochemical rearrangement, a 
conjugate addition reaction and a Nozaki–Hiyama–Kishi coupling (Figure 10).[35,36] 
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Figure 10: Molander Group Strategy for Synthesis of (−)-7-Deacetoxyalcyonin Acetate (45) 
The synthesis commenced with the [2+2]-cycloaddition reaction of α-phellandrene 70 with 
methoxyketene to give cyclobutanone 71 which underwent sequential photochemical 
rearrangement and acetylation to give acetate 72 (Scheme 12). The next step was the formal 
[4+3]-annulation reaction with diene 73 in the presence of titanium tetrachloride. This 
afforded tricyclic β-keto acid 74 in a 43-80% yield. The major benefit to this approach was 
that the majority of the stereocentres in the final compound had been introduced by the third 
step.  
 
Scheme 12: Tricyclic Formation through Formal [4,3]-Annulation 
Next, β-keto acid 74 was converted into the enone 75 in five steps before conjugate addition 
of an organocopper reagent generated from Z-bromo ethyl vinyl ether (76, Scheme 13). This 
reaction was followed by direct formation of an enol triflate using Comins reagent (77) and 
subsequent hydrolysis of the side-chain enol ether to afford corresponding aldehyde 78.[36] 
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Scheme 13: Completion of 7-Deacetoxyalcyonin Acetate (45) 
An intramolecular Nozaki–Hiyama–Kishi coupling reaction produced the tetracyclic ring 
structure and subsequent acetylation gave acetate 79. The synthesis of 
(−)-7-deacetoxyalcyonin acetate (45) was completed in a further 6 steps that involved 
epoxidation followed by ozonolysis to give dione 80. The synthesis was completed in a total 
of 18 overall steps. 
1.3.4 Kim Group Strategy: Intramolecular Amide Enolate Alkylation and   
Diels–Alder Cycloaddition 
In 2006, Kim and co-workers reported the first total synthesis of an E-cladiellin –  
(−)-cladiella-6,11,dien-3-ol (81) – as well as four other members of the cladiellin family of 
natural products.[37] Their strategy involved the use (−)-cladiella-6,11,dien-3-ol as an 
intermediate to prepare the other members. Key steps in their synthesis involved an 
intramolecular amide enolate alkylation reaction and an intramolecular Diels–Alder 
cycloaddition reaction similar to that described by Crimmins and co-workers in their 
cladiellin synthesis (Figure 11).[12,13] 
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Figure 11: Key Disconnections in the Synthesis of (−)-Cladiella-6,11,dien-3-ol (81) 
The first step in the synthesis was the asymmetric glycolate aldol reaction between 
oxazolidinone 82 and 5-methylhex-4-enal 83 (Scheme 14).[38,39] This gave the secondary 
alcohol 84 in 75% yield and with excellent diastereoselectivity (dr 98:2).  
 
Scheme 14: Synthesis of Tricyclic Core of (−)-Cladiella-6,11,dien-3-ol (81) 
Reduction of the chiral auxiliary followed by protecting group manipulation gave protected 
triol 85 in three steps. A further four steps were required to convert this intermediate into the 
cyclisation precursor 86. The E-allylic chloride 86 then underwent the key intramolecular 
alkylation reaction upon treatment with LiHMDS to give cis-E-oxonene 87 in excellent 
yield. cis-E-Oxonene 87 was obtained as a single diastereoisomer and this amide was 
converted into the intramolecular Diels–Alder cycloaddition precursor 88 in four steps. 
Triene 88 was treated with butylated hydroxytoluene (BHT) to give the fused tricyclic ester 
89 in excellent yield and with high selectivity. BHT was a necessary additive for the      
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Diels–Alder cycloaddition to proceed as required and complete decomposition of the 
precursor was observed when the reaction was performed in its absence.  
The synthesis of tricycle 89 was followed by double methylation of the exo-methyl ester 
followed by acetylation of tertiary alcohol and chemoselective deoxygenation with 
concomitant cleavage of trityl ether, which produced alcohol 90 in three steps 
(Scheme 15).[40] Finally, the synthesis of (−)-cladiella-6,11,dien-3-ol (81) was completed 
through an oxidation-Grignard addition sequence to introduce the methyl group and the last 
stereocentre. This was accomplished through oxidation of the secondary alcohol with DMP 
followed by addition of MeLi in the presence of sodium tetrafluoroborate.[41]  
 
Scheme 15: Completion of (−)-Cladiella-6,11,dien-3-ol (81) 
(−)-Cladiella-6,11,dien-3-ol (81) was used as a late-stage intermediate for the synthesis of a 
further four cladiellin natural products (Scheme 16). 
  
Scheme 16: Synthesis of Four Cladiellin Members from (−)-Cladiella-6,11,dien-3-ol (81) 
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(−)-Cladiella-6,11,dien-3-ol (81) was converted into deactylpolyanthellin A (91) through an 
oxymercuration-demercuration process and acetylation of the tertiary alcohol produced 
polyanthellin A (92) thereafter. Treatment of (−)-cladiella-6,11,dien-3-ol (81) under Upjohn 
dihydroxylation conditions afforded (−)-cladiell-11-ene-3,6,7-triol (93) in excellent yield.[42] 
(−)-Cladiella-6,11,dien-3-ol (81) was also converted into diol 94 by use of a three-step route. 
Exposure of diol 94 to Burgess reagent (95) resulted in formation of the exocyclic alkene by 
regioselective elimination of the tertiary alcohol,[43] and subsequent deprotection gave 
(−)-7-deacetoxyalcyonin acetate (45) in 92% yield over two steps. 
1.3.5 Hoppe Group Strategy: Asymmetric Homo-aldol and Ring-closing 
Metathesis 
In 2008, Hoppe and co-workers reported an enantioselective synthesis of (+)-vigulariol (96), 
which was completed in just 10 linear steps (Figure 12).[44] Paquette and co-workers had 
synthesised (+)-vigulariol in 2001 during their synthesis of sclerophytin A (59), but at that 
time this compound had not been isolated as a natural product and the compound was not 
fully characterised (Section 1.3.2).[31] The key steps used by Hoppe and co-workers in their 
synthesis of (+)-vigulariol were an asymmetric homo-aldol reaction, an application of 
Krämer’s THF synthesis to build up the bicycle and a RCM reaction to close the 
nine-membered ring.[45] 
 
Figure 12: Key Disconnections in the Synthesis of (+)-Vigulariol (96) 
The synthesis started with (−)-cryptone 97, obtained from commercially available 
eucalyptus oil through flash column chromatography, which was reduced to give an allylic 
alcohol that was then converted into the carbamate 98 (Scheme 17). 
 Introduction 
 
 
21 
 
 
Scheme 17: Total Synthesis of (+)-Vigulariol (96) 
Stereoselective deprotonation of carbamate 98 with s-butyl lithium in the presence of 
N,N,Nʹ,Nʹ-tetramethyl-1,2-diaminocyclohexane gave lithiated intermediate 99. Addition of 
chlorotriisopropoxytitanium and reaction of the enolate with aldehyde 100 delivered a 
diastereomeric mixture of alcohols 101 (dr 83:13). Lewis acid-promoted condensation of 
alcohols 101 with acetal 102 gave bicyclic ether 103 in a yield of 71%. Subsequent RCM of 
diene 103 to close the nine-membered ring gave tricyclic ketone 104 in 45% yield. From 
ketone 104, the synthesis of (+)-vigulariol (96) was completed in just three further steps. 
1.3.6 Johnson Group Strategy: [3+2]-Cycloaddition and Ring-closing 
Metathesis 
In 2009, Johnson and co-workers completed the second asymmetric synthesis of 
polyanthellin A (92) after that of Kim and co-workers in 2006.[46] The key reactions in the 
strategy employed by Johnson and co-workers included a [3+2]-cycloaddition reaction and 
RCM (Figure 13).  
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Figure 13: Key Disconnections in the Synthesis of Polyanthellin A (92) 
The Johnson synthesis started with a Sharpless epoxidation of allylic alcohol 105 to create 
what was to become the C-7 stereocentre with the required configuration followed by cuprate 
addition to open the epoxide and produce diol 106 (Scheme 18).[47] A further three steps 
were required to form aldehyde 107. 
 
Scheme 18: Synthesis of Enantioenriched Aldehyde 107 
Aldehyde 107 was one component to be used in their [3+2]-cycloaddition reaction. The 
synthesis of the second component – bicyclo[4.1.0]heptanone 114 – started with an 
enantioselective organocatalytic conjugate addition reaction of isovaleraldehyde 108 to 
methyl vinyl ketone to give keto aldehyde 111 (Scheme 19). Johnson and co-workers found 
the addition of catechol 110 increased both the reaction rate and the yield.  
 
Scheme 19: Construction of Cyclopropane 114 
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From here, keto aldehyde 111 underwent selective Wittig olefination of the aldehyde to give 
the Z-diene and subsequent carboalkoxylation using Mander’s reagent giving 
β-ketoester 112.[48] Cyclopropanation of dicarbonyl 112 was performed by diazotisation of 
the β-ketoester followed copper-catalysed intramolecular cyclopropanation using 
complex 113 to give bicyclo[4.1.0]heptanone 114 in 71% yield over two steps. 
The [3+2]-cycloaddition of aldehyde 107 and bicyclo[4.1.0]heptanone 114 was 
accomplished using the sterically hindered catalyst MADNTf2, which helped drive the 
formation of bicyclic ether 116 (Scheme 20).  
 
Scheme 20: Completion of Polyanthellin A (92) 
RCM of diene 116 followed by decarboxylation under Krapcho conditions delivered 
tricyclic ketone 117.[49] Hydroboration of the tricyclic alkene 117 and TPAP oxidation of the 
intermediate organoborane led to formation of a diketone which then underwent double 
Wittig methylenation to produce diene 118. From here, the synthesis of polyanthellin A (92) 
was completed in a further four steps; the synthesis was accomplished in a total of 15 linear 
steps. 
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1.3.7 Morken Group Strategy: Oshima–Utimoto Reaction, Radical Cyclisation 
and Ring-closing Metathesis 
The total synthesis of (−)-sclerophytin A (59) has been accomplished several times, but 
Morken and co-workers reported the shortest total synthesis to date in 2010 (13 steps).[50] 
The key features of their synthesis were the use of an Oshima–Utimoto reaction to construct 
the reduced furan, a radical cyclisation reaction to form the hydroisobenzofuran and RCM 
to close the nine-membered ring forming the oxonene (Figure 14).  
 
Figure 14: Key Disconnections in the Synthesis of (−)-Sclerophytin A (59) 
The synthesis started with Brown methallyation of geranial 120 to give allylic alcohol 122 
which was subjected to Oshima–Utimoto reaction to deliver THF 124 (Scheme 21).[51,52] 
This was followed by subsequent Jones oxidation then α-iodination of the lactone to give 
iodide 125.  
 
Scheme 21: Synthesis of Bicycle 126 through Radical Cyclisation 
Radical cyclisation under reductive conditions using indium trichloride and sodium 
borohydride followed by diisobutylaluminium hydride reduction of lactone delivered lactol 
126 with excellent selectivity (>10:1). Lactol 126 was then converted into triene 127 in a 
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further 3 steps (Scheme 22). Oxonene 128 was synthesised from triene 127 by RCM in a 
55% yield. 
 
Scheme 22: Completion of (−)-Sclerophytin A (59) 
Regioselective epoxidation (dr 1.8:1) delivered epoxide 129 which then was treated with 
lithium hydroxide followed by scandium triflate and potassium bisulfate to give the 
lactol 130. This reaction occurs through initial hydroxide addition to the ketone followed by 
attack of the resulting alcohol to spontaneously cyclise, mediated by scandium triflate with 
potassium bisulfate acting as a mild base which was described by Clark in 2007.[53] Finally, 
subjection of lactol 130 to a Grignard addition reaction with methyl magnesium chloride 
gave (−)-sclerophytin A (59). 
1.3.8 Yang Group Strategy: Gold-catalysed Cascade and Ring-closing 
Metathesis 
In 2014, Yang and co-workers reported the synthesis of nine members of cladiellin family 
of natural products stemming from a common intermediate.[54] Their strategy relied upon the 
gold-catalysed tandem reaction of a 1,7-diyne to construct the reduced benzofuran core 
before RCM to form the oxonene (Figure 15).  
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Figure 15: Key Disconnections in the Synthesis of Common Intermediate 128 
Their synthesis started from commercially available hex-5-ynoic acid 131 which was 
coupled with amine 132 using EDCI to give amide 133 (Scheme 23). Diastereoselective 
α-alkylation using lithium diisopropylamine followed by addition of isopropyl iodide gave 
amide 134.  
 
Scheme 23: Synthesis of Bicyclic Core 136 of the Common Intermediate 
Amide 134 was then converted into 1,7-diyne 135, the precursor to the key gold-catalysed 
cascade reaction, in a further six steps. 1,7-Diyne 135 underwent rearrangement in the 
presence of a gold-catalyst and p-nitrobenzyl alcohol to produce the reduced 
benzofuran 136. This product was obtained as a mixture of diastereoisomers (dr 3:1) and 
these isomers were used the next reaction before the resulting isomeric compounds were 
separated. 
The bicyclic intermediate 136 was reacted with TMSOTf and excess 
(methylallyl)trimethylsilane 137 to give diastereoisomeric dienes 138 and 139 (Scheme 24). 
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Ester 138 was then converted to the triene 127 by formation of the Weinreb amide followed 
by the Grignard addition of 3-butenylmagnesium chloride. 
 
Scheme 24: Synthesis of Common Tricyclic Intermediate 124 
The final step necessary to prepare the advanced tricyclic intermediate 128 was RCM to 
form the oxonene. Initially, Yang and co-workers utilised the conditions that had been 
described by Morken and co-workers, but they found use of the Zhan 1B catalyst 140 
resulted in a significant increase in the yield of the RCM reaction.[50,55] 
Nine members of the cladiellin family were synthesised from the ketone 128 following 
protocols similar to those previously discussed (Scheme 25). Ketone 128 was converted into 
(+)-cladiella-6(Z)-11(17)-dien-3-ol (141) by reaction with methyl magnesium chloride. This 
alcohol was then oxidised with m-CPBA to deliver (+)-vigulariol (96). 
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Scheme 25: Synthesis of Four Members of the Cladiellin Family from Common Intermediate 128 
The ketone 128 was also converted into (−)-sclerophytin A (59) in three steps before 
acetylation gave (−)-sclerophytin B (142). Five further members of the cladiellin family were 
synthesised from this late-stage intermediate but this work will not be described in detail 
(Figure 16). 
 
Figure 16: Five Further Members of the Cladiellin Family Synthesised by Yang and Co-workers 
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1.3.9 Inoue Group Strategy: Radical Polar Crossover Coupling Reaction and 
Ring-closing Metathesis 
Recently, Inoue and co-workers have published work that is directed towards the synthesis 
of cladieunicellin D (146) in which the tricyclic core is built up in concise fashion 
(Figure 17).[56] A key difference in this synthesis is the requirement to install the additional 
hydroxyl group that is present at the C-4 position. 
 
Figure 17: Structure of Cladieunicellin D (146) 
The synthesis of this tricyclic core relied on the use of a three-component radical coupling 
reaction and a subsequent rearrangement reaction to give the reduced benzofuran core 
(Figure 18).[57,58] The oxonene could then be completed using RCM.[56] 
 
Figure 18: Key Disconnections in Synthesis of Tricyclic Core 147 of Cladieunicellin D (146) 
For the three-component radical coupling reaction, α-alkoxyacyl telluride 149 was used as 
the radical precursor. This intermediate was synthesised in six steps from commercially 
available diprogulic acid 148 (Scheme 26). 
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Scheme 26: Radical Polar Crossover Coupling Reaction Sequence 
Treatment of α-alkoxyacyl telluride 149 with triethylborane under air produced the radical 
150 which then reacted with radical acceptor (−)-cryptone 97 to give a boron enolate. The 
enolate was trapped by Z-4-hexenal 151 in an aldol reaction that proceeded through 
transition state 152 to give product 153 after aqueous work-up. This β-hydroxyketone was 
then reacted with sodium triacetoxyborohydride to give diol 154 in a 37% yield over two 
steps. 
From here, the diol 154 was converted into the bicyclic intermediate 157 by sequential 
addition of isopropyl magnesium chloride and sec-butyl lithium which resulted in reductive 
cleavage of the bromo ether (Scheme 27).  
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Scheme 27: Synthesis of Tricyclic Core 147 of Cladieunicellin D (146) 
Initially, both hydroxyl groups are deprotonated with isopropyl magnesium chloride then 
lithium-halogen exchange occurs to give lithiated intermediate 155. This intermediate then 
undergoes ring opening with fragmentation to eliminate acetone giving ketone 156 before 
nucleophilic addition from the C-9 alkoxide to the ketone produces the hemi-acetal 157. The 
remaining steps required to form tricyclic core 147 involved reductive etherification to 
convert hemi-acetal 157 into diene 158 followed by an oxidation and epimerisation sequence 
to set the stereocentre at C-10. Finally, RCM in the presence of p-benzoquinone gave 
oxonene 147. This completed the synthesis of the tricyclic core of cladieunicellin D.
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2. Clark Group Strategy and Previous Work 
 
The Clark group have been interested in the synthesis of members of the 2,11-cyclised 
cembranoids for many years, with initial reported studies towards the cladiellins in 2000 and 
2006.[59,60] In 2007, Clark and co-workers reported the total synthesis of (±)-vigulariol (96) 
utilising a novel oxonium ylide formation, [2,3]-sigmatropic rearrangement reaction to 
construct an oxabicyclic intermediate and a subsequent intermolecular Diels–Alder 
cycloaddition reaction to yield the tricyclic core (Figure 19).[53] 
 
Figure 19: Clark Group Strategy Towards (±)-Vigulariol (96) 
Their synthesis started with addition of the Grignard reagent prepared from bromide 159 to 
methacrolein to give allylic alcohol (±)-160 (Scheme 28). Bromide 159 was easily prepared 
from propan-1,3-diol.[61]  
 
Scheme 28: Construction of Diazo-ketone (±)-165 
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Allylic alcohol (±)-160 was then converted to α,β-unsaturated ester (±)-161 through a 
hetero-Michael addition with ethyl propiolate. Deprotection of the hydroxyl group followed 
by a Swern oxidation resulted in formation of aldehyde (±)-162. Reductive cyclisation 
mediated by samarium diiodide gave tetrahydropyranol (±)-163 which was converted to 
carboxylic acid (±)-164 through silyl ether formation and saponification of the ester with 
lithium hydroxide.[62,63] Finally, diazo-ketone (±)-165 was synthesised by reaction of the 
carboxylic acid (±)-164 with isobutyl chloroformate and treatment of the resulting mixed 
anhydride with diazomethane to produce diazo-ketone (±)-165.  
Treatment of the diazo-ketone (±)-165 with copper hexafluoroacetylacetone produced an 
electrophilic copper carbenoid that underwent tandem oxonium ylide formation and 
[2,3]-sigmatropic rearrangement through intermediate (±)-166 to give a mixture of bicyclic 
ethers (±)-167 and (±)-168 (Z:E, 5:1) which could be separated by column chromatography 
(Scheme 29).  
 
Scheme 29: Synthesis of Bicycles (±)-163 and (±)-164 from Diazo-ketone (±)-165 
The Z-bicyclic ketone (±)-167 was subjected to the Stille/Diels–Alder cycloaddition 
sequence to build up the tricyclic core. This started with conversion of Z-bicyclic ketone 
(±)-167 into the enol triflate (±)-169 followed by Stille cross-coupling with readily available 
tributyl(1-ethoxyvinyl)tin 170 to give triene (±)-171 (Scheme 30).  
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Scheme 30: Tricyclic Core Formation through Intermolecular Diels–Alder Cycloaddition 
This triene then underwent intermolecular Diels–Alder cycloaddition with methyl vinyl 
ketone to deliver a 1:1 mixture of exo:endo adducts (±)-172 and subsequent epimerisation 
with potassium carbonate and methanol resulted in formation of the diastereoisomer (±)-173 
exclusively. Wittig methenylation of tricyclic ketone (±)-173 followed by acid hydrolysis of 
the enol ether gave ketone (±)-174 with the required configuration at C-10 (Scheme 31).  
 
Scheme 31: Completion of (±)-Vigulariol (96) 
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Hydrogenation of exo-alkene and a second Wittig methenylation reaction produced the diene 
(±)-175 which was converted to ketone (±)-176 by deprotection followed by oxidation of the 
resulting alcohol. The ketone (±)-176 then underwent Grignard addition with methyl 
magnesium chloride giving alcohol (±)-177 setting the stereocentre of the tertiary alcohol 
with the required configuration. The final step of the synthesis was selective epoxidation of 
the tri-substituted alkene with concomitant nucleophilic epoxide opening to give 
(±)-vigulariol (96).  
This route to racemic vigulariol was used as a basis for the enantioselective synthesis of 
multiple members of the cladiellin family.[64,65] In this case, the synthesis commenced with 
commercially available butan-1,4-diol 178 which was converted to aldehyde 179 by 
mono-silyl protection and Swern oxidation (Scheme 32).  
 
Scheme 32: Enantioenriched Synthesis of Allylic Alcohol 160 
Aldehyde 179 underwent Wittig olefination with stabilised ylide 180 to give α,β-unsaturated 
ester 181 in excellent yield and with high selectivity. The ester was reduced with 
diisobutylaluminium hydride to give allylic alcohol 182 before a Sharpless epoxidation 
reaction gave epoxide 183. Mesylate formation on the primary alcohol followed by 
displacement by sodium iodide and zinc-mediated epoxide opening gave enantioenriched 
allylic alcohol 160 in excellent yield over two steps and with a high enantiomeric excess 
(93% ee). 
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Enantioenriched allylic alcohol 160 was then into Z-bicyclic ketone 167 using the same route 
previously employed in the synthesis of (±)-vigulariol. From here, the enantioselective 
syntheses of (+)-cladiella-6(Z),11(17)-dien-3-ol (141) and (+)-vigulariol (96) were 
completed following a similar route to that previously discussed (Scheme 33).[64] 
 
Scheme 33: Members of Cladiellin Family Synthesised from Z-Bicyclic Ketone 167 
The Clark group then used E-bicyclic ketone 168 as a key intermediate for the synthesis of 
further members of the cladiellin family.[64,66] This approach required conversion of 
diazo-ketone 165 selectively into E-bicyclic ketone 168 instead of the previously favoured 
Z-bicyclic ketone 167 (Scheme 34). This involved switching from a copper catalyst (5:1, 
Z:E) to a rhodium catalyst (1:6.3, Z:E). 
 
Scheme 34: Conversion of Diazo-ketone 165 Under Rhodium Catalysis 
 The E-bicyclic ketone 168 was converted into the tricyclic core of the cladiellins by a the 
Stille/Diels–Alder cycloaddition sequence that was analogous to the one used before 
(Scheme 35). 
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Scheme 35: Stille/Diels–Alder Cycloaddition Sequence of E-Bicyclic Ketone 168 
An important difference between routes of the Z- and E-tricyclic cores was the reactivity of 
the tri-substituted alkene in each case. Previously, selective hydrogenation of an exo-alkene 
was used to install the isopropyl group but this approach was not possible with the E-alkene 
(Scheme 36).[66] 
 
Scheme 36: Attempted Hydrogenation of E-Tricyclic Ketone 189 
To overcome this problem, the tricyclic ketone 187 was converted into alcohol 191 by a 
Grignard addition reaction with methyl magnesium chloride (Scheme 37). Acetylation of 
alcohol 191 followed by reductive removal of the acetate gave tricyclic alcohol 192. 
Prevention of silyl deprotection of the secondary alcohol was not possible so reprotection of 
secondary alcohol using TBSOTf was necessary after hydrolysis of the enol ether. 
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Scheme 37: Elaboration of Tricyclic Ketone 187 to Overcome Hydrogenation Incompatibility 
The resulting ketone 190 was converted into diene 193 through vinyl triflate formation and 
a palladium-catalysed Kumada-type coupling with methyl magnesium chloride 
(Scheme 38).  
 
Scheme 38: Synthesis of (−)-Cladiella-6,11-dien-3-ol (81) 
Diene 193 then underwent deprotection followed by oxidation and methyl addition to give 
(−)-cladiella-6,11-dien-3-ol (81).[64,66] This natural product was then used an intermediate to 
prepare other cladiellins. Kim and co-workers had previously reported that 
(−)-cladiell-11-ene-3,6,7-triol (93) could be obtained by dihydroxylation of 
(−)-cladiella-6,11-dien-3-ol (81, Scheme 39).[37] 
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Scheme 39: Synthesis of Multiple Members of the Cladiellin Family from (−)-Cladiella-6,11-dien-3-ol (81) 
Prior to dihydroxylation, acetylation afforded (−)-3-acetoxycladiella-6,11-diene (195) but 
acetylation proved to be very difficult and a low yield when acetic anhydride was used as 
the solvent and it was necessary to perform the reaction at 40 °C to observe any conversion. 
Dihydroxylation of (−)-3-acetoxycladiella-6,11-diene (195) resulted in formation of 
(−)-3-acetoxycladiell-11-ene-6,7-diol (196) in modest yield.  
The Clark group synthesised four further members of the cladiellin family from E-bicyclic 
ketone 168 (Scheme 40) following similar protocols to those used by Paquette and 
co-workers and Kim and co-workers as discussed previously.[31,37]  
 
Scheme 40: Four Further Members of the Cladiellin Family Synthesised by the Clark Group 
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After the completion of the syntheses of these members of the cladiellin family of natural 
products, attention was turned to the synthesis of the proposed structure of sclerophytin F 
(197, Figure 20).[67-69]  
 
Figure 20: Purported Structure of Sclerophytin F (197) 
Clark and co-workers reported the synthesis of the purported structure of sclerophytin F 
(197) in 2014 along with three diastereoisomeric (at C-6 and C-7 positions) triols in 2015 
which allowed re-evaluation of the structure of the natural product. The synthesis started 
with methylation of aldehyde 162 (Scheme 41).[67-69] 
 
Scheme 41: Synthesis of Tricyclic Core of Sclerophytin F (197) 
Methylation prior to tricycle formation was necessary because it had been shown previously 
that Grignard addition to a ketone in the C-3 position late in the synthesis would give the 
opposite stereochemistry to that required (Section 2, Scheme 31). Following methylation, 
Swern oxidation gave ketone 198 which underwent reductive cyclisation to give 
tetrahydropyranol 199 with excellent selectivity (dr 12:1). This intermediate was converted 
into the tricyclic core 200 of sclerophytin F in a further 13 steps using a similar route as 
before.  
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The compound corresponding to the purported structure of sclerophytin F (197) and its three 
diastereoisomers at the C-6 and C-7 positions were then synthesised in a further 4-6 steps 
from tricyclic alcohol 200 (Scheme 42).[68,69] 
 
Scheme 42: Synthesis of the Purported Structure of Sclerophytin F (197) and Three Diastereoisomers 
Comparison of the NMR data for the four diastereoisomers with the data reported for 
sclerophytin F revealed that the natural product was not any of these four compounds. The 
structure also did not match any of the structures with an inversion of stereochemistry at the 
C-3 position. Through extensive analysis of the data described from the original isolation, it 
was concluded that the structure of sclerophytin F was in fact identical to that reported for 
sclerophytin E (204) and there had been a mistake during characterisation of the compound 
(Figure 21). 
 
Figure 21: Structure of Sclerophytins E and F (204) 
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2.1 Previous Work on Asbestinins Within the Clark Group 
In unpublished work performed by the Clark group, the formal synthesis of 
11-acetoxy-4-deoxyasbestinin D [(±)-18] was completed.[70] This was through the synthesis 
of a tricyclic intermediate (±)-36 previously prepared by Crimmins and co-workers during 
their published synthesis (Scheme 43).[12,13] 
 
Scheme 43: Formal Synthesis of 11-Acetoxy-4-deoxyasbestinin D [(±)-18] 
The synthesis of intermediate (±)-36 began from tricycle (±)-173 which underwent Wittig 
methenylation followed by hydrolysis of the ethyl vinyl ether to give ketone (±)-174 
(Scheme 44).[70] Methylation of ketone (±)-174 was performed to produce a mixture of the 
diastereoisomers (±)-205 and (±)-206, favouring diastereoisomer (±)-205 (dr 1.8:1). 
 
Scheme 44: Methylation of Tricyclic Core (±)-174 
When epimerisation of diastereoisomer (±)-205 was performed under various conditions, 
only diastereoisomer (±)-205 was obtained. This result showed the important influence that 
the C-3 stereocentre has on epimerisation in comparison to a similar transformation 
performed by Crimmins and Ellis on a substrate that possesses a quaternary centre at the C-3 
position (Scheme 45).[12,13]  
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Scheme 45: Epimerisation Performed by Crimmins and Co-workers 
The synthesis of ketone (±)-206 allowed the formal synthesis of 
11-acetoxy-4-deoxyasbestinin D [(±)-18] to be completed in five steps. The first step 
involved reduction of the ketone with L-Selectride and this reaction was followed by 
acetylation to give acetate (±)-207. Cleavage of the silyl ether and oxidation of the resulting 
alcohol afforded the ketone (±)-208 before nucleophilic addition of methyllithium in the 
presence of sodium tetrafluoroborate gave formal intermediate (±)-36. 
 
Scheme 46: Completion of Formal Synthesis of 11-Acetoxy-4-deoxyasbestinin D [(±)-18] 
The problems concerning the installation of the methyl group selectively at C-12 meant that 
an alternative approach was investigated to allow completion of the total synthesis of 
11-acetoxy-4-deoxyasbestinin D (Scheme 47).[71] It was envisaged that having the methyl 
substituent installed prior to the Diels–Alder cycloaddition reaction would allow the 
stereochemistry to be set during this reaction. This approach relied on stereoselective 
formation of the Z-diene (±)-210 as a substrate for the intermolecular Diels–Alder 
cycloaddition. In principle, triene (±)-210 should be readily prepared from 
previously-prepared triflate (±)-169. 
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Scheme 47: Alternative Approach to Installation of Methyl Substituent 
The triflate (±)-169 was subjected to a palladium-catalysed carbonylation reaction to give 
α,β-unsaturated ester (±)-211 and a subsequent Takai olefination reaction with 
1,1-dibromoethane 212 gave Z-diene (±)-213 (Scheme 48).[72] This diene then underwent an 
intermolecular Diels–Alder cycloaddition reaction with methyl vinyl ketone. 
 
Scheme 48: Installation of Methyl Substituent Prior to Diels–Alder Cycloaddition 
The Diels–Alder cycloaddition was successful and produced a 1:1 mixture of endo:exo 
adducts (±)-214 as before. However, attempts to epimerise this mixture to obtain mainly the 
required diastereoisomer (±)-215 were unsuccessful and a mixture of adducts was obtained 
in each case. Epimerisation was performed under various basic and acidic conditions and 
changes were made to the enol ether substituent but none of these approaches was 
successful.[71]  
An alternative approach was investigated in which the α,β-unsaturated ester (±)-211 was 
reacted with the diene 216 to discover whether the Diels–Alder cycloaddition would 
proceed, but this approach was unsuccessful (Scheme 49).[71] 
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Scheme 49: Alternative Diels–Alder Cycloaddition Approach 
Installation of the methyl substituent prior to the Diels–Alder cycloaddition was problematic 
and so a different approach was investigated. It was proposed that the tricyclic ketone 
(±)-206 could be synthesised by conjugate reduction of the enone (±)-218, which in turn 
could be synthesised from the ketone (±)-174 (Scheme 50). 
 
Scheme 50: Third Strategy for Installation of Methyl substituent 
The synthesis of enone (±)-218 started with the reaction of the tricyclic ketone (±)-174 with 
Bredereck’s reagent 219 to give enaminone (±)-220 (Scheme 51).[73] Reduction of 
enaminone (±)-220 with diisobutylaluminium hydride followed by addition of methyl iodide 
led to formation of enone (±)-218. 
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Scheme 51: 1,4-Conjugate Reduction of Enone (±)-218 
Enone (±)-218 underwent 1,4-conjugate reduction with Stryker’s reagent to give 
diastereoisomer (±)-205 as the sole product.[74] The finding that conjugate reduction of the 
enone led to formation of the epimer at the C-12 position, meant that an alternative route 
was required. It was proposed that direct methylation of tetracyclic ketone (±)-221 might 
lead to an improved ratio of diastereoisomers being formed (previously, a dr 1.8:1 had been 
obtained for a similar tricyclic system, Scheme 52).  
 
Scheme 52: Direct Methylation of Tetracycle (±)-221 
Tetracyclic ketone (±)-221 was synthesised in 8 steps from tricyclic enol ether (±)-173 
before the attempted methylation with methyl iodide and sodium hexamethyldisilazide. 
When the methylation was performed only diastereoisomer (±)-222 was obtained.[71]  
Even though the routes discussed above were unsuccessful or led to poor diastereoselectively 
when installing the methyl substituent at the C-12 position, they demonstrated that it was 
possible to construct the tetracyclic core and that this would serve as an excellent building 
block for the synthesis of the asbestinins. However, an alternative method to set the methyl 
stereocentre at the C-12 position late in the synthesis would be required.
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3. Results and Discussion 
 
3.1 Synthetic Strategy 
Previous work performed by the Clark group had established an efficient and rapid method 
for construction of the tricyclic core present in both the cladiellins and asbestinins 
(Figure 22).[59-61,64-71] Further work had been performed to elaborate this tricyclic core to 
give the tetracyclic structure of the asbestinins in racemic form (Section 2).[70,71] Previous 
attempts to install the methyl substituent at C-12 had either led to poor diastereoselectivity 
or formation of the epimer as the major product. Consequently, stereoselective introduction 
of this methyl group was one of the issues that needed to be addressed.[70,71]  
 
Figure 22: Structures of 11-Acetoxy-4-deoxyasbestinin D (18), 4-Deoxyasbestinin C (19) and Asbestinins 
Derived from 11-Acetoxy-4-deoxyasbestinin D (18) 
The initial natural product target selected for synthesis was 11-acetoxy-4-deoxyasbestinin D 
(18) because this compound could be used as an intermediate for the synthesis of many other 
members of the family such as asbestinin 10 (15), asbestinin 20 (14) and asbestinin 21 (2239) 
by functionalisation of the trisubstituted alkene present in the oxonene.[9-11] The structurally 
related butyrate derivative, 4-deoxyasbestinin C (19) would also be a feasible target because 
it could be obtained from the same advanced intermediate used to prepare 
11-acetoxy-4-deoxyasbestinin D (18). This would make it possible to synthesise further 
members of the asbestinin family derived from 4-deoxyasbestinin C (19).[10]  
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Retrosynthetic analysis of 11-acetoxy-4-deoxyasbestinin D (18) starts with cleavage of the 
ester at the C-11 position and formation of the ketone (Scheme 53). Subsequent removal of 
the methyl substituent at the C-12 position gives the tetracyclic core of the asbestinins 221. 
 
Scheme 53: Retrosynthetic Analysis of 11-Acetoxy-4-deoxyasbestinin D (18) 
Sequential opening of the oxepane affords a tertiary alcohol at the C-3 position and 
conversion of the methyl substituent into a methylene group leads to the diol 224. 
Transformation of the ketone at C-11 into an enol ether followed by removal of the C-3 
methyl substituent suggests tricyclic ketone 225 as an intermediate. Subsequent conversion 
of the allylic ether into a ketone gives tricyclic ketone 173. This ketone has been shown to 
be available from bicyclic triene 171 through a Diels–Alder cycloaddition reaction in 
previous studies. The bicyclic triene 171 is available from bicyclic ketone 167 and an 
intermediate that had been used in previous total syntheses of the cladiellins family reported 
by Clark and co-workers.[64,65] 
The synthesis of 11-acetoxy-4-deoxyasbestinin D (18) commenced with the synthesis of 
tricyclic ketone 173 on a large scale following the previously developed route (Section 2).  
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3.2 Synthesis of Tetrahydropyranol 163 
The synthesis of tetrahydropyranol 163 began with conversion of butan-1,4-diol 178 to 
allylic alcohol 160 in 6 steps (54%, 93% ee, Scheme 54).[64] The next steps involved the 
transformation of allylic alcohol 160 into E-vinylogous carbonate 226 through 
hetero-Michael addition with ethyl propiolate and subsequent acid-catalysed cleavage of the 
tert-butyldimethylsilyl group. Purification was performed after silyl deprotection because 
purification of ester 161 resulted in significant loss of material and the alcohol 226 was 
obtained in 92% yield. 
 
Scheme 54: Synthesis of Tetrahydropyranol 163 from Butan-1,4-diol 178 
The primary alcohol 226 then underwent Swern oxidation to give aldehyde 162 in excellent 
yield (87%) and this compound was then converted into tetrahydropyranol 163 through a 
samarium-mediated cyclisation reaction.[62,53] This yielded the tetrahydropyranol core in 
80% yield and with excellent diastereoselectivity (dr >20:1).  The formation of 
tetrahydropyranol 163 proceeds through formation of the radical anion 227 followed by 
cyclisation onto the α,β-unsaturated ester to give tetrahydropyranol radical 228 (Scheme 55).  
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Scheme 55: Rationale for the Stereochemical Outcome of the Samarium-mediated Cyclisation Reaction 
Radical 228 undergoes single-electron reduction with a second equivalent of samarium 
diiodide to give the carbanion which undergoes protonation with methanol to form desired 
tetrahydropyranol 163. The stereochemical outcome of the reaction is dictated by chelation 
of the samarium to the aldehyde and ester functionality in a chair-like structure to form a 
seven-membered ring. The well-defined transition state for the reaction results in high 
diastereoselectivity. [62,75] 
3.3 Synthesis of Diazo-ketone 165 
The next objective was the synthesis of the diazo-ketone 165, the precursor for the pivotal 
oxonium ylide formation, [2,3]-sigmatropic rearrangement reaction (Scheme 56). 
Tetrahydropyranol 163 was initially reacted with tert-butyldimethylsilyl chloride to provide 
silyl ether 229 in quantitative yield. 
 
Scheme 56: Synthesis of Diazo-ketone 165 
The silyl ether 229 then underwent lithium hydroxide-mediated saponification to form the 
corresponding carboxylic acid 164. The acid 164 was converted into a mixed anhydride 
through the reaction with isobutyl chloroformate in the presence of triethylamine and this 
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intermediate was reacted immediately with a freshly prepared ethereal solution of 
diazomethane. The formation of diazo ketone 165 required a large excess of diazomethane 
(10 equiv.) for high yields to be obtained (80%). Diazomethane was prepared and reacted 
according to a literature procedure.[76,77]  
3.4 Synthesis of Z-Bicyclic Ketone 167 
Diazo ketone 165 was converted into the bicyclic ketones 167 and 168 through treatment 
with copper hexafluoroacetyacetone.[61,64-66] The catalyst promoted the tandem oxonium 
ylide formation and [2,3]-sigmatropic rearrangement through the presumed intermediate 166 
or the metal-bound equivalent of this ylide (Scheme 57). 
 
Scheme 57: Synthesis of Bicyclic Ketones 167 and 168 
At this stage, the isomeric bicyclic ketones were separated by chromatography using silica 
gel impregnated with silver nitrate.[78,79] The E-bicyclic ketone 168 was isomerised to 
Z-bicyclic ketone 167 through the reaction with 1,1ʹ-azobis(cyclohexanecarbonitrile) 
(VAZO 88™) and ethanethiol (Scheme 58). In previous studies, it had been noted that direct 
isomerisation of the mixture of bicyclic ketones had delivered lower yields of Z-bicyclic 
ketone 167 overall.[71] 
 
Scheme 58: Isomerisation of E-Bicyclic Ketone 168 to Z-Bicyclic Ketone 167 
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3.5 Alternative Routes to Z-Bicyclic Ketone 167 
The explosive nature of diazomethane, which can make it problematic to handle on a large 
scale, coupled with the need for specialised glassware, meant that alternative routes to the 
Z-bicyclic ketone 167 were investigated. 
3.5.1 Rearrangement of Triazole 237 
In 2014, Boyer reported the use of 1-sulfonyl-1,2,3-triazoles for the stereoselective synthesis 
of dihydrofuran-3-imines through rhodium-catalysed denitrogenation followed by 
[2,3]-sigmatropic rearrangement (Scheme 59).[80] 
 
Scheme 59: Boyer’s Synthesis of Dihydrofuran-3-imines from 1-Tosyl-1,2,3-triazoles 
The synthesis of dihydrofuran-3-imine 232 started with conversion of alkyne 230 into the 
1-tosyl-1,2,3-triazole 231 through deprotonation of the alkyne with n-butyl lithium and 
subsequent addition of tosyl azide. From here, the triazole could be reacted with rhodium 
acetate to give a reactive carbenoid which undergoes [2,3]-sigmatropic rearrangement to 
give desired trans-dihydrofuran-3-imine 232 in excellent yield and diastereoselectivity.[81] 
trans-Dihydrofuran-3-imine 232 is converted into the ketone 233 by hydrolysis of the imine 
using basic alumina (Brockmann III).[82] This methodology was applied to the synthesis of 
Z-bicyclic ketone 167, to provide a scalable alternative route that avoids formation of the 
diazo ketone 165. 
Initial work focussed on the synthesis of triazole 237 from tetrahydropyranol 229 
(Scheme 60). Reduction of ester 229 with diisobutylaluminium hydride afforded aldehyde 
234 and the alkyne 236 was obtained by treatment of this aldehyde with the Bestmann-Ohira 
reagent (235) under basic conditions.[83,84] 
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Scheme 60: Synthesis of Triazole 237 from Tetrahydropyranol 229 
Finally, the triazole was synthesised according to the Boyer protocol: deprotonation of the 
alkyne 235 with n-butyl lithium followed by rapid addition of tosyl azide afforded the 
triazole 237 in 81% yield.[80] An efficient method for the synthesis of triazole 237 had been 
established, which meant that reaction of the triazole under rhodium-catalysed conditions 
could be investigated.[85] 
The triazole 237 was converted into the bicyclic system under the standard conditions 
reported by Boyer for the synthesis dihydrofuran-3-imines (rhodium acetate, toluene, reflux) 
(Scheme 61).[80] After work-up with basic alumina (Brockmann III), the Z-bicyclic ketone 
167 was isolated with excellent diastereoselectivity (>20:1, Z:E). 
 
Scheme 61: Synthesis of Z-Bicyclic Ketone 167 from Triazole 237 through Rhodium-catalysis 
Although an excellent level of diastereocontrol had been obtained for formation of the 
Z-alkene, the yield was modest. Optimisation experiments were performed to investigate if 
the yield of the reaction could be improved. Optimisation involved screening the catalyst, 
reaction solvent and time. The findings of these studies are summarised in Table 2. 
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Table 2: Optimisation of the Rhodium-catalysed Formation of Z-Bicyclic Ketone 167 
Entry [Rh] Catalyst Solvent Time (min) Yield of Z-bicyclic 
ketone 167 (%) a,b 
1 Rh2(OAc)4 PhMe 30 42
c 
2 Rh2(TPA)4 PhMe 30 − 
3 Rh2(TFA)4 PhMe 30 − 
4 Rh2(Oct)4 PhMe 30 39 
5 Rh2(OAc)4 PhMe 120 39 
6 Rh2(OAc)4 DCE 30 11 
7 Rh2(OAc)4 DCE 120 49
d 
8 Rh2(OAc)4 DCE 240 47 
9 Rh2(OAc)4 DCE 120 44
e 
10 Rh2(OAc)4 PhMe 90 19 (10% 168)
f 
a Yield determined by 1H NMR analysis of crude material after work-up using 1,3,5-trimethoxybenzene as an internal 
standard; b Diastereocontrol >20:1 Z:E unless otherwise stated; c Longer work-up with basic alumina (Brockmann III), 
30 mins → 90 mins had no effect on yield; d isolated yield, no starting material recovered; e Performed at higher 
concentration (0.075 M); f Performed at 90 °C 
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When rhodium(II) acetate was replaced with a rhodium(II) catalyst that possessed bulkier or 
more electron-withdrawing groups (e.g. triphenyl- and trifluoroacetyl-), the required product 
was not obtained and starting material isolated (Entries 2 and 3). Switching to a bulkier 
catalyst in the form of rhodium(II) octanoate had negligible effect on the yield of the reaction 
(Entry 4). Rhodium(I) and iridium(I) catalysts were also tested, but the required product was 
not obtained and starting material was recovered. 
Rhodium(II) acetate delivered the best results from the catalyst screening and so the reaction 
time and choice of solvent were investigated. The use of rhodium(II) acetate in toluene and 
an increased reaction time had no effect on the yield (Entry 5). When dichloroethane was 
used as the solvent, a longer reaction time was required to yield the best results (Entries 6−8). 
The reaction time had to be increased from 30 minutes to 120 minutes for the highest yield 
to be obtained. An increase in concentration of the reaction mixture did not alter the yield of 
the reaction (Entry 9).  
Interestingly, when rhodium(II) acetate was employed as the catalyst in toluene at 90 °C, a 
much lower yield of the Z-bicyclic ketone 167 was obtained (19%) and a higher proportion 
of the E-bicyclic ketone 168 was obtained (10%, approx. 2:1 Z:E compared to previous 
>20:1 Z:E). The highest yield of the Z-bicyclic ketone 167 was obtained when the reaction 
was performed using rhodium(II) acetate as the catalyst in dichloroethane over 120 minutes 
(Entry 7). 
3.5.2 Direct Reaction of Alkyne 236  
In 2010, Zhang and co-workers reported the first α-oxo gold carbene, which was prepared 
by intermolecular oxidation of a terminal alkyne followed by OH insertion (Scheme 62).[86] 
Alkyne 238 was reacted with a gold catalyst in the presence of an oxidant to give α-oxo gold 
carbene 239 which then underwent OH insertion to yield cyclic product 240. 
 
Scheme 62: General Procedure by Zhang and Co-workers 
In 2019, Xu and co-workers expanded on this work and reported the gold-catalysed oxidative 
cyclisation/aldol addition of homopropargyl alcohols with isatins (Scheme 63).[87] 
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Homopropargylic alcohol 241 can be reacted with a gold catalyst in the presence of an 
oxidant and an acid to give gold carbene 242. Subsequent rearrangement is believed produce 
the metal-bound ylides 243 and 244. The required product 245 is obtained by addition to 
isatin in an aldol-type reaction. 
 
Scheme 63: General Approach Employed by Xu and Co-workers 
Xu and co-workers demonstrated that 3-hydroxyoxindole 248 could be synthesised using 
the reaction (Scheme 64).[87] It was noted that only one diastereoisomer was formed and its 
structure was confirmed by X-ray crystallography. 
 
Scheme 64: Synthesis of 3-Hydroxyoxindole 248 
The direct oxidative gold-catalysed cyclisation reaction offered an alternative approach 
to -the synthesis of the Z-bicyclic ketone 167 without the need to prepare the diazo-ketone 
165 or the triazole 237. The alkyne 236 was reacted with SPhosAuNTf2 in the presence of 
oxidant 5-bromo-2-methyl-pyridine-N-oxide (247) and an acid to promote the formation of 
Z-bicyclic ketone 167.The findings of this study are summarised in Table 3. 
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Table 3: Attempted Direct Gold-catalysed Oxidative Cyclisation of Alkyne 236 
Entry Acid Outcome 
1 TFA By-product 249 (47%) 
2 MsOH Decomposition 
3 TPA No reaction 
4 Chloroacetic acid By-product 250 (36%) 
5 No acid No reaction 
 
When the reaction was performed under conditions reported by Xu and co-workers in the 
presence of trifluoroacetic acid (TFA), the bicyclic ketones 167 and 168 were not produced 
and the by-product 249 was obtained instead (Entry1). Tetrahydropyranol ester 249 results 
from addition of TFA to the intermediate α-oxo gold carbene species that is formed. Xu and 
co-workers reported that methanesulfonic acid could be used as an alternative to TFA but 
use of these conditions resulted in decomposition of the starting material (Entry 2). It was 
hypothesised that the use of a weaker and more hindered base such as triphenyl acetic acid 
(TPA) would prevent formation of the analogous by-product to that observed during the TFA 
reaction. However, no reaction occurred when TPA was used as an additive and only starting 
material was isolated (Entry 3). Chloroacetic acid was chosen as an alternative to TFA 
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because it is less acidic, but in this case the ester 250 was obtained as the by-product 
(Entry 4). When the reaction was performed in the absence of an acid source, only starting 
material was recovered and no reaction observed (Entry 5). The results in presented in 
Entries 1 and 4 appear to show that [2,3]-sigmatropic rearrangement occurs at a much slower 
rate than the addition of the acid source to the α-oxo gold carbene species under these 
conditions. 
3.6 Synthesis of Tricyclic Ketone 173 
Two routes were available to synthesise the bicyclic ketone 167 and so the next objective 
was to synthesise the tricyclic core present in the asbestinins. This transformation had been 
optimised by the Clark group during the synthesis of several members of the cladiellin family 
of natural products and involved a Stille/Diels–Alder cycloaddition sequence.[64,65] The 
synthesis started with conversion of Z-bicyclic ketone 167 into the vinyl triflate 169 followed 
by Stille cross-coupling with tributyl(1-ethoxyvinyl)tin 170 to give triene 171 (Scheme 65).  
 
Scheme 65: Synthesis of Tricyclic Ketone 173 by an Intermolecular Diels–Alder Cycloaddition Reaction 
Triene 171 then underwent intermolecular Diels–Alder cycloaddition with methyl vinyl 
ketone to give a 1:1 mixture of exo:endo adducts 172 which upon epimerisation with 
potassium carbonate in methanol resulted in the isolation of diastereoisomer 173 exclusively. 
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3.7 Synthesis of Tetracyclic Core 221 of the Asbestinins 
The next objective in the synthesis was conversion of the tricyclic intermediate into the 
complete tetracyclic core.[71] The next transformation was conversion of the methyl ketone 
into an α,β-unsaturated ester. Vinyl triflate 251 was obtained from tricyclic ketone 173 by 
deprotonation with sodium hexamethyldisilazide and treatment of the resulting enolate with 
N-phenyltriflimide (Scheme 66). Vinyl triflate 251 then underwent a palladium-catalysed 
carbonylation to afford α,β-unsaturated ester 252 in excellent yield over two steps. 
 
Scheme 66: Synthesis of α,β-Unsaturated Ester 252 
The next step was reduction of α,β-unsaturated ester 252 to deliver the corresponding allylic 
alcohol (Scheme 67). Selective reduction of the α,β-unsaturated ester 252 was achieved by 
reaction with diisobutylaluminium hydride. Cleavage of the silyl ether was observed upon 
aqueous work-up to give diol 253 as the product. 
 
Scheme 67: Selective Reduction of α,β-Unsaturated Ester 252 
Alcohol 254 was obtained as a by-product from the reduction reaction and was formed as a 
result of conjugate reduction prior to reduction of the ester carbonyl group. This side reaction 
could be minimised by lowering the reaction temperature from −20 °C (49% 253) to −35 °C 
(84% 253). If the reaction temperature was lowered further (−40 °C or below), the reaction 
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proceeded extremely slowly and only trace quantities of the allylic alcohol 253 were 
obtained after three hours.  
As mentioned above, cleavage of the silyl ether was observed upon work-up of the reduction 
reaction. The likely cause was the close proximity of the secondary silyl ether to the primary 
hydroxyl group / alkoxide formed by reduction of the α,β-unsaturated ester. This could 
promote migration of the tert-butyldimethylsilyl which would weaken the oxygen-silicon 
bond allowing the silyl ether to be cleaved upon aqueous work-up. Diol 253 proved to be 
acid-sensitive; exposure to acidic conditions caused decomposition to occur. 
To introduce the methyl substituent regioselectively at C-3 it was necessary to oxidise the 
C-3 hydroxyl group selectively and so the more reactive allylic alcohol had to be protected 
first. Selective acetylation of diol 253 using acetic anhydride furnished acetate 255 
(Scheme 68). 
 
Scheme 68: Synthesis of Tetracyclic Precursor 224 
Now that the allylic alcohol had been protected, the secondary alcohol was oxidised using 
Dess–Martin periodinane to afford ketone 256 in excellent yield.[88] It was found that a 
two-step procedure (acetylation then oxidation) from diol 255 resulted in a higher yield of 
ketone 256 being obtained (98% over two steps) than if performed stepwise with purification 
of the intermediate ester which gave yields of 98% and 83% respectively (81% over two 
steps). Grignard addition of methyl magnesium chloride to ketone 256 resulted in 
stereoselective formation of the tertiary alcohol and removal of the acetate group to afford 
allylic alcohol 257. The resulting product 257 was treated with aqueous hydrochloric acid, 
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which cleaved the ethoxy enol ether and delivered diol 224. The C-10 stereocentre was 
created stereoselectively.[71] 
To form the bridging oxepane present in the tetracyclic core, the diol 224 was treated with 
triflic anhydride to yield the primary triflate which then underwent displacement by the 
tertiary alcohol to give tetracyclic ketone 258 (Scheme 69).[71,12,13] 
 
Scheme 69: Synthesis of Tetracyclic Core 221 of the Asbestinins 
Selective hydrogenation of the 1,1-disubstituted alkene resulted in formation of tetracycle 
221 as a single diastereoisomer. It was necessary to avoid over-reduction of the trisubstituted 
alkene because this led to a difficult separation of the resulting products. The selectivity of 
the hydrogenation reaction is dictated by the conformation of the tetracycle with only one 
face of the alkene accessible which results in formation of a single diastereoisomer.  
3.8 Installation of Methyl Substituent at the C-12 Position 
The tetracyclic core of the asbestinins had now been synthesised and so the next objective 
was stereoselective introduction of the methyl substituent at the C-12. Previous attempts to 
introduce this substituent to the tricyclic or tetracyclic core of the asbestinins had been 
unsuccessful or had failed to deliver the required diastereoisomer (Section 2.1).[70,71] For 
example, it had been shown that direct methylation of the tetracyclic ketone (±)-221 led 
solely to formation of the undesired diastereoisomer (±)-222(Scheme 70).[71] 
 
Scheme 70: Direct Methylation of Tetracyclic Ketone (±)-221 
Since direct methylation was not possible, an alternative approach to complete the synthesis 
of 11-acetoxy-4-deoxyasbestinin D (18) was undertaken. It was envisaged that 
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hydrogenation of allylic alcohol 259 followed by acetylation would give 
11-acetoxy-4-deoxyasbestinin D (18, Scheme 71).  This would allow the stereocentre at the 
C-12 position to be introduced stereoselectively by having the C-11 alcohol stereocentre set 
previously. 
 
Scheme 71: Retrosynthetic Analysis of 11-Acetoxy-4deoxyasbestinin D (18) from Tetracyclic Ketone 221 
Allylic alcohol 259 could be synthesised from the corresponding enone 260 by 1,2-reduction 
which could be accessible from the readily prepared tetracyclic ketone 221. This route was 
very similar to one used by the Clark group to functionalise the tricyclic core of the 
asbestinins that had involved 1,4-conjugate reduction of an enone in an attempt to control 
the configuration of the C-12 stereocentre (Section 2.1, Scheme 51).[71] 
The synthesis of enone 260 started by treatment of the tetracyclic ketone 221 with 
Bredereck’s reagent 219 to give enaminone 261 (Scheme 72).[73] Reduction of enaminone 
261 with diisobutylaluminium hydride followed by addition of methyl iodide led to 
formation of enone 260. Attempts to prepare the enone 260 directly by use of Eschenmoser’s 
salt were unsuccessful and only starting material was recovered from the reaction.[89]  
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Scheme 72: Synthesis of Allylic Alcohol 262 through 1,2-Reduction of Enone 260 
At this stage, enone 260 could be isolated and characterised. However, higher yields were 
obtained when the enone was subjected to immediate 1,2-reduction under Luche 
conditions.[90] This procedure afforded the allylic alcohol 262 as the sole diastereoisomer in 
a 49% yield (over three steps). Allylic alcohol 262 had the undesired configuration at the 
C-11 position and there was no evidence for formation of the other diastereoisomer. The 
stereochemistry of the C-11 position was confirmed by single crystal X-ray analysis 
(Figure 23).  
 
Figure 23: Crystal Structure of Allylic Alcohol 262 
1,2-Reduction of the enone under Luche conditions produced the C-11 epimer of the 
required allylic alcohol and so a bulkier reducing agent was explored to discover whether it 
might be possible to reverse the selectivity observed previously (Scheme 73).[91]  
 Results and Discussion 
 
 
64 
 
 
Scheme 73: 1,4-Conjugate Reduction of Enone 260 using L-Selectride 
Enone 260 was treated with L-Selectride but there was no evidence of the 1,2-reduction 
products. Instead, enone 260 underwent 1,4-conjugate reduction to produce a separable 
mixture of diastereomeric ketones 263 and 222 (dr 1:1.5, 263:222). The desired 
diastereoisomer 263 was formed as the minor conjugate reduction product. Reproducibility 
of the reaction was a major issue because formation of the dimer 264 was difficult to control. 
Altering reaction conditions (concentration, temperature, reactant equivalents and order of 
addition) had a negligible effect on preventing formation of this dimer and variable yields 
were obtained. Both diastereoisomers were fully characterised in order to establish the 
relative stereochemistry of the newly formed centre. This was accomplished by single crystal 
X-ray analysis of major diastereoisomer 222 (C-12 epimer, Figure 24). 
 
Figure 24: Crystal Structure of Major Diastereoisomer 222 
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Reduction of enone 260 using L-Selectride enabled formation of the desired diastereoisomer 
263. Unfortunately, the diastereoselectivity of the reaction was poor (dr 1:1.5, 263:222) and 
there were issues with reproducibility as a consequence of dimer formation. To address these 
issues, alternative reducing conditions were explored based on previous work within the 
Clark group that had shown Stryker’s reagent to be a useful alternative for the 1,4-conjugate 
reduction.[71] This reagent had been used to reduce the tricyclic enone (±)-218 during initial 
attempts to install the methyl substituent at the C-12 position (Scheme 74). Even though the 
product with incorrect configuration at the C-12 stereocentre was produced, the reaction 
shows that 1,4-conjugate reduction of related systems in possible with Stryker’s reagent. 
 
Scheme 74: Previous Work Concerning 1,4-Conjugate Reduction of Enone (±)-218 with Stryker’s Reagent 
When 1,4-conjugate reduction of tetracyclic enone 260 was performed using Stryker’s 
reagent, it resulted in the formation of diastereomeric ketones 263 and 222 (dr 1:1.4, 
263:222, Scheme 75).[74] Crucially, even though the ratio of diastereoisomers was nearly 
identical to that obtained when the reduction reaction was performed with L-Selectride, there 
was no evidence that dimerisation had occurred. Ketones 263 and 222 were isolated in a 
54% yield with no starting material recovered. 
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Scheme 75: 1,4-Conjugate Reduction of Enone 260 with Stryker’s Reagent 
A possible explanation for the abolition of dimerisation is the strength of the complex formed 
between copper and enolate generated. Stronger complexation would make the enolate less 
nucleophilic and thus reduce the rate of competitive Michael addition to unreacted enone. 
The diastereoisomers were separable and so epimerisation at C-12 of 222 to give the required 
ketone 263 was investigated under various conditions (Table 4).  
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Table 4: Epimerisation of 222  
Entry Base Solvent Time (h) Ratio (dr 263:222)a 
1 K2CO3 MeOH 16 1:1.3
b 
2 DBU THF 16 1:4 
3 Et3N CH2Cl2 16 1:9 
4 K2CO3 MeOH 64 1:1.3 
a dr determined was by 1H NMR analysis of crude material after aqueous work-up; b isolated yield of 99% 
Under conditions previously employed after the Diels–Alder cycloaddition reaction to form 
the tricyclic core of the asbestinins (potassium carbonate in methanol for 16 hours), a 
diastereomeric ratio of 1:1.3 (263:222) was obtained (Entry 1). The ratio of diastereoisomers 
was not improved when weaker bases such as DBU and triethylamine were employed 
(Entries 2 and 3). Prolonged reaction times had no effect on the ratio of diastereomeric 
products when the reaction was performed with potassium carbonate and methanol (Entry 4). 
The observation that extended reaction times had no effect on the diastereomeric ratio (1:1.3, 
263:222) suggested that this the final thermodynamic mixture of products had been obtained.  
To confirm the thermodynamic ratio of products, the required diastereoisomer 263 was 
treated with potassium carbonate and methanol under identical conditions (Scheme 76). The 
diastereomeric ratio was identical to that obtained from the epimerisation of 222, which 
proved that this was the thermodynamic ratio for the diastereomeric ketones. 
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Scheme 76: Epimerisation of Desired Diastereoisomer 263 
At this stage, direct methylation of tetracyclic ketone 221 was revisited because full 
characterisation of both diastereoisomers permitted easier analysis of the reaction products. 
Direct methylation was performed by treating tetracyclic ketone 221 with sodium 
hexamethyldisilazide followed by addition of methyl iodide (Scheme 77).[71] Even though 
the yield of the reaction could not be replicated, the stereochemical outcome was identical 
to that obtained previously and the ketone 222 was obtained without formation of the 
required diastereoisomer 263. Direct alkylation of 221 was not explored further because it 
was clear that the facial selectivity for reaction of the enolate with electrophiles would result 
in formation of the diastereoisomer with the incorrect configuration at C-12. 
 
Scheme 77: Direct Methylation of Tetracyclic Ketone 221 with Methyl Iodide 
3.9 Completion of the Total Syntheses of 11-Acetoxy-4-deoxyasbestinin D (18) 
and 4-Deoxyasbestinin C (19) 
Successful synthesis of the required diastereoisomer 263 meant that the final steps of the 
synthesis of natural product 11-acetoxy-4-deoxyasbestinin D (18) could be explored 
(Scheme 78). The first step was stereoselective reduction of ketone 263. Reduction of the 
ketone with sodium borohydride was highly diastereoselective (dr >20:1) and gave the 
required alcohol 265, which was of sufficient purity to be used directly in the subsequent 
reaction. Immediate acetylation of alcohol 265 delivered the natural product 
11-acetoxy-4-deoxyasbestinin D (18) in excellent yield over two steps (88%). 
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Scheme 78: Completion of Total Synthesis of 11-Acetoxy-4-deoxyasbestinin D (18) 
This sequence completed the second total synthesis of 11-acetoxy-4-deoxyasbestinin D (18). 
The synthesis had been accomplished in a total of 31 steps and with an overall yield of 2% 
from butan-1,4-diol 178. The spectroscopic and other characterisation data (optical rotation, 
mass spectrometry, IR spectrum) matched those reported for the isolated natural product as 
well as those reported by Crimmins and co-workers for the synthetic material.[8,12,13] 
The next synthetic target was 4-deoxyasbestinin C (19) which could be obtained by 
esterification of the alcohol 265 to form a butanoate instead of an acetate.[8] The natural 
product was synthesised from ketone 263 in two steps (Scheme 79).  
 
Scheme 79: Completion of Total Synthesis of 4-Deoxyasbestinin C (19) 
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As before, reduction of ketone 263 with sodium borohydride gave alcohol 265 with excellent 
diastereoselectivity. Subsequent esterification with butyric anhydride gave the natural 
product 4-deoxyasbestinin C (19) in 50% yield over two steps. Thus, the first total synthesis 
of 4-deoxyasbestinin C (19) was completed in 31 steps and with an overall yield of 1% from 
butan-1,4-diol 178. The spectroscopic and other characterisation data matched those 
reported for the isolated natural product.[8] 4-Deoxyasbestinin C (19) was also synthesised 
from purified alcohol 265 in 75% yield. 
3.10 Synthesis of Further Members of the 4-Deoxyasbestinin Series 
Completion of 11-acetoxy-4-deoxyasbestinin D (18) and 4-deoxyasbestinin C (19) allowed 
the synthesis of other members of the 4-deoxyasbestinin series to be explored. Several 
targets (proposed structures) that could be synthesised from 
11-acetoxy-4-deoxyasbestinin D (18) are shown in Figure 25.[9-11] 
 
Figure 25: Members of the Asbestinin Family (Proposed Structures) Accessible from 
11-Acetoxy-4-deoxyasbestinin D (18) 
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3.10.1 Synthesis of Asbestinin 20 (14) and 6-epi-Asbestinin 20 (16) 
The initial goal was to use 11-acetoxy-4-deoxyasbestinin D (18) as a starting point for the 
synthesis of asbestinin 20 (14).[10] Asbestinin 20 (14) had originally been identified as the 
alcohol 13, but its structure had been revised upon re-isolation of the natural product by 
Rodriguez and Ospina in 2006 (Figure 26).[11] 
 
Figure 26: Original (13) and Revised (14) Structures of Asbestinin 20 
Structural reassignment related to relocation of the hydroxyl group at the C-4 position in the 
originally proposed structure 13 to the C-6 position to give 14 as the new structure for 
asbestinin 20. This reassignment applies to the whole 4-deoxyasbestinin series and 
completion of the total synthesis of asbestinin 20 (14) would either confirm the reassignment 
or provide evidence that further structural revision was required. The strategy employed to 
synthesise asbestinin 20 (14) was to epoxidise 11-acetoxy-4-deoxyasbestinin D (18) and 
then rearrange the epoxide to give an allylic alcohol. 
Initially, epoxidation was performed by treatment of 11-acetoxy-4-deoxyasbestinin D (18) 
with meta-chloroperoxybenzoic acid (Scheme 80). This reaction delivered diastereomeric 
epoxides 269 and 270 in excellent yield with a diastereomeric ratio of 2:1 (269:270).  
 
Scheme 80: Epoxidation of 11-Acetoxy-4-deoxyasbestinin D (18) with meta-Chloroperoxybenzoic Acid 
The crystalline epoxides 269 and 270 were separable by chromatography and their structures 
established by single crystal X-ray analysis (Figure 27). Identification of the 
diastereoisomers meant that studies to enhance or reverse the diastereoselectivity could be 
undertaken. 
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Shi’s asymmetric protocol was investigated as a method to amplify or reverse the weak 
substrate bias of the epoxidation reaction.[93,94] Both enantiomers of Shi’s fructose-derived 
catalyst were prepared and employed in the epoxidation reaction (Scheme 81). For the 
catalyst derived from unnatural fructose [(+)-Shi ketone (271)], the weak substrate bias was 
reinforced and the ratio of diastereoisomers improved to 10.5:1 (269:270). In the 
mismatched case where the catalyst derived from natural fructose [(−)-Shi ketone (272)] was 
used, the substrate bias was overturned and a 1:5.5 mixture of diastereoisomers (269:270) 
was obtained. 
 
Scheme 81: Shi Epoxidation of 11-Acetoxy-4-deoxyasbestinin D (18) 
Figure 27: Crystal Structures of Diastereomeric Epoxides 269 and 270 
269 270 
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The use of Shi’s asymmetric epoxidation protocol allowed both epoxides to be obtained in 
a highly diastereoselective manner, which would allow the synthesis of asbestinin 20 as well 
its C-6 diastereoisomer. This would provide conclusive proof of the configuration of the 
hydroxyl-bearing carbon and also confirm the position of the hydroxyl group on the 
nine membered ring. 
Previous work performed within the Clark group during the total synthesis of members of 
the cladiellin family of natural products showed that an analogous Lewis acid-mediated 
epoxide rearrangement reaction was possible (Scheme 82).[69] 
 
Scheme 82: Rearrangement of Epoxide 273 under Lewis Acid Conditions Used in the Synthesis of Members 
of the Cladiellin Family 
It had been shown that reaction of epoxide 273 with scandium triflate in the presence of 
potassium bisulfate afforded the allylic alcohol 274 in reasonable yield. Interestingly, when 
the reaction was performed under strong Brönsted acid conditions (sulfuric acid in this case) 
the triol 202 was obtained as a side product. It is likely that the triol was obtained by 
protonation of the epoxide followed by formation of a stable tertiary carbocation at the C-7 
position. Subsequent addition of water present in the reaction mixture, results in formation 
of the triol 202.  
Based on this precedent, epoxide 269 was treated with scandium triflate in the presence of 
potassium bisulfate (Scheme 83). Two products were formed from the rearrangement 
reaction and the major product was diol 275 in contrast to the result obtained for the cladiellin 
system. The allylic alcohol was asbestinin 20 (14), but it was a minor product and was 
obtained in a yield of 10%. 
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Scheme 83: Rearrangement of Epoxide 269 under Lewis Acid Conditions 
The spectroscopic and other characterisation data for allylic alcohol 14 matched those of the 
isolated natural product reported by Rodriguez and Ospina. The relative structures of the 
diol 275 and asbestinin 20 (14) were established unambiguously by single crystal X-ray 
analysis (Figure 28). Thus, the first total synthesis of asbestinin 20 had been completed and 
structural revision proposed by Rodriguez and Ospina had been confirmed.[10,11,95] 
 
Figure 28: Crystal Structures of Diol 275 and Asbestinin 20 (14) 
 
When the rearrangement reaction of the epoxide 269 is compared to that for cladiellin 273, 
some keys differences are apparent. Firstly, the allylic alcohol 13 was the minor product and 
the diol 275 was the major product. Secondly, the relative stereochemistry of diol 275 differs 
from that of diol 274, which suggests that the oxepane ring influences the reactivity of the 
epoxide and the conformation of the cationic intermediate.  
Following completion of the synthesis of asbestinin 20, rearrangement of epoxide 270 to 
produce the diastereomeric alcohol was investigated. In the case of epoxide 269, 
rearrangement led to the formation of asbestinin 20 (14) and diol 275 and so it was expected 
that rearrangement of epoxide 270 would produce 6-epi-asbestinin 20 (16) and the 
corresponding diol.[11] Reaction conditions were altered slightly and the amount of water 
was decreased in an effort to favour formation the allylic alcohol by making nucleophilic 
attack less likely. When the reaction was performed under these conditions, the epoxide 270 
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underwent rearrangement to give a mixture of diols 276 and 6-epi-asbestinin 20 
(16, Scheme 84). 
 
Scheme 84: Rearrangement of Epoxide 270 under Lewis Acid Conditions 
Synthetic 6-epi-asbestinin 20 (16) had spectroscopic and other characterisation data that 
matched data reported by Rodriguez and Ospina in 2006 for compound obtained by 
reduction of natural asbestinin 10.[11,95] The relative stereochemistry and structure of 
6-epi-asbestinin 20 (16) was established unambiguously by single crystal X-ray (Figure 29).  
 
Figure 29: Crystal Structure of 6-epi-Asbestinin 20 (16) 
The diols 276 obtained from the rearrangement reaction were inseparable and it was not 
possible to obtain a diastereomeric ratio from this mixture of the C-7 diol diastereoisomers 
due to overlapping peaks in the proton NMR.  
Neither epoxide rearrangement reaction had provided the allylic alcohol as the major product 
and so alternative routes to accomplish this rearrangement reaction were investigated. Yang 
and co-workers had reported the use of tert-butyldimethylsiyl trifluoromethanesulfonate to 
rearrange the tricyclic epoxide 277 to give the silyl protected allylic alcohol 278 in 
reasonable yield (67%) during their stereoselective total synthesis of 
(±)-5-epi-cyanthiwigin I (Scheme 85).[96] 
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Scheme 85: Rearrangement of Epoxide 277 During the Synthesis of (±)-5-epi-Cyanthiwigin I 
This procedure was applied to rearrangement of the epoxides 269 and 270 and they were 
treated with tert-butyldimethylsiyl trifluoromethanesulfonate in the presence of 2,6-lutidine 
(Scheme 86). For epoxide 269, asbestinin 20 (14) was obtained by initial formation of 
silyl-protected allylic alcohol 279 and then treated with tetra-N-butylammonium fluoride. 
This procedure gave asbestinin 20 (14) in moderate yield over two steps (39%). In the case 
of epoxide 270, sequential rearrangement followed by silyl deprotection gave 
6-epi-asbestinin 20 (16) in a much higher yield over two steps (64%). The difference in yield 
for the two reactions is likely to be due to the different conformations adopted by the 
epoxides, with the conformation of the epoxide 270 allowing easier silylation of the epoxide 
in this case. This hypothesis is supported by examination of the X-ray crystal structures of 
the epoxides 269 and 270 (Section 3.10.1): the epoxide oxygen of 269 points to the interior 
of the ring whereas the epoxide lies outside the medium-sized ring in 270. 
 
Scheme 86: Rearrangement of Epoxides 269 and 270 to Give Allylic Alcohols 14 and 16 
An alternative method for the epoxide rearrangement was investigated in an attempt to 
improve the yield of the allylic alcohol 14 from the epoxide 269. The new method was based 
on work performed by Garcia and Stratakis.[97] These workers had reported the 
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rearrangement of epoxide 281 to give allylic alcohol 282 by reaction with titania-supported 
gold nanoparticles (Scheme 87). 
 
Scheme 87: Rearrangement of Epoxide 281 Reported by Garcia and Stratakis 
It had been shown that the reaction was generally applicable to a variety of different epoxides 
and exhibits high selectivity for formation of the allylic alcohol over other products and so 
the procedure was applied to the rearrangement of epoxide 269.Treatment of epoxide 269 
with titania-supported gold nanoparticles afforded asbestinin 20 (14) in 35% yield, a yield 
that was comparable to that obtained from the previous the two-step procedure using 
tert-butyldimethylsilyl trifluoromethanesulfonate (Scheme 88).  
 
Scheme 88: Rearrangement of Epoxide 269 using Titania-supported Gold Nanoparticles 
The reaction progressed slowly and it was necessary to heat the reaction mixture for an 
extended period (two days compared to 30 minutes reported by Garcia and Stratakis in their 
general procedure).[97] The reaction of epoxide 269 in the presence of the titania-supported 
gold nanoparticles not only gave allylic alcohol 14 but also led to formation of 
decomposition products.  The only characterisable product isolated from the reaction was 
asbestinin 20 (14) and starting material was not recovered.  
3.10.2 Synthesis and Reduction of Asbestinin 10 (15)  
Following the successful total synthesis of asbestinin 20 (14) and the synthesis of 
6-epi-asbestinin 20 (16), the next objective was the synthesis of asbestinin 10 (15, 
Scheme 89).[9] This goal was achieved by oxidation of a mixture of the allylic alcohols (1:2, 
14:16) with Dess–Martin periodinane to give asbestinin 10 (15). 
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Scheme 89: Completion of the Total Synthesis of Asbestinin 10 (15) 
This oxidation reaction completed the first total synthesis of asbestinin 10 (15) and this 
natural product had been obtained from 11-acetoxy-4-deoxyasbestinin D (18) in three steps. 
The spectroscopic and other characterisation data for compound 15 matched those reported 
for isolated of asbestinin 10 (15) by Rodriguez and Ospina and confirmed their structural 
reassignment.[9,95] 
In 2006, Rodriguez and Ospina reported that reduction of asbestinin 10 (15) with sodium 
borohydride produced asbestinin 20 (14) and 6-epi-asbestinin 20 (16) in a 3:1 ratio 
(14:16).[11] A similar reduction of asbestinin 10 (15) was performed under Luche conditions 
to limit competitive conjugate reduction (Scheme 90). 
 
Scheme 90: Reduction of Asbestinin 10 (15) under Luche Conditions 
The 1,2-reduction afforded the allylic alcohols in a 2.6:1 ratio (14:16) which was consistent 
with the product ratio reported by Rodriguez and Ospina. Completion of the synthesis of 
asbestinin 10 (15) meant that attention could be focussed on the synthesis of the butanoate 
derivative asbestinin 9 (283). 
3.10.3 Towards the Synthesis of Asbestinin 9 (283)  
Asbestinin 9 (283) is structurally related to asbestinin 10 and the only difference in their 
structures is the presence of a butanoate group instead of an acetate group at C-11 
(Figure 30).[9] It was expected that asbestinin 9 (283) could be synthesised from 
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4-deoxyasbestinin C (19) following the previously described route for the synthesis of 
asbestinin 10 (14).  
 
Figure 30: Structure of Asbestinin 9 (283) 
The synthesis of asbestinin 9 (283) commenced with epoxidation of 4-deoxyasbestinin C 
(19) using Shi’s asymmetric protocol and employing the (+)-Shi ketone (271) as the catalyst 
(Scheme 91).[93] This reaction afforded the required epoxide 284 with extremely high 
diastereoselectivity (dr 12:1, 284:285). 
 
Scheme 91: Synthesis of Epoxide 284 from 4-Deoxyasbestinin C (19) 
The rearrangement of the newly formed epoxide 284 was attempted (Scheme 92). It was 
expected that switching from the use of tert-butyldimethylsilyl trifluoromethanesulfonate to 
trimethylsilyl trifluoromethanesulfonate would allow silyl deprotection to been 
accomplished during work-up and the allylic alcohol would be obtained directly from the 
rearrangement reaction. Epoxide 284 was treated with trimethylsiyl 
trifluoromethanesulfonate in the presence of 2,6-lutidine but only decomposition was 
observed. 
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Scheme 92: Attempted Rearrangement of Epoxide 284 
This unfortunate result combined with a lack of material meant that the synthesis of 
asbestinin 9 (283) was not completed. Instead, work focussed on the synthesis of other 
members of the asbestinin family that could be prepared from 
11-acetoxy-4-deoxyasbestinin D (18). 
3.10.4 Synthesis of Asbestinin 21 (288) by Dihydroxylation of 
11-Acetoxy-4-deoxyasbestinin D (18)  
The diol 275 had been obtained during the synthesis of asbestinin 20 (14) and it was 
envisaged that this diol could be used for the synthesis of the proposed structure of 
asbestinin 21 (223) by simple oxidation of the secondary hydroxyl group (Scheme 93).[10,11] 
 
Scheme 93: Proposed Route for the Synthesis of Asbestinin 21 (223) 
The goal was to synthesise asbestinin 21 (223) and its C-7 epimer which would be available 
from diol 287. Since it was not possible to obtain diol 287 by use of the previously described 
routes, the dihydroxylation reaction of 11-acetoxy-4-deoxyasbestinin D (18) was 
investigated. Treatment of 11-acetoxy-4-deoxyasbestinin D (18) with osmium tetroxide 
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under Upjohn conditions provided a diastereomeric mixture of syn-diols 275 and 287 (dr 5:1, 
275:287) in moderate yield (Scheme 94).[98] 
 
Scheme 94: Dihydroxylation of 11-Acetoxy-4-deoxyasbestinin D (18) under Upjohn Conditions 
The diols were difficult to separate but they were later found to be separable by 
chromatography using a mixture of dichloromethane and methanol. At this stage, the 5:1 
mixture of diols was oxidised directly with Dess–Martin periodinane to deliver a mixture of 
asbestinin 21 (288) and 7-epi-asbestinin 21 (223, Scheme 95). 
 
Scheme 95: Oxidation of Diols 275 and 287 to Afford Asbestinin 21 (288) and 7-epi-Asbestinin 21 (223) 
The α-hydroxy ketones were separable by chromatography and permitted full 
characterisation of both asbestinin 21 (288) and 7-epi-asbestinin 21 (223) to be 
accomplished. Comparison of the proton and carbon NMR data of the α-hydroxy ketones 
288 and 223 with the data reported for asbestinin 21 isolated from natural sources revealed 
that the natural product had been mis-assigned by Rodriguez and Ospina when they 
performed their structural revision (Appendix 7.1).[10,11,95] The proposed structure of 
asbestinin 21 in fact corresponded to the C-7 epimer 223 and the natural product was 
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compound 288. The other characterisation data for α-hydroxy ketone 288 matched those 
reported for the isolated asbestinin 21 (288).[10] 
7-epi-Asbestinin 21 (223) was also synthesised directly in 87% yield by oxidation of the diol 
275 with Dess–Martin periodinane (Scheme 96). 
 
Scheme 96: Oxidation of Diol 275 to give 7-epi-Asbestinin 21 (223) 
After completion of the total synthesis of asbestinin 21 (288) and its C-7 epimer 223, 
attempts were made to reverse the selectivity of the dihydroxylation reaction of 
11-acetoxy-4-deoxyasbestinin D (18). The dihydroxylation of 18 was performed according 
to the Sharpless asymmetric protocol with the expectation that there would be a 
matched-mismatched relationship between the catalyst and substrate (Scheme 97).[99] Use of 
AD-mix-α to perform the dihydroxylation reaction resulted in enhanced selectivity for the 
diol 275 (5:1, 275:287 → >12:1, 275:287) but the diols were isolated in only 23% yield. The 
major product was the α-hydroxy ketone 223 (7-epi-asbestinin 21), which is produced by 
over oxidation of the diol during the reaction. 
 
Scheme 97: Dihydroxylation of 11-Acetoxy-4-deoxyasbestinin D (18) Using AD-mix-α 
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In what was expected to be the mis-matched case, the use of AD-mix-β resulted in a higher 
level of diastereocontrol than had been obtained from the reactions performed under standard 
Upjohn conditions (5:1, 275:287 → 8:1, 275:287, Scheme 98). The cause of this unexpected 
increase in diastereocontrol is likely to have resulted from the larger steric bulk of the chiral 
osmium complex and so the reaction proceeds under substrate control instead of reagent 
control. 
 
Scheme 98: Dihydroxylation of 11-Acetoxy-4-deoxyasbestinin D (18) Using AD-mix-β 
The diols 275 and 287 were obtained in a combined yield of 75% and 7-epi-asbestinin 21 
(223) was also obtained in 10% yield. The lower yield of the α-hydroxy ketone than in the 
previous reaction can be attributed to a shorter reaction time and the lower catalyst loading. 
The use of Sharpless asymmetric dihydroxylation protocol allowed for enhanced 
diastereocontrol for the synthesis of diol 275 but it could not overcome the substrate bias. 
3.10.5 Synthesis of Asbestinin 23 (266) and 7-epi-Asbestinin 23 (289)  
Following the completed synthesis of asbestinin 21 (288), the synthesis of asbestinin 23 
(266) and its C-7 epimer (289) was investigated (Figure 31).[10,11] The intention was to 
perform hydroboration-oxidation of 11-acetoxy-4-deoxyasbestinin D (18) and then oxidise 
the resulting alcohols. 
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Figure 31: Structures of Asbestinin 23 (266) and 7-epi-Asbestinin 23 (289) 
The synthesis of asbestinin 23 (266) and 7-epi-asbestinin 23 (289) started with hydroboration 
of 11-acetoxy-4-deoxyasbestinin D (18) with borane-THF complex and by oxidative 
work-up using sodium perborate (Scheme 99). This reaction delivered an inseparable 
mixture of alcohols 290 and 291. 
 
Scheme 99: Hydroboration-Oxidation of 11-Acetoxy-4-deoxyasbestinin D (18) 
Immediate oxidation of the diastereomeric mixture of alcohols 290 and 291 with               
Dess–Martin periodinane afforded a separable mixture of 7-epi-asbestinin 23 (289) and 
asbestinin 23 (266) in a 69% yield over two steps (dr 2.7:1, 289:266). The spectroscopic data 
for the major ketone 289 obtained from the two-step sequence did not match that of the 
natural product asbestinin 23 and it was identified to be the C-7 epimer. The stereochemistry 
of the proposed C-7 epimer was determined by the reduction of 7-epi-asbestinin 23 (289) 
with L-Selectride to give a pure sample of the crystalline alcohol 290 (Scheme 100). Alcohol 
290 was obtained with an excellent diastereomeric ratio (dr >20:1) and the its structure was 
established conclusively by single crystal X-ray analysis. 
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Scheme 100: Synthesis of Alcohol 290 by Reduction of 7-epi-Asbestinin 23 (289) 
Unambiguous assignment of the structure of alcohol 290 enabled the configuration of the 
methyl-bearing carbon in both asbestinin 23 (266) and 7-epi-asbestinin 23 (289) to be 
confirmed as well. The spectroscopic and other characterisation data obtained for the ketone 
266 matched those of asbestinin 23 reported for by Rodriguez and Ospina.[10,11,95] The total 
synthesis of asbestinin 23 (266) was completed in two steps from 
11-acetoxy-deoxyasbestinin D (18) with the structure and relative configuration of the 
stereocentres in 7-epi-asbestinin 23 (289) being established by X-ray analysis and so 
confirmed the structure of asbestinin 23 (266) with certainty. 
3.10.6 Towards the Synthesis of Asbestinin 25 (267)  
The final member of the 4-deoxyasbestinin series that was selected for synthesis was 
asbestinin 25 (267).[11] Asbestinin 25 (267) was to be synthesised from epoxide 292 by 
epoxide opening and methylation of the secondary hydroxyl group of the resulting diol 
(Scheme 101). Epoxide 292 would be available from the previously synthesised 
asbestinin 20 (14). 
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Scheme 101: Synthesis of Asbestinin 25 (267) from Asbestinin 20 (14) 
The synthesis of asbestinin 25 (267) started with epoxidation of asbestinin 20 (14) using the 
Sharpless asymmetric protocol.[47] This reaction produced the epoxide 292 in a yield of 75% 
and with excellent stereoselectivity (dr >20:1, Scheme 102). The epoxide 292 was a 
crystalline solid and so the structure of the epoxide was established unambiguously by single 
crystal X-ray analysis. 
 
Scheme 102: Epoxidation of Asbestinin 20 (14) 
In previous work performed in the Clark group, diisobutylaluminium hydride had been used 
for regioselective epoxide opening of an analogous epoxide during the synthesis of the 
compound proposed to be sclerophytin F (Scheme 103).[67-69] A complicating issue was 
potential reduction of the labile acetate group by diisobutylaluminium hydride. 
 Results and Discussion 
 
 
87 
 
Consequently, the reaction was performed at a low temperature (−78 °C) and monitored 
carefully in an attempt to avoid this problem. 
 
Scheme 103: Regioselectively Opening of Epoxide 293 Using Diisobutylaluminium Hydride 
Attempted reductive epoxide opening with diisobutylaluminium hydride delivered a 
complex mixture of products (Scheme 104). Due to the scale of the reaction, products could 
not be characterised fully but mass spectrometry data and NMR data of related compounds 
aided the elucidation of possible products. The masses for diol 294 and triol 295 were 
obtained and this suggests that these products were formed. There was evidence of unreacted 
starting material by crude NMR analysis and by mass spectrometry. Diol 294 is likely 
formed by reductive cleavage of the ester and triol 295 would result from epoxide opening 
and ester cleavage. 
 
Scheme 104: Attempted Opening of Epoxide 292 
Further work towards the synthesis of asbestinin 25 (267) was not undertaken due to the lack 
of material and a focus on the synthesis of the C-4 hydroxylated asbestinins. 
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3.11 α-Hydroxylation of Tricyclic Ketone 256 
The total synthesis of several members of the asbestinin family from the 4-deoxyasbestinin 
series encouraged a broadening of the scope of the project to include the C-4 hydroxylated 
asbestinins such as asbestinin 11 (297) and asbestinin 12 (22, Figure 32).[10] The strategy 
was to adapt the now established synthetic route to the 4-deoxyasbestinins and perform 
α-hydroxylation on a tricyclic intermediate prior to construction of the oxepane. 
 
Figure 32: Structures of Asbestinin 11 (297) and Asbestinin 12 (22) 
Crimmins and Ellis had reported that it is possible to perform α-hydroxylation of an enolate 
generated from the tricyclic ketone 33, using Davis oxaziridine 39, to give the α-hydroxy 
ketone 40 as the sole product, during their total synthesis of asbestinin 12 (22, 
Scheme 105).[13] This precedent showed that highly diastereoselective α-hydroxylation on 
the tricyclic core of the asbestinins should be possible. 
 
Scheme 105: α-Hydroxylation of Tricyclic Ketone 33 Performed by Crimmins and Ellis 
The synthesis started from tricyclic ketone 256 which had been used as an intermediate in 
our synthesis of members of the 4-deoxyasbestinin series (Scheme 106). The presence of an 
acetate group was problematic because it was likely to undergo competitive deprotonation 
when the substrate was treated with base and might also undergo transesterification with the 
enolate formed at the C-3 position. Consequently, it was necessary to remove the acetate 
group and this was achieved by treatment of 256 with potassium carbonate in methanol to 
give alcohol 298.  
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Scheme 106: Attempted Synthesis of Tricyclic Ketone 299 
Following removal of the acetate group, silyl protection of the allylic alcohol was performed 
with initial formation of tricyclic ketone 299. However, tricyclic ketone 299 underwent 
unexpected isomerisation at room temperature to produce the tricyclic ketone 300 as the sole 
product after 2-3 hours.[100] The isomerisation of tricyclic ketone 299 generated the 
stereocentre at the C-10 position (dr >20:1). It is possible that isomerisation of the alkene 
occurs after silylation due to the increased steric bulk of the silyl protecting group which 
results in a significant conformational change in the 6,5,9-tricyclic system. 
To determine the configuration of the newly created stereocentre at the C-10 position, 
selective 1H NMR NOE spectroscopy was performed but the results were inconclusive and 
so the relative stereochemistry could not be determined. In an attempt to solve this problem, 
the tricyclic ketone 300 was treated with tetra-N-butylammonium fluoride to give alcohol 
301. However, NMR analyse was again inconclusive. 
The silyl protecting group seemed to have resulted in this unexpected issue and so the 
para-methoxybenzyl protecting group was investigated as a potential alternative. Allylic 
alcohol 298 was deprotonated with sodium hydride and para-methoxybenzyl chloride was 
added, but this reaction was unsuccessful and starting material was recovered (Scheme 107). 
 
Scheme 107: Attempted PMB Protection of Allylic Alcohol 298 
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Alternative conditions for introduction of the para-methoxybenzyl protection were 
investigated.[101] This involved the use of para-methoxybenzyl acetimidate and 
sub-stoichiometric quantities of camphorsulfonic acid; the quantity of the acid was 
minimised because of the acid-sensitive nature of the enol ether. When these conditions were 
employed, the required tricyclic ketone 302 was not formed and starting material was not 
recovered. Instead, the enol ether underwent hydrolysis to give diketone 303 along with 
para-methoxybenzyl protected diketone 304 (Scheme 108). 
 
Scheme 108: Attempted Protection of Allylic Alcohol 298 with para-Methoxybenzyl Acetimidate 
The diketones 303 and 304 were isolated as single diastereoisomers but the relative 
stereochemistry of the newly formed centre at the C-10 position was not determined because 
neither of the compounds 303 and 304 were further functionalised. This was because any 
attempt to α-hydroxylate the ketone at the C-3 position in either compound was likely to 
result in hydroxylation of the ketone at C-11 as well. 
3.12 Biological Testing of Asbestinin Natural Products and Related 
Intermediates 
Completion of the synthesis of several members of the 4-deoxyasbestinin series of natural 
products along with their various diastereoisomers meant that the anti-cancer activities of 
these compounds could be tested (Figure 33).[2,5] Structurally-related late-stage 
intermediates generated after the synthesis of 11-acetoxy-deoxyasbestinin D (18) were also 
tested. 
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Figure 33: Asbestinin Natural Products and Related Compounds Tested 
The compounds were tested against two different cancer cell lines, breast cancer cell line 
MCF7 and brain cancer cell line U87MG, in viability assay studies.[102,103] Preliminary 
results from testing by Dr. S. Sharp from the Institute of Cancer Research, London showed 
that none of the compounds tested had detectable activity at concentrations of up to 10 µM 
for either cell line (Figure 34).[104] When the assays were repeated at higher concentration 
(up to 100 µM), no activity was detected either. 
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Figure 34: Viability Assay Results for Tested Asbestinin Compounds 
The results obtained from these preliminary studies raises doubts about anti-cancer activities 
of members of the asbestinin family that have been reported in the past.[2,5] Further biological 
testing is required before any conclusions can be drawn regarding the activities of these 
asbestinins members and the validity of previously published activities.
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4. Conclusions 
 
4.1 Summary of Work 
The second enantioselective total synthesis of 11-acetoxy-4-deoxyasbestinin D (18) was 
achieved from butan-1,4-diol 178 in 31 steps and an overall yield of 2% (Figure 35). The 
first enantioselective total syntheses of five further members of the 4-deoxyasbestinin series 
of natural products were also accomplished: 4-deoxyasbestinin C (19), asbestinin 10 (15), 
asbestinin 20 (14), asbestinin 21 (288) and asbestinin 23 (266). Syntheses of the natural 
product epimers, 6-epi-asbestinin 20 (16), 7-epi-asbestinin 21 (223) and 7-epi-asbestinin 23 
(289) were also completed. 
 
Figure 35: Structures of Members of the Asbestinin Family Synthesised 
The completed total syntheses of asbestinin 10 (15), asbestinin 20 (14) and asbestinin 23 
(266) confirmed the structural reassignment of these natural products by Rodriguez and 
Ospina.[11] In the case of asbestinin 21 (288), completion of the total synthesis resulted in its 
structural reassignment because the structure (223) that had been assigned to it previously 
was in fact an epimer of the natural product. 
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The synthetic route towards the asbestinins started from butan-1,4-diol 178 which could be 
transformed into allylic alcohol 160 in 6 steps. From here, allylic alcohol 160 was converted 
into ketone 167 in eight steps to give the bicyclic core of the asbestinins (Scheme 109). Key 
reactions in the synthesis of this bicyclic core included a samarium-mediated reductive 
cyclisation to from a tetrahydropyranol and subsequent tandem oxonium ylide formation and 
[2,3]-sigmatropic rearrangement to give the core structure.  
 
Scheme 109: General Synthetic Route for the Synthesis of Tetracyclic Ketone 221 
The tricyclic core of the asbestinins was prepared from the bicyclic ketone 167 in four further 
steps. The sequence involves a Stille/Diels–Alder cycloaddition sequence to construct the 
cyclohexyl ring. The tricyclic ketone 173 was then converted into the tetracyclic core of the 
asbestinins in eight steps. Key reactions in the synthesis of the tetracyclic core included 
triflation followed by palladium-mediated carbonylation, to insert an additional one-carbon 
unit, and triflate displacement to form the oxepane. 
Diazomethane is required to synthesise the diazoketone 165 which is then converted to 
bicyclic ketone 167 by tandem oxonium ylide formation and [2,3]-sigmatropic 
rearrangement (Scheme 110). Diazomethane can be difficult to handle on large scale because 
of its explosive nature and the limitations of the specialised glassware required to generate 
it. For this reason, alternative routes to prepare the bicyclic ketone 167 were investigated. It 
was demonstrated that a rhodium-mediated reaction of the triazole 237 could be used to 
synthesise the bicyclic ketone 167 with high selectivity. Subjection of the alkyne 236 to 
sequential gold-catalysed α-oxo gold carbene formation and oxonium ylide generation 
followed by [2,3]-sigmatropic rearrangement was unsuccessful. 
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Scheme 110: Routes to the Bicyclic Ketone 167 
Tetracyclic ketone 221 was converted into 11-acetoxy-4-deoxyasbestinin D (18) in five steps 
(Scheme 111). 4-Deoxyasbestinin C (19) was also synthesised from the tetracyclic ketone 
221 in five steps. Four further members of the 4-deoxyasbestinin group of natural products 
were synthesised from 11-acetoxy-4-deoxyasbestinin D (18), in 2-4 steps.   
 
Scheme 111: Summary of Synthetic Routes to 11-Acetoxy-4-deoxyasbestinin D (18) and Related Natural 
Products 
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4.1.1 Comparison of Strategies Employed in the Synthesis of 
11-Acetoxy-4-deoxyasbestinin D (18) 
A direct comparison of total step count shows that Crimmins and Ellis completed the 
synthesis of 11-acetoxy-4-deoxyasbestinin D (18) in 26 steps starting from commercially 
available R-benzyl glycidyl ether 26 (Section 1.2.2). The expensive nature of R-benzyl 
glycidyl ether 26 would result in an increased step count when synthesised from cheaper 
starting materials. In comparison, starting from butan-1,4-diol 178, the synthesis of 
11-acetoxy-4-deoxyasbestinin D (18) was completed in 31 steps using a readily abundant 
starting material. Comparable overall yields of 4% and 2% respectively were achieved. 
Crimmins and Ellis utilised a RCM approach for the synthesis of the nine-membered 
oxonene followed by intramolecular Diels–Alder cycloaddition to form the 6,5,9-tricyclic 
ring system. This differs from the strategy detailed in Section 3 which involved a 
samarium-mediated cyclisation to form a tetrahydropyranol which then underwent tandem 
oxonium ylide formation and [2,3]-sigmatropic rearrangement to give the 9,5-bicyclic ring 
system. From here, a Stille/intermolecular Diels–Alder cycloaddition sequence built up the 
6,5,9-tricyclic core. 
A key difference in synthetic strategy related to construction of the final seven-membered 
ring. Crimmins and Ellis had to perform an asymmetric hydroboration-etherification 
procedure using a chiral borane reagent to install the desired stereochemistry at the C-15 
position and the required alcohol for etherification. Subsequent silyl deprotection followed 
by triflate formation and displacement gave the desired tetracycle and completed their 
synthesis of 11-acetoxy-4-deoxyasbestinin D (18). In comparison, the C-15 stereocentre was 
installed stereoselectively using substrate control through initial formation of the tetracyclic 
system by etherification followed by hydrogenation of the exo-alkene. 
The C-12 methyl stereocentre proved difficult in both syntheses with the need for 
epimerisation of the C-12 epimer being performed in the synthetic routes. Crimmins and 
Ellis formed the C-12 stereocentre on the tricyclic system through hydrolysis of an enol ether 
while reduction of a tetracyclic enone was the method chosen in the work detailed in this 
thesis.  
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4.2 Future Work 
Future work on the asbestinins should focus on three main areas: improving the 
diastereoselectivity during introduction of the methyl substituent at the C-12 position on the 
tetracyclic core, completion of further members of the 4-deoxyasbestinin series and 
α-hydroxylation of the tricyclic ketone so that members of the 4-hydroxylated asbestinin 
series can be synthesised. 
Introduction of the methyl substituent at the C-12 position could be achieved 
diastereoselectively by screening various reducing reagents such as samarium diiodide 
which has been shown to reduce enones (Scheme 112).[105-109] 
 
Scheme 112: Reduction of Tetracyclic Enone 260 
To address the failure to open the epoxide 292 to give diol 296, further work should focus 
on the discovery of alternative conditions to facilitate ring-opening while leaving the acetate 
group intact (Scheme 113). This would then allow the completion of the proposed structure 
of asbestinin 25 (267) after methylation of the secondary alcohol. As an alternative, the 
acetate should be replaced by a temporary protecting group. 
 
Scheme 113: Strategy for the Synthesis of Asbestinin 25 (267) 
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Other members of the 4-deoxyasbestinin series that could be synthesised are asbestinin 24 
(306) and asbestinin 26 (268, Scheme 114).[11] Asbestinin 24 (306) could be synthesised 
from asbestinin 20 (14) by directed hydrogenation followed by methylation of the hydroxyl 
group. For asbestinin 26 (268), dehydration of 7-epi-asbestinin 21 (223) might produce 
enone 307 which could then undergo 1,2-reduction to give asbestinin 26 (268). 
 
Scheme 114: Proposed Synthetic Routes for Asbestinins 24 (306) and 26 (268) 
Finally, the α-hydroxylation of tricyclic ketone 308 would be investigated further and an 
appropriate hydroxyl protecting group would be used so that α-hydroxylation using Davis 
oxaziridine could be explored (Scheme 115).[22] This would allow the completion of 
members of the 4-hydroxylated series of asbestinins such as asbestinin 12 (22).[10] 
 
Scheme 115: Synthetic Route to Asbestinin 12 (22) 
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5. Experimental 
 
5.1 General Experimental 
Reagents and solvents were purchased from commercial suppliers and were used without 
further purification, unless otherwise stated.  
Air and/or moisture sensitive reactions were performed under an atmosphere of argon in 
flame-dried apparatus. THF, toluene, acetonitrile, dichloromethane and diethyl ether were 
purified using a Pure-SolvTM 500 Solvent Purification System. Reactions were monitored 
by thin layer chromatography (TLC) using Merck silica gel 60 covered aluminium backed 
plates F254. TLC plates were visualised under UV light and stained using potassium 
permanganate solution or acidic ethanolic anisaldehyde solution. Flash column 
chromatography was performed with silica gel (Geduran Si 60 35-70 µm, purchased from 
Merck and SilicaGel 60A 40-63 µm, purchased from Fluorochem) as the solid support. 
Petroleum ether used for column chromatography was the 40–60 °C fraction.  
IR spectra were recorded as thin films employing a Shimadzu FTIR-8400S spectrometer 
equipped with a Pike Technologies MIRacle ATR accessory; selected frequencies (νmax) are 
reported. NMR spectra were recorded using dilute solutions in deuterated chloroform or 
benzene on a Bruker AvanceIII 400 MHz, or Bruker AvanceIII UltraShield 500 MHz 
spectrometer using the deuterated solvent as the internal deuterium lock. 1H chemical shift 
data are given in units δ relative to the residual protic solvent where δ (CDCl3) = 7.26 ppm 
and δ (C6D6) = 7.16 ppm. 1H signals are described as singlets (s), doublets (d), triplets (t), 
quartets (q), multiplets (m), broad (br), apparent (app) or a combination of these. 
13C chemical shift data were recorded with broadband proton decoupling and are given in 
units δ relative to the solvent where δ (CDCl3) = 77.16 ppm and δ (C6D6) = 128.1 ppm. 
Assignments were determined using 2D NMR spectra (COSY, HSQC and HMBC). High 
resolution mass spectra (HRMS) were recorded using positive chemical ionisation (CI+) and 
ion impact (EI+) on a Joel MStation JMS-700 instrument or using positive ion electrospray 
(ESI+) technique on a Bruker micrOTOF-Q instrument by technical staff at the University 
of Glasgow.  
Melting points were recorded using a Barnstead Electrothermal 9100 melting point 
apparatus. Where no solvent is indicated, the solids obtained from the described procedure 
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were melted directly without recrystallisation. Optical rotations ([α]D) were determined 
using a Rudolph Research Analytical Autopol IV or V digital polarimeter. Elemental 
analyses were performed using an Exeter Analytical Elemental Analyser EA 440. X-ray 
crystallography was performed at the University of Glasgow by Dr. Claire Wilson. 
5.1.1 Nomenclature 
The carbon numbering drawn on the molecule corresponds to the conventional asbestinin 
numbering used for NMR signal assignment (Figure 36).[2] IUPAC numbering was used for 
the molecular names.  
 
Figure 36: Carbon Numbering in the Asbestinins Skeleton 
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Ethyl (2E)-3-{[(3R)-6-[(tert-butyldimethylsilyl)oxy]-2-methylhex-1-en-3-yl]oxy}prop-
2-enoate (161)[64] 
 
To a stirred solution of allylic alcohol 160 (1.0 g, 4.1 mmol) in anhydrous dichloromethane 
(10 mL) was added ethyl propiolate (0.83 mL, 8.2 mmol) and N-methylmorpholine 
(0.90 mL, 8.2 mmol) at room temperature. The resulting solution was left to stir for 16 hours 
before being concentrated under reduced pressure. The residue was purified by flash column 
chromatography on silica gel (petroleum ether-ethyl acetate, 15:1) to afford ester 161 
(0.51 g, 36%) as a colourless oil. 
Rf = 0.68 (petroleum ether-ethyl acetate, 5:1); νmax 2955, 2930, 2858, 1711, 1642, 1472, 
1254, 833, 775 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.44 (1H, d, J = 12.4 Hz, CH-C8), 5.21 
(1H, d, J = 12.4 Hz, CH-C9), 4.94 (1H, s, CH2-C6a), 4.92 (1H, s, CH2-C6b), 4.22 (1H, dd, 
J = 7.6, 5.2 Hz, CH-C4), 4.11 (2H, app qd, J = 7.2, 1.6 Hz, CH2-OEt), 3.62−3.53 (2H, m, 
CH2-C1), 1.78−1.65 (2H, m, CH2-C2), 1.62 (3H, s, CH3-C7), 1.58−1.41 (2H, m, CH2-C3), 
1.22 (3H, app t, J = 7.2 Hz, CH3-OEt), 0.84 (9H, s, CH3-tBu OTBS), 0.00 (6H, s, 
2 × CH3-OTBS); 
13C NMR (101 MHz, CDCl3) δ 168.2 (C-C10), 161.6 (CH-C8), 142.9 
(C-C5), 114.8 (CH2-C6), 98.0 (CH-C9), 86.7 (CH-C4), 62.7 (CH2-C1), 59.8 (CH2-OEt), 29.6 
(CH2-C2), 28.6 (CH2-C3), 26.1 (CH3-tBu OTBS), 18.5 (C-tBu OTBS), 17.0 (CH3-C7), 14.5 
(CH3-OEt), −5.2 (2 × CH3-OTBS); [α]D
23 −11.2 (c = 0.505, CHCl3) {Lit.64 [α]D
18 −7.94 
(c = 1.41, CHCl3); HRMS (ESI+) [M+Na]
+ calcd. for C18H34O4SiNa 365.2106, found 
365.2119, Δ 3.5 ppm. 
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Ethyl (2E)-3-{[(3R)-6-hydroxy-2-methylhex-1-en-3-yl]oxy}prop-2-enoate (226)[64] 
 
To a stirred solution of allylic alcohol 160 (20.0 g, 82.0 mmol) in anhydrous 
dichloromethane (200 mL) was added ethyl propiolate (16.3 mL, 164 mmol) and 
N-methylmorpholine (18.0 mL, 164 mmol) at room temperature. The resulting solution was 
left to stir for 16 hours before being concentrated under reduced pressure. The crude mixture 
was passed through a small column of silica (petroleum ether-ethyl acetate, 4:1) to remove 
any polar impurities giving vinylogous carbonate 161, which was used in the next without 
further purification.  
To a stirred solution of vinylogous carbonate 161 in ethanol (660 mL) was added 
camphorsulfonic acid (3.80 g, 16.4 mmol) in one portion. The resulting solution was stirred 
for 16 hours before the reaction was quenched by the addition of sodium bicarbonate (1.38 g, 
16.4 mmol). The remaining solids were removed by filtration before the filtrate was 
concentrated under reduced pressure. The residue was purified by flash column 
chromatography on silica gel (petroleum ether-ethyl acetate, gradient elution from 
5:1 → 1:1) to afford alcohol 226 (15.6 g, 83%) as a yellow oil. 
Rf = 0.30 (petroleum ether-ethyl acetate, 2:1); νmax 3439, 2949, 1705, 1638, 1620, 1447, 
1228, 959, 831 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.50 (1H, d, J = 12.4 Hz, CH-C8), 5.28 
(1H, d, J = 12.4 Hz, CH-C9), 5.01 (1H, s, CH2-C6a), 4.99 (1H, s, CH2-C6b), 4.30 (1H, dd, 
J = 7.6, 5.2 Hz, CH-C4), 4.14 (2H,  app qd, J = 7.2, 1.5 Hz, CH2-OEt), 3.71−3.67 (2H, m, 
CH2-C1), 1.89−1.73 (2H, m, CH2-C2), 1.70 (3H, s, CH3-C7), 1.67−1.55 (2H, m, CH2-C3), 
1.51 (1H, br s, OH), 1.28 (3H, app t, J = 7.2 Hz, CH3-OEt); 
13C NMR (101 MHz, CDCl3) 
δ 168.1 (C-C10), 161.3 (CH-C8), 142.7 (C-C5), 114.7 (CH2-C6), 98.1 (CH-C9), 86.4 
(CH-C4), 62.4 (CH2-C1), 59.7 (CH2-OEt), 29.5 (CH2-C3), 28.5 (CH2-C2), 17.0 (CH3-C7), 
14.5 (CH3-OEt); [α]D
23
 −10.8 (c = 0.495, CHCl3) {Lit.64 [α]D
24
 −8.30 (c = 1.01, CHCl3);  
HRMS (ESI+) [M+Na]+ calcd. for C12H20O4Na 251.1245, found 251.1254, Δ 3.5 ppm. 
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Ethyl (2E)-3-{[(3R)-2-methyl-6-oxohex-1-en-3-yl]oxy}prop-2-enoate (162)[64] 
 
To a stirred solution of oxalyl chloride (6.86 mL, 81.1 mmol) in anhydrous dichloromethane 
(75 mL) at −78 °C was added a solution of anhydrous DMSO (5.76 mL, 81.1 mmol) in 
anhydrous dichloromethane (75 mL) dropwise by cannula. The resulting solution was stirred 
for 30 minutes before a solution of alcohol 226 (15.3 g, 67.0 mmol) in anhydrous 
dichloromethane (80 mL) was added dropwise by cannula. The reaction mixture was left to 
stir for 3 hours and to this was added triethylamine (37.6 mL, 268 mmol) and warmed to 
room temperature over 1 hour. The reaction mixture was diluted with dichloromethane 
(100 mL) and water (150 mL). The aqueous phase was separated and extracted with 
dichloromethane (2 × 50 mL). The combined organic extracts were washed with brine 
(100 mL), dried (MgSO4) and concentrated under reduced pressure. The residue was purified 
by flash column chromatography on silica gel (petroleum ether-ethyl acetate, gradient 
elution from 10:1 → 5:1) to afford aldehyde 162 (13.2 g, 87%) as a colourless oil. 
Rf = 0.45 (petroleum ether-ethyl acetate, 5:1); νmax 2980, 2729, 1705, 1640, 1622, 1447, 
1283, 955, 912, 833 cm−1; 1H NMR (400 MHz, CDCl3) δ 9.80 (1H, t, J = 1.2 Hz, CH-C1), 
7.45 (1H, d, J = 12.4 Hz, CH-C8), 5.27 (1H, d, J = 12.4 Hz, CH-C9), 5.03 (1H, s, CH2-C6a), 
4.99 (1H, s, CH2-C6b), 4.31 (1H, dd, J = 7.6, 5.2 Hz, CH-C4), 4.17 (2H, app qd, J = 7.2, 1.5 
Hz, CH2-OEt), 2.58−2.54 (2H, m, CH2--C2), 2.12−1.94 (2H, m, CH2-C3), 1.70 (3H, s, 
CH3-C7), 1.27 (3H, app t, J = 7.2 Hz, CH3-OEt); 
13C NMR (101 MHz, CDCl3) δ 200.9 
(CH-C1), 167.8 (C-C10), 160.9 (CH-C8), 142.1 (C-C5), 115.0 (CH2-C6), 98.5 (CH-C9), 
85.0 (CH-C4), 59.8 (CH2-OEt), 39.6 (CH2-C2), 25.6 (CH2-C3), 17.0 (CH3-C7), 14.4 
(CH3-OEt); [α]D
23
 −18.0 (c = 0.500, CHCl3) {Lit.64 [α]D
23
 −1.90 (c = 1.00, CHCl3); HRMS 
(ESI+) [M+Na]+ calcd. for C12H18O4Na 249.1098, found 249.1097, Δ 0.3 ppm. 
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Ethyl 2-[(2R,3S,6R)-3-hydroxy-6-(prop-1-en-2-yl)oxan-2-yl] acetate (163)[64] 
 
To a stirred solution of aldehyde 162 (4.00 g, 19.7 mmol) and anhydrous methanol (2.90 mL, 
70.7 mmol) in anhydrous THF (170 mL) at room temperature was added a freshly prepared 
solution of samarium diiodide (0.2 м in THF) until the solution remained dark blue in colour 
(approx. 4 equiv.). The resulting solution was stirred for 30 minutes before the reaction was 
quenched with saturated aqueous solution of sodium thiosulfate (240 mL) and diluted with 
ethyl acetate (90 mL). The aqueous phase was separated and extracted with ethyl acetate 
(3 × 60 mL). The combined organic extracts were washed with brine (200 mL), dried 
(MgSO4) and concentrated under reduced pressure. The residue was purified by flash column 
chromatography on silica gel (petroleum ether-ethyl acetate, gradient elution from 
6:1 → 2:1) to afford tetrahydropyranol 163 (3.22 g, 79%) as a colourless oil.  
Rf = 0.45 (petroleum ether-ethyl acetate, 2:1); νmax 3451, 2942, 1736, 1721, 1651, 1439, 
1258, 990, 901 cm−1; 1H NMR (400 MHz, CDCl3) δ 4.95 (1H, s, CH2-C6a), 4.82 (1H, s, 
CH2-C6b), 4.17 (2H, q, J = 7.2 Hz, CH2-OEt), 3.76 (1H, d, J = 9.6 Hz, CH-C4), 3.65−3.60 
(1H, ddd, J = 9.2, 6.8, 4.8 Hz, CH-C8), 3.44−3.37 (1H, m, CH-C1), 2.84 (1H, dd, J = 15.2, 
4.8 Hz, CH2-C9a), 2.59 (1H, dd, J = 15.2, 6.8 Hz, CH2-C9b), 2.20−2.15 (2H, m, CH2-C2a, 
HO-C1), 1.88−1.83 (1H, m, CH2-C3a), 1.73 (3H, s, CH3-C7), 1.57−1.52 (2H, m, CH2-C2b, 
CH2-C3b), 1.28 (3H, t, J = 7.2 Hz, CH3-OEt); 
13C NMR (101 MHz, CDCl3) δ 172.3 (C-C10), 
145.0 (C-C5), 110.5 (CH2-C6), 80.1 (CH-C4), 78.9 (CH-C8), 70.4 (CH-C1), 60.6 
(CH2-OEt), 38.8 (CH2-C9), 33.1 (CH2-C2), 29.7 (CH2-C3), 19.1 (CH3-C7), 14.2 (CH3-OEt); 
[α]D
23
 +34.6 (c = 0.500, CHCl3) {Lit.
64 [α]D
25
 +42.6 (c = 1.02, CHCl3); HRMS (ESI+) 
[M+Na]+ calcd. for C12H20O4Na 251.1254, found 251.1254, Δ 0.2 ppm. 
 
 
  
 Experimental 
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Ethyl 2-[(2R,3S,6R)-3-[(tert-butyldimethylsilyl)oxy]-6-(prop-1-en-2-yl)oxan-2-yl] 
acetate (229)[64] 
 
To a stirred solution of alcohol 163 (6.31 g, 27.6 mmol) and imidazole (3.76 g, 55.3 mmol) 
in anhydrous DMF (60 mL) at room temperature was added tert-butyldimethylsilyl chloride 
(7.50 g, 49.8 mmol) portionwise over 5 minutes. The resulting solution was stirred for 
16 hours before the reaction was quenched by the addition of water (400 mL) and diluted 
with diethyl ether (200 mL). The aqueous phase was separated and the organic phase washed 
with water (5 × 150 mL). The aqueous portions were combined and extracted with diethyl 
ether (250 mL). The combined organic extracts were washed with brine (200 mL), dried 
(MgSO4) and concentrated under reduced pressure. The residue was purified by flash column 
chromatography on silica gel (petroleum ether-ethyl acetate, gradient elution from 
40:1 → 20:1) to afford silyl ether 229 (9.46 g, quant.) as a colourless oil. 
Rf = 0.72 (petroleum ether-ethyl acetate, 5:1); νmax 2930, 2857, 1740, 1653, 1464, 1251, 899, 
835, 775, 669 cm−1; 1H NMR (400 MHz, CDCl3) δ 4.84 (1H, s, CH2-C6a), 4.76 (1H, s, 
CH2-C6b), 4.08 (2H, q, J = 7.2 Hz, CH2-OEt), 3.67 (1H, d, J = 10.0 Hz, CH-C4), 3.58 (1H, 
ddd, J = 9.2, 9.2, 3.2 Hz, CH-C8), 3.34−3.28 (1H, m, CH-C1), 2.74 (1H, dd, J = 14.8, 3.2 
Hz, CH2-C9a), 2.31 (1H, dd, J = 14.8, 9.2 Hz, CH2-C9b), 1.99−1.95 (1H, m, CH2-C2a), 
1.76−1.72 (1H, m, CH2-C3a), 1.64 (3H, s, CH3-C7), 1.51−1.41 (2H, m, CH2-C2b, CH2-C3b), 
1.18 (3H, t, J = 7.2 Hz, CH3-OEt), 0.81 (9H, s, CH3-tBu OTBS), 0.00 (3H, s, CH3-OTBS), 
−0.01 (3H, s, CH3-OTBS); 13C NMR (101 MHz, CDCl3) δ 171.9 (C-C10), 145.1 (C-C5), 
110.2 (CH2-C6), 79.9 (CH-C4), 79.5 (CH-C8), 70.8 (CH-C1), 60.3 (CH2-OEt), 38.3 
(CH2-C9), 33.4 (CH2-C2), 29.6 (CH2-C3), 25.8 (CH3-tBu), 19.2 (CH3-C7), 17.9 (C-tBu), 
14.3 (CH3-OEt), −4.0 (CH3-Si), −4.8 (CH3-Si); [α]D
23
 +70.2 (c = 0.505, CHCl3) {Lit.
64 [α]D
24
 
+59.0 (c = 1.03, CHCl3); HRMS (ESI+) [M+Na]
+ calcd. for C18H34O4SiNa 365.2108, found 
365.2119, Δ 3.0 ppm. 
 
 
  
 Experimental 
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2-[(2R,3S,6R)-3-[(tert-Butyldimethylsilyl)oxy]-6-(prop-1-en-2-yl)oxan-2-yl] acetic acid 
(164)[64] 
 
To a stirred solution of ester 229 (9.40 g, 27.5 mmol) in ethanol (135 mL) and water (45 mL) 
was added lithium hydroxide (2.63 g, 110 mmol) portionwise over 5 minutes at room 
temperature. The reaction mixture was stirred for 16 hours before being acidified to pH 2-3 
with aqueous HCl (1 M). The reaction mixture was diluted with ethyl acetate (250 mL) and 
water (150 mL). The aqueous phase was separated and extracted with ethyl acetate 
(3 × 100 mL). The combined organic extracts were washed with brine (100 mL), dried 
(MgSO4) and concentrated under reduced pressure. The residue was purified by flash column 
chromatography on silica gel (petroleum ether-ethyl acetate, gradient elution from 
40:1 → 2:1) to afford carboxylic acid 164 (7.39 g, 86%) as a colourless oil. 
Rf = 0.28 (petroleum ether-ethyl acetate, 5:1); νmax 2930, 2859, 1713, 1653, 1437, 1252, 899, 
835, 775, 669 cm−1; 1H NMR (400 MHz, CDCl3) δ 4.87 (1H, s, CH2-C6a), 4.75 (1H, s, 
CH2-C6b), 3.73 (1H, d, J = 10.0 Hz, CH-C4), 3.56 (1H, ddd, J = 8.8, 8.8, 3.2 Hz, CH-C8), 
3.33−3.27 (1H, m, CH-C1), 2.80 (1H, dd, J = 15.6, 3.2 Hz, CH2-C9a), 2.39 (1H, dd, J = 
15.6, 8.8 Hz, CH2-C9b), 2.00−1.96 (1H, m, CH2-C2a), 1.77−1.71 (1H, m, CH2-C3a), 1.65 
(3H, s, CH3-C7), 1.51−1.45 (2H, m, CH2-C2b, CH2-C3b), 0.81 (9H, s, CH3-tBu OTBS), 0.00 
(6H, s, 2 × CH3-OTBS); 
13C NMR (101 MHz, CDCl3) δ 175.5 (C-C10), 144.6 (C-C5), 110.9 
(CH2-C6), 80.5 (CH-C4), 78.9 (CH-C8), 70.6 (CH-C1), 37.7 (CH2-C9), 33.2 (CH2-C2), 29.5 
(CH2-C3), 25.7 (CH3-tBu OTBS), 19.0 (CH3-C7), 17.9 (C-tBu OTBS), −4.0 (CH3-OTBS), 
−4.8 (CH3-OTBS); [α]D
22 +68.0 (c = 0.500, CHCl3) {Lit.64 [α]D
25
 +67.5 (c = 1.00, CHCl3); 
HRMS (ESI+) [M+Na]+ calcd. for C16H30O4SiNa 337.1800, found 337.1806, Δ 1.8 ppm. 
 
 
  
 Experimental 
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1-[(2R,3S,6R)-3-[(tert-Butyldimethylsilyl)oxy]-6-(prop-1-en-2-yl)oxan-2-yl]-3-
diazopropan-2-one (165)[64] 
 
To a stirred solution of carboxylic acid 164 (3.00 g, 9.54 mmol) and triethylamine (1.86 mL, 
13.4 mmol) in anhydrous diethyl ether (100 mL) was added isobutyl chloroformate 
(1.61 mL, 12.4 mmol) dropwise over 5 minutes and the resulting solution left to stir for 
2.5 hours. The solution was filtered under suction and the residue left behind washed with 
diethyl ether (10 mL) then immediately added to a freshly prepared ethereal solution of 
diazomethane (approx. 95 mmol). The resulting solution was left to stir for 3 days before the 
reaction was quenched by the addition of glacial acetic acid (12.0 mL, 210 mmol) and poured 
into a saturated aqueous solution of sodium bicarbonate (300 mL) with vigorous stirring and 
left for 15 minutes. The aqueous phase was separated and extracted with ethyl acetate 
(3 × 100 mL). The combined organic extracts were washed with brine (200 mL), dried 
(MgSO4) and concentrated under reduced pressure. The residue was purified by flash column 
chromatography on silica gel (petroleum ether-ethyl acetate, gradient elution from 
20:1 → 10:1) to afford diazo-ketone 165 (2.69 g, 83%) as a yellow oil. 
Rf = 0.46 (petroleum ether-ethyl acetate, 5:1); νmax 3092, 2930, 2857, 2101, 1641,1252, 897, 
835, 775, 669 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.33 (1H, br s, CH-C11), 4.86 (1H, s, 
CH2-C6a), 4.74 (1H, s, CH2-C6b), 3.66 (1H, br d, J = 10.0 Hz, CH-C4), 3.52 (1H, ddd, 
J = 9.2, 9.2, 2.4 Hz, CH-C8), 3.27 (1H, ddd, J = 9.2, 4.8, 4.8 Hz, CH-C1), 2.71 (1H, dd, J = 
14.4, 2.4 Hz, CH2-C9a), 2.37−2.31 (1H, m, CH2-C9b), 2.00−1.95 (1H, m, CH2-C2a), 
1.76−1.72 (1H, m, CH2-C3a), 1.65 (3H, s, CH3-C7), 1.53−1.37 (2H, m, CH2-C2b, CH2-C3b), 
0.81 (9H, s, CH3-tBu OTBS), 0.00 (6H, s, 2 × CH3-OTBS); 
13C NMR (101 MHz, CDCl3) 
δ 193.6 (C-C10), 145.2 (C-C5), 110.3 (CH2-C6), 80.1 (CH-C4), 79.8 (CH-C8), 70.7 (CH-
C1), 55.2 (CH-C11), 44.0 (CH2-C9), 33.4 (CH2-C2), 29.7 (CH2-C3), 25.8 (CH3-tBu OTBS), 
19.2 (CH3-C7), 17.9 (C-tBu OTBS), −4.0 (CH3-OTBS), −4.7 (CH3-OTBS); [α]D
22
 +88.8 
(c = 0.500, CHCl3) {Lit.
64 [α]D
23
 +95.7 (c = 1.01, CHCl3); HRMS (ESI+) [M+Na]
+ calcd. for 
C17H30N2O3SiNa 361.1921, found 361.1918, Δ 1.0 ppm.  
 Experimental 
 
 
110 
 
(1R,2S,5Z,8R)-2-[(tert-Butyldimethylsilyl)oxy]-6-methyl-11-oxabicyclo[6.2.1]undec-5-
en-9-one (167)[64] and (1R,2S,5E,8R)-2-[(tert-Butyldimethylsilyl)oxy]-6-methyl-11-
oxabicyclo[6.2.1]undec-5-en-9-one (168)[64] 
 
To a stirred solution of Cu(hfacac)2 (263 mg, 0.551 mmol) in anhydrous dichloromethane 
(130 mL) at reflux was added a solution of diazo-ketone 165 (3.73 g, 11.0 mmol) in 
anhydrous dichloromethane (570 mL) dropwise over 1 hour while maintaining reflux. The 
resulting solution was left to stir for 30 minutes before being cooled to room temperature. 
The volatiles were removed under reduced pressure before rapid flash column 
chromatography on deactivated alumina (Brockmann III, petroleum ether-ethyl acetate, 
15:1) allowed removal of the catalyst. The residue was purified by flash column 
chromatography on silver nitrate (10% w/w) impregnated silica gel (petroleum ether-ethyl 
acetate, gradient elution from 40:1 → 10:1) to afford Z-alkene 167 (2.53 g, 74%) and 
E-alkene 168 (0.55 g, 16%) as colourless solids. 
167: Rf = 0.60 (petroleum ether-ethyl acetate, 5:1); m.p. 87−89 °C; νmax 2928, 2857, 1753, 
1470, 1260, 947, 833, 775 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.36 (1H, dd, J = 11.6, 5.6 
Hz, CH-C6), 4.19 (1H, dd, J = 4.4, 4.4 Hz, CH-C9), 4.12 (1H, dd, J = 8.4, 8.4 Hz, CH-C2), 
3.37 (1H, ddd, J = 11.2, 8.4, 2.8 Hz, CH-C3), 2.76−2.64 (3H, m, CH2-C1a, CH2-C5a, 
CH2-C8a), 2.25 (1H, d, J = 17.6 Hz, CH2-C1b), 2.17 (1H, dd, J = 14.8, 4.4 Hz, CH2-C8b), 
1.96−1.89 (1H, m, CH2-C5b), 1.86−1.78 (1H, m, CH2-C4a), 1.70 (3H, s, CH3-C11), 
1.64−1.55 (1H, m, CH2-C4b), 0.81 (9H, s, CH3-tBu OTBS), 0.00 (3H, s, CH3-OTBS), −0.04 
(3H, s, CH3-OTBS); 
13C NMR (101 MHz, CDCl3) δ 215.8 (C-C10), 132.4 (C-C7), 127.5 
(CH-C6), 80.3 (CH-C2), 78.8 (CH-C9), 75.3 (CH-C3), 42.3 (CH2-C1), 33.3 (CH2-C8), 33.1 
(CH2-C4), 26.7 (CH3-C11), 25.8 (CH2-C5, CH3-tBu OTBS), 17.9 (C-tBu OTBS), −3.9 
(CH3-OTBS), −4.5 (CH3-OTBS); [α]D
22
 +11.2 (c = 0.505, CHCl3) {Lit.
64 [α]D
28
 +31.8 
(c = 1.03, CHCl3); HRMS (CI+, isobutane) [M+H]
+ calcd. for C17H31O3Si 311.2042, found 
311.2042, Δ 0.0 ppm. 
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168: Rf = 0.60 (petroleum ether-ethyl acetate, 5:1); m.p. 57−59 °C ;νmax 2930, 2859, 1755, 
1462, 1258, 910, 835, 773 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.35 (1H, dd, J = 12.0, 4.2 
Hz, CH-C6), 4.16−4.11 (2H, m, CH-C2, CH-C9), 3.02 (1H, dd, J = 9.2, 8.0 Hz, CH-C3), 
2.77 (1H, ddd, J = 17.6, 9.2, 1.2 Hz, CH2-C1a), 2.56−2.48 (2H, m, CH2-C8), 2.27 (1H, d, 
J = 17.6 Hz, CH2-C1b), 2.24−2.12 (2H, m, CH2-C5), 1.96 (1H, dddd, J = 14.0, 11.6, 7.6, 3.6 
Hz, CH2-C4a), 1.70 (1H, ddd, J = 14.0, 3.6, 3.6 Hz, CH2-C4b), 1.55 (3H, s, CH3-C11), 0.86 
(9H, s, CH3-tBu OTBS), 0.08 (3H, s, CH3-OTBS), 0.03 (3H, s, CH3-OTBS); 
13C NMR 
(101 MHz, CDCl3) δ 217.2 (C-C10), 133.2 (C-C7), 124.7 (CH-C6), 80.8 (CH-C2), 78.3 
(CH-C9), 76.5 (CH-C3), 41.9 (CH2-C1), 40.3 (CH2-C8), 35.7 (CH2-C4), 26.9 (CH2-C5), 
25.7 (CH3-tBu OTBS), 18.8 (CH3-C11), 17.8 (C-tBu OTBS), −3.9 (CH3-OTBS), −4.9 
(CH3-OTBS); [α]D
22
 −3.0 (c = 0.50, CHCl3) {Lit.64 [α]D
28
 −38.7 (c = 0.99, CHCl3); HRMS 
(ESI+) [M+Na]+ calcd. for C17H30O3SiNa 333.1846, found 333.1856, Δ 3.1 ppm. 
  
 Experimental 
 
 
112 
 
(1R,2S,5Z,8R)-2-[(tert-Butyldimethylsilyl)oxy]-6-methyl-11-oxabicyclo[6.2.1]undec-5-
en-9-one (167) 
  
To a stirred solution of E-alkene 168 (1.50 g, 4.83 mmol) and ethanethiol (3.50 mL, 
48.3 mmol), in anhydrous PhMe (100 mL) was added Vazo™ 88 (0.24 g, 1.0 mmol) in one 
portion and the resulting solution was heated to 90 °C for 3 hours. The reaction mixture was 
cooled down to room temperature and concentrated under reduced pressure. The residue was 
purified by flash column chromatography on silica gel (petroleum ether-ethyl acetate, 
gradient elution from 50:1 → 25:1) to afford Z-alkene 167 (1.18 g, 79%) as a colourless 
solid. 
The NMR (1H and 13C), IR and mass spectrometry data were consistent with those reported 
for compound 167 previously (see p. 110). 
 
 
  
 Experimental 
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tert‐Butyldimethyl{[(2R,3S,6R)‐6‐(prop‐1‐en‐2‐yl)‐2‐(prop‐2‐yn‐1‐yl)oxan‐3‐
yl]oxy}silane (236) 
 
To a stirred solution of ester 229 (1.75 g, 5.11 mmol) in anhydrous dichloromethane 
(100 mL) at −78 °C was added DIBAL-H (5.50 mL of a 1.0 M solution in dichloromethane, 
5.50 mmol) dropwise over 5 minutes. The resulting solution was left to stir for 1 hour before 
the reaction was quenched by the addition of water (15 mL) and warmed to 0 °C for 
15 minutes. A saturated aqueous solution of potassium sodium tartrate (30 mL) was added 
and the resulting solution stirred vigorously for 1 hour at room temperature (two clear phases 
were obtained). The aqueous phase was separated and extracted with ethyl acetate 
(3 × 30 mL). The combined organic extracts were washed with brine (50 mL), dried 
(MgSO4) and concentrated under reduced pressure to give crude aldehyde 234, which was 
used in the next step without further purification.  
To a stirred solution of aldehyde 234 and potassium carbonate (1.41 g, 10.2 mmol) in 
anhydrous methanol (100 mL) at room temperature was added Bestmann-Ohira reagent 
(1.30 mL, 8.66 mmol) dropwise over 5 minutes. The resulting solution was stirred for 
16 hours before the reaction was quenched by the addition of a saturated aqueous solution 
of sodium bicarbonate (40 mL) and diluted with water (80 mL) and ethyl acetate (200 mL). 
The aqueous phase was separated and extracted with ethyl acetate (3 × 80 mL). The 
combined organic extracts were washed with brine (150 mL), dried (MgSO4) and 
concentrated under reduced pressure. The residue was purified by flash column 
chromatography on silica gel (petroleum ether-ethyl acetate, 100:1) to afford alkyne 236 
(1.29 g, 86%) as a colourless oil. 
Rf = 0.83 (petroleum ether-ethyl acetate, 20:1); νmax 3314, 2949, 2930, 2885, 2857, 2122, 
1653, 1472, 1252, 885, 835, 775, 669 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.00 (1H, br s, 
CH2-C6a), 4.82 (1H, s, CH2-C6b), 3.75 (1H, br d, J = 8.9 Hz, CH-C4), 3.54−3.46 (1H, m, 
CH-C1), 3.27 (1H, ddd, J = 8.9, 6.0, 3.4 Hz, CH-C8), 2.63 (1H, ddd, J = 16.9, 3.4, 2.8 Hz, 
CH2-C9a), 2.47 (1H, ddd, J = 16.9, 6.0, 2.7 Hz, CH2-C9b), 2.09−1.98 (1H, m, CH2-C2a), 
1.95 (1H, dd, J = 2.8, 2.7 Hz, CH-C11), 1.82−1.76 (1H, m, CH2-C3a), 1.75 (3H, s, CH3-C7), 
1.56−1.49 (2H, m, CH2-C2b, CH2-C3b), 0.89 (9H, s, CH3-tBu OTBS), 0.10 (3H, s, 
 Experimental 
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CH3-OTBS), 0.08 (3H, s, CH3-OTBS); 
13C NMR (101 MHz, CDCl3) δ 145.6 (C-C5), 110.7 
(CH2-C6), 81.6 (C-C10), 80.4 (CH-C4), 80.2 (CH-C8), 69.8 (CH-C11), 69.4 (CH-C1), 33.4 
(CH2-C2), 29.9 (CH2-C3), 25.9 (CH3-tBu OTBS), 22.4 (CH2-C9), 19.1 (CH3-C7), 18.1 
(C-tBu OTBS), −3.9 (CH3-OTBS), −4.6 (CH3-OTBS); [α]D
23
 +45.5 (c = 0.390, CHCl3); 
HRMS (ESI+) [M+Na]+ calcd. for C17H30O2SiNa 317.1898, found 317.1907, Δ 3.0 ppm. 
Anal. calcd for C17H30O2Si: C, 69.33%; H, 10.27%. Found: C, 68.93%, H, 10.46%.        
  
 Experimental 
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5‐{[(2R,3S,6R)‐3‐[(tert‐Butyldimethylsilyl)oxy]‐6‐(prop‐1‐en‐2‐yl)oxan‐2‐yl]methyl}‐
1‐[(4‐methylphenyl)sulfonyl]‐1H‐1,2,3‐triazole (237) 
 
To a stirred solution of alkyne 236 (0.22 g, 0.75 mmol) in anhydrous THF (3.8 mL) at −78 °C 
was added n-butyl lithium (0.36 mL of a 2.5 M solution in dichloromethane, 0.90 mmol) 
dropwise over 5 minutes. The reaction mixture was left to stir for 40 minutes before addition 
of tosyl azide (0.12 mL, 0.78 mmol) in one portion. The reaction mixture was left to stir for 
1 hour before the reaction was quenched by the addition of saturated aqueous solution of 
ammonium chloride (3 mL), diluted with ethyl acetate (5 mL) and warmed to room 
temperature. The aqueous phase was separated and extracted with ethyl acetate (3 × 5 mL). 
The combined organic extracts were washed with brine (10 mL), dried (MgSO4) and 
concentrated under reduced pressure. The residue was purified by flash column 
chromatography on silica gel (petroleum ether-ethyl acetate, gradient elution from 
20:1 → 10:1) to afford triazole 237 (0.32 g, 87%) as a colourless oil. 
Rf = 0.46 (petroleum ether-ethyl acetate, 9:1); νmax 2949, 2928, 2857, 1653, 1595, 1545, 
1472, 893, 835, 775, 667, 583, 542 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.97−7.93 (2H, m, 
2 × CH-Ar Ts), 7.55 (1H, s, CH-C11), 7.37−7.31 (2H, m, 2 × CH-Ar Ts), 4.89 (1H, br s, 
CH2-C6a), 4.78 (1H, s, CH2-C6b), 3.71−3.65 (2H, m, CH-C4, CH2-C9a), 3.47−3.38 (2H, m, 
CH-C1, CH-C8), 2.94−2.86 (1H, m, CH2-C9b), 2.44 (3H, s, CH3-Ts), 2.14−2.07 (1H, m, 
CH2-C2a), 1.86−1.80 (1H, m, CH2-C3a), 1.67 (3H, s, CH3-C7), 1.60−1.52 (2H, m, CH2-C2b, 
CH2-C3b), 0.94 (9H, s, CH3-tBu OTBS), 0.15 (3H, s, CH3-OTBS), 0.12 (3H, s, CH3-OTBS); 
13C NMR (101 MHz, CDCl3) δ 146.9 (C-Ar Ts), 144.8 (C-C5), 137.8 (C-Ar Ts), 134.3 
(C-C10), 134.0 (CH-C11), 130.4 (2 × CH-Ar Ts), 128.7 (2 × CH-Ar Ts), 110.9 (CH2-C6), 
80.5 (CH-C4), 80.4 (CH-C8), 71.2 (CH-C1), 33.6 (CH2-C2), 29.7 (CH2-C3), 27.4 (CH2-C9), 
26.0 (CH3-tBu OTBS), 21.9 (CH3-Ts), 19.4 (CH3-C7), 18.1 (C-tBu OTBS), −3.9 
(CH3-OTBS), −4.5 (CH3-OTBS); [α]D
20
 −16.6 (c = 0.375, CHCl3); HRMS (ESI+) [M+Na]+ 
calcd. for C24H37N3O4 SSiNa 514.2166, found 514.2155, Δ 2.1 ppm. 
  
 Experimental 
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(1R,2S,5Z,8R)-2-[(tert-Butyldimethylsilyl)oxy]-6-methyl-11-oxabicyclo[6.2.1]undec-5-
en-9-one (167)  
 
To a solution of triazole 237 (18 mg, 37 µmol) in anhydrous DCE (1.4 mL) was added 
Rh(OAc)4 (1.6 mg, 3.6 μmol) in one portion. The resulting solution was stirred at reflux in 
a sealed tube for 2 hours. The reaction mixture was cooled down to room temperature and 
basic alumina (Brockmann III, 0.37 g) was added in one portion and left to stir for 30 
minutes. The resulting mixture was filtered through celite and filter cake washed with DCM 
(5 mL) before the filtrate was concentrated under reduced pressure. The residue was purified 
by flash column chromatography on silica gel (petroleum ether-ethyl acetate, gradient 
elution from 50:1 → 25:1) to afford Z-alkene 167 (5.5 mg, 49%) as a colourless solid.      
The NMR (1H and 13C), IR and mass spectrometry data were consistent with those reported 
for compound 167 previously (see p. 110). 
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3-[(2R,3S,6R)-3-[(tert-Butyldimethylsilyl)oxy]-6-(prop-1-en-2-yl)oxan-2-yl]-2-
oxopropyl 2-chloroacetate (250) 
 
To a solution of alkyne 236 (0.50 g, 1.7 mmol) in anhydrous DCE (1.7 mL) was added 
SPhosAuNTf2 (7.5 mg, 8.5 µmol), chloroacetic acid (32 mg, 0.34 mmol) and 
5-bromo-2-methylpyridine-N-oxide (38 mg, 0.20 mmol) in one portion. The resulting 
solution was stirred at room temperature in a sealed vial for 16 hours before being 
concentrated under reduced pressure. The residue was purified by flash column 
chromatography on silica gel (petroleum ether-ethyl acetate, gradient elution from 
40:1 → 20:1) to afford ester 250 (25 mg, 36%) as a colourless solid. 
Rf = 0.45 (petroleum ether-ethyl acetate, 5:1); νmax 2953, 2930, 2857, 1761, 1742, 1655, 
1472, 1254, 837, 777 cm−1; 1H NMR (500 MHz, CDCl3) δ 5.24 (1H, dd, J = 7.5, 5.6 Hz, 
CH-C4), 4.99 (1H, br s, CH2-C6a), 4.96−4.93 (1H, m, CH2-C6b), 4.21 (1H, ddd, J = 8.9, 
6.5, 3.3 Hz, CH-C8), 4.05 (2H, s, CH2-C13), 4.03 (1H, d, J = 17.0 Hz, CH2-C11a), 3.94 (1H, 
ddd, J = 6.5, 5.2, 3.3 Hz, CH-C1), 3.85 (1H, d, J = 17.0 Hz, CH2-C11b), 2.58 (1H, ddd, 
J = 18.0, 8.9, 1.1 Hz, CH2-C9a), 2.35 (1H, dd, J = 18.0, 6.5 Hz, CH2-C9b), 1.89−1.80 (1H, 
m, CH2-C3a), 1.73 (3H, s, CH3-C17), 1.73−1.65 (1H, m, CH2-C3b), 1.51−1.35 (2H, m, 
CH2-C2), 0.87 (9H, s, CH3-tBu OTBS), 0.08 (3H, s, CH3-OTBS), 0.05 (3H, s, CH3-OTBS); 
13C NMR (126 MHz, CDCl3) δ 214.9 (C-C10), 166.7 (C-C12), 141.9 (C-C5), 114.1 
(CH2-C6), 80.9 (CH-C8), 79.2 (CH-C4), 72.8 (CH-C1), 71.4 (CH2-C11), 41.1 (CH2-C13), 
37.3 (CH2-C9), 30.0 (CH2-C2), 28.2 (CH2-C3), 26.0 (CH3-tBu OTBS), 18.3 (C-tBu OTBS), 
18.1 (CH3-C7), −4.2 (CH3-OTBS), −4.4 (CH3-OTBS); [α]D
23
 +86.4 (c = 0.500, CHCl3);  
HRMS (ESI+) [M+Na]+ calcd. for C19H33O5SiClNa 427.1678, found 417.1672, Δ 1.3 ppm. 
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1-[(1R,2R,3S,8R,10Z,14S)-14-[(tert-Butyldimethylsilyl)oxy]-6-ethoxy-10-
methyltricyclo[6.6.1.0²,⁷]pentadeca-6,10-dien-3-yl]ethan-1-one (173)[64] 
 
To a stirred solution of ketone 167 (501 mg, 1.61 mmol) and N-phenyltriflimide (1.15 g, 
4.00 mmol) in anhydrous THF (35 mL) at −78 °C was added NaHMDS (4.0 mL of a 1.0 M 
solution in THF, 4.0 mmol) dropwise over 10 minutes. The resulting solution was stirred for 
2.5 hours before the reaction was quenched by the addition of water (15 mL) and diluted 
with diethyl ether (30 mL) before being allowed to warm to room temperature. The aqueous 
phase was separated and extracted with diethyl ether (3 × 30 mL). The combined organic 
extracts were washed with brine (50 mL), dried (MgSO4) and concentrated under reduced 
pressure to give crude enol triflate 169, which was used in the next step without further 
purification.   
To a stirred solution of enol triflate 169 and tributyl(1-ethoxyvinyl)stannane (1.62 mL, 
4.80 mmol) in anhydrous THF (30 mL) was added lithium chloride (243 mg, 5.73 mmol) 
and  palladium tetrakis(triphenylphosphine) (277 mg, 0.240 mmol) in one portion. The 
resulting solution was heated at reflux for 16 hours. The reaction mixture was cooled down 
to room temperature and diluted with ethyl acetate (30 mL), water (20 mL) and brine 
(20 mL). The organic phase was separated and washed with 5% aqueous solution of 
ammonium hydroxide (20 mL) and brine (20 mL). The organic phase was dried (MgSO4) 
and concentrated under reduced pressure. The residue was purified by flash column 
chromatography on silica gel (petroleum ether-ethyl acetate, 15:1 with 1% triethylamine) to 
afford diene 171 as a colourless oil. 
To a solution of diene 171 in anhydrous toluene (50 mL) was added distilled methyl vinyl 
ketone (1.58 mL, 16.0 mmol) and the resulting solution was heated to 120 °C in a sealed 
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tube for 16 hours. The volatiles were removed under reduced pressure. The residue was 
purified by flash column chromatography on silica gel (petroleum ether-ethyl acetate, 15:1) 
to afford a 1:1 mixture of endo:exo Diels–Alder cycloadducts 172 as a colourless oil. 
To a stirred solution of Diels–Alder cycloadducts 172 in anhydrous methanol (15 mL) was 
added potassium carbonate (265 mg, 1.92 mmol) and the resulting solution was stirred at 
room temperature for 16 hours. The reaction mixture was diluted with saturated aqueous 
solution of ammonium chloride (15 mL) and ethyl acetate (30 mL). The aqueous phase was 
separated and extracted with ethyl acetate (3 × 20 mL). The combined organic extracts were 
washed with brine (30 mL), dried (MgSO4) and concentrated under reduced pressure. The 
residue was purified by flash column chromatography on silica gel (petroleum ether-ethyl 
acetate, 10:1) to afford ketone 173 (471 mg, 67%) as a colourless oil.  
Rf = 0.47 (petroleum ether-ethyl acetate, 4:1); νmax 2952, 2928, 2858, 1708, 1463, 1251, 835, 
775 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.37 (1H, dd, J = 11.5, 5.5 Hz, CH-C6), 4.86 (1H, 
ddd, J = 4.0, 2.7, 2.7 Hz, CH-C9), 3.79 (2H, q, J = 7.0 Hz, CH2-OEt), 3.71 (1H, dd, J = 9.2, 
2.7 Hz, CH-C2), 3.60−3.57 (1H, m, CH-C3), 3.15−3.07 (1H, m, CH2-C5a), 2.96−2.89 (1H, 
m, CH-C1), 2.84 (1H, br d, J = 14.0 Hz, CH2-C8a), 2.35−2.22 (3H, m, CH2-C12, CH-C14), 
2.15 (3H, s, CH3-C17), 2.03 (1H, dddd, J = 9.1, 7.4, 4.5, 2.5 Hz, CH2-C13a), 1.93 (1H, dd, 
J = 14.0, 4.0 Hz, CH2-C8b), 1.89−1.73 (3H, m, CH2-C4, CH2-C5b), 1.67 (3H, s, CH3-C19), 
1.65−1.55 (1H, m, CH2-C13b), 1.24 (3H, t, J = 7.0 Hz, CH3-OEt), 0.88 (9H, s, CH3-tBu 
OTBS), 0.04 (3H, s, CH3-OTBS), 0.03 (3H, s, CH3-OTBS); 
13C NMR (101 MHz, CDCl3) 
δ 211.3 (C-C15), 143.8 (C-C11), 130.6 (C-C7), 130.2 (CH-C6), 119.3 (C-C10), 88.2 
(CH-C2), 75.2 (CH-C9), 72.0 (CH-C3), 63.2 (CH2-OEt), 52.4 (CH-C14), 43.6 (CH-C1), 
37.5 (CH2-C8), 33.0 (CH2-C4), 29.8 (CH3-C17), 28.4 (CH3-C19), 27.2 (CH2-C13), 26.3 
(CH3-tBu OTBS), 24.6 (CH2-C12), 22.1 (CH2-C5), 18.7 (C-tBu OTBS), 15.9 (CH3-OEt), 
−4.3 (CH3-OTBS), −4.4 (CH3-OTBS); [α]D
21 +109 (c = 1.02, CHCl3) {Lit.64 [α]D
24
 +143 
(c = 0.99, CHCl3)}; HRMS (ESI+) [M+Na]
+ calcd. for C25H42O4SiNa 457.2745, found 
457.2730, Δ 3.2 ppm. 
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2-(Ethoxy)-2-(tributylstannyl)ethene (170) 
 
To a stirred solution of distilled ethyl vinyl ether 310 (3.50 mL, 36.4 mmol) in anhydrous 
THF (25 mL) at −78 °C was added tert-butyl lithium (15.0 mL of a 1.7 M solution in pentane, 
25.5 mmol) dropwise over 10 minutes. The resulting solution was stirred for 1.5 hours and 
then allowed to warm to 0 °C over 50 minutes. The reaction mixture was stirred for a further 
30 minutes before being cooled down to −78 °C. Tributyltin chloride (4.50 mL, 16.4 mmol) 
was added dropwise over 10 minutes and the resulting solution was stirred for 20 minutes. 
The reaction mixture was warmed to room temperature before the reaction was quenched by 
the addition of water (15 mL) and diluted with diethyl ether (30 mL). The organic phase was 
separated and washed with water (3 × 15 mL), brine (30 mL), dried (MgSO4) and 
concentrated under reduced pressure. The residue was purified by vacuum distillation (b.p. 
175−180 °C at 5 mbar) to afford stannane 170 (4.15 g, 70%) as a colourless oil.   
1H NMR (400 MHz, CDCl3) δ 4.70 (1H, d, J = 1.6 Hz, CH2-C1a), 4.06 (1H, d, J = 1.6 Hz, 
CH2-C1b), 3.72 (2H, q, J = 7.0 Hz, CH2-C3), 1.59−1.51 (6H, m, CH2-nBu), 1.34 (6H, app 
dq, J = 14.4, 7.3 Hz, CH2-nBu), 1.28 (3H, t, J = 7.0 Hz, CH3-C4), 0.99−0.94 (6H, m, 
CH2-nBu), 0.91 (9H, t, J = 7.3 Hz, CH3-nBu). 
The 1H NMR data was consistent with those reported for compound 170 previously.[70] 
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Methyl 2-[(1R,2S,3S,8R,10Z,14S)-14-[(tert-butyldimethylsilyl)oxy]-6-ethoxy-10-
methyl-15-oxatricyclo[6.6.1.0²,⁷]pentadeca-6,10-dien-3-yl]prop-2-enoate (252) 
 
To a stirred solution of ketone 173 (600 mg, 1.38 mmol) and N-phenyltriflimide (1.23 g, 
3.44 mmol) in anhydrous THF (28 mL) at −78 °C was added NaHMDS (1.4 mL of a 2.0 M 
solution in THF, 2.8 mmol) dropwise over 10 minutes. The resulting solution was stirred for 
2.5 hours before the reaction was quenched by the addition of water (15 mL) and diluted 
with diethyl ether (20 mL) before being allowed to warm to room temperature. The aqueous 
phase was separated and extracted with diethyl ether (3 × 10 mL). The combined organic 
extracts were washed with brine (20 mL), dried (MgSO4) and concentrated under reduced 
pressure to give crude enol triflate 251, which was used in the next step without further 
purification.   
To a stirred solution of enol triflate 251, N,N-diisopropylethylamine (0.96 mL, 5.5 mmol) in 
anhydrous methanol (69 mL) was added palladium tetrakis(triphenylphosphine) (159 mg, 
0.138 mmol) and sparged with CO for 15 minutes. The resulting solution was stirred under 
an atmosphere of carbon monoxide at room temperature for 16 hours. The reaction was 
quenched by sparging the reaction mixture with argon for 30 minutes and the reaction 
mixture concentrated under reduced pressure. The residue was purified by flash column 
chromatography on silica gel (petroleum ether-diethyl ether, 20:1) to afford ester 252 
(633 mg, 96%) as a colourless oil. 
Rf = 0.80 (petroleum ether-ethyl acetate, 3:1); νmax 2955, 2930, 2895, 2857, 1721, 941, 833, 
773 cm−1; 1H NMR (400 MHz, CDCl3) δ 6.19 (1H, d, J = 1.2 Hz, CH2-C17a), 5.56 (1H, d, 
J = 1.2 Hz, CH2-C17b), 5.29 (1H, dd, J = 11.2, 5.5 Hz, CH-C6), 4.89−4.85 (1H, m, CH-C9), 
3.79 (1H, qd, J = 7.0, 1.9 Hz, CH2-OEt), 3.79 (1H, qd, J = 7.0, 1.9 Hz, CH2-OEt), 3.76−3.71 
(1H, m, CH-C2), 3.75 (3H, s, CH3-OMe), 3.58 (1H, ddd, J = 3.6, 2.8, 2.8 Hz, CH-C3), 3.14 
(1H, app td, J = 11.9, 8.9 Hz, CH2-C5a), 2.86−2.75 (2H, m, CH-C1, CH2-C8a), 2.35−2.27 
(1H, m, CH-C14), 2.27−2.21 (2H, m, CH2-C12), 1.94 (1H, dd, J = 14.0, 4.0 Hz, CH2-C8b), 
1.90−1.72 (4H, m, CH2-C4a, CH2-C5b, CH2-C13), 1.69 (3H, s, CH3-C19), 1.52 (1H, ddd, 
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J = 14.3, 8.9, 3.6 Hz, CH2-C4b), 1.23 (3H, dd, J = 7.0, 7.0 Hz, CH3-OEt), 0.86 (9H, s, 
CH3-tBu OTBS), 0.01 (3H, s, CH3-OTBS), −0.01 (3H, s, CH3-OTBS); 13C NMR (101 MHz, 
CDCl3) δ 167.2 (C-C16), 144.3 (C-C15), 143.6 (C-C11), 131.1 (C-C7), 129.8 (CH-C6), 
125.5 (CH2-C17), 120.1 (CH-C10), 88.0 (CH-C2), 75.4 (CH-C9), 72.0 (CH-C3), 63.0 
(CH2-OEt), 52.0 (CH3-OMe), 46.5 (CH-C1), 42.1 (CH-C14), 37.6 (CH2-C8), 33.1 
(CH2-C4), 30.9 (CH2-C13), 28.5 (CH3-C19), 26.3 (CH3-tBu OTBS), 25.1 (CH2-C12), 22.0 
(CH2-C5), 18.6 (C-tBu OTBS), 15.9 (CH3-OEt), −4.4 (CH3-OTBS), −4.5 (CH3-OTBS); 
[α]
D
24
  +142 (c = 0.353, CHCl3); HRMS (ESI+) [M+Na]
+ calcd. for C27H44O5SiNa 499.2850, 
found 499.2832, Δ 3.6 ppm. Anal. calcd for C27H44O5Si: C, 68.03%; H, 9.30%. Found: C, 
68.27%, H, 9.30%.   
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(1R,6S,7R,8R,9S,12Z)-3-Ethoxy-6-(3-hydroxyprop-1-en-2-yl)-13-methyl-15-
oxatricyclo[6.6.1.0²,⁷]pentadeca-2,12-dien-9-ol (253) 
 
To a stirred solution of ester 252 (250 mg, 0.524 mmol) in anhydrous dichloromethane 
(8.6 mL) at −30 °C was added DIBAL-H (1.6 mL of a 1.0 M solution in dichloromethane, 
1.6 mmol) dropwise over 15 minutes. The resulting solution was stirred for 1.5 hours before 
the reaction was quenched by the addition of water (2 mL) and warmed to 0 °C for 
15 minutes. A saturated aqueous solution of potassium sodium tartrate (10 mL) was added 
and the resulting solution stirred vigorously for 1 hour at room temperature (two clear phases 
were obtained). The aqueous phase was separated and extracted with diethyl ether 
(3 × 10 mL). The combined organic extracts were washed with brine (20 mL), dried 
(MgSO4) and concentrated under reduced pressure. The residue was purified by flash column 
chromatography on silica gel (petroleum ether-ethyl acetate, gradient elution from 
2:1 → 1:2) to afford diol 253 (140 mg, 80%) as a colourless solid. 
Rf = 0.21 (petroleum ether-ethyl acetate, 1:2); m.p. 108−110 °C; νmax 3366, 2965, 2922, 
2857, 1713, 1643, 991, 895, 731 cm−1; 1H NMR (400 MHz, C6D6) δ 5.39 (1H, dd, J = 11.2, 
5.7 Hz, CH-C6), 5.13−5.08 (1H, m, CH-C9), 5.02 (1H, d, J = 1.1 Hz, CH2-C17a), 4.77 (1H, 
d, J = 1.1 Hz, CH2-C17b), 3.99 (1H, dd, J = 9.0, 3.2 Hz, CH-C2), 3.86−3.71 (3H, m, CH-C3, 
CH2-16), 3.45 (1H, dq, J = 9.5, 7.0 Hz, CH2-OEt), 3.40 (1H, dq, J = 9.5, 7.0 Hz, CH2-OEt), 
3.07−2.88 (2H, m, CH2-C5a, HO-C16), 2.87 (1H, br d, J = 13.8 Hz, CH2-C8a), 2.77−2.68 
(1H, m, CH-C1), 2.19−2.08 (1H, m, CH2-C4a), 2.11 (1H, dd, J = 13.8, 4.0 Hz, CH2-C8b), 
1.92−1.81 (3H, m, CH2-C5b, CH2-C12), 1.80 (3H, s, CH3-C19), 1.73−1.55 (3H, m, 
CH2-C4b, CH2-C13a, CH-C14), 1.50−1.30 (2H, m, HO-C3, CH2-C13b), 1.02 (3H, dd, J = 
7.0, 7.0 Hz, CH3-OEt); 
13C NMR (101 MHz, C6D6) δ 152.0 (C-C15), 144.7 (C-C11), 131.5 
(C-C7), 129.6 (CH-C6), 120.0 (C-C10), 109.6 (CH2-C17), 87.9 (CH-C2), 75.6 (CH-C9), 
72.2 (CH-C3), 65.0 (CH2-C16), 62.5 (CH2-OEt), 47.3 (CH-C1), 43.1 (CH-C14), 37.9 
(CH2-C8), 33.0 (CH2-C4), 30.8 (CH2-C13), 28.4 (CH3-C19), 25.0 (CH2-C12), 22.4 
(CH2-C5), 15.8 (CH3-OEt); [α]D
23
 +150 (c = 1.40, CHCl3); HRMS (ESI+) [M+Na]
+ calcd. 
for C20H30O4Na 357.2036, found 357.2031, Δ 1.4 ppm. 
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2-[(1R,2S,3S,8R,10Z,14S)-6-Ethoxy-14-hydroxy-10-methyl-15-oxatricyclo[6.6.1.0²,⁷] 
pentadeca-6,10-dien-3-yl]prop-2-en-1-yl acetate (255) 
 
To a stirred solution of diol 253 (250 mg, 0.747 mmol), DMAP (91 mg, 0.74 mmol) and 
distilled triethylamine (0.21 mL, 1.5 mmol) in anhydrous dichloromethane (30 mL) at 0 °C 
was added distilled acetic anhydride (4.0 mL of a 0.2 M solution in dichloromethane, 
0.80 mmol). The resulting solution was warmed to room temperature and allowed to stir for 
45 minutes before being cooled to 0 °C. The reaction was quenched by the addition of 
saturated aqueous solution of ammonium chloride (20 mL) and diluted with diethyl ether 
(60 mL). The aqueous phase was separated and extracted with diethyl ether (3 × 20 mL). 
The combined organic extracts were washed with brine (40 mL), dried (MgSO4) and 
concentrated under reduced pressure. The residue was purified by flash column 
chromatography on silica gel (petroleum ether-ethyl acetate, 10:1) to afford acetate 255 
(274 mg, 98%) as a colourless oil.  
Rf = 0.62 (petroleum ether-ethyl acetate, 1:2); νmax 3439, 2974, 2928, 2882, 2857, 1742, 
1709, 1670, 955, 907, 777 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.34 (1H, dd, J = 11.2, 
5.8 Hz, CH-C6), 5.08 (1H, d, J = 1.3 Hz, CH2-C17a), 4.98 (1H, d, J = 1.3 Hz, CH2-C17b), 
4.87−4.83 (1H, m, CH-C9), 4.48 (2H, br s, CH2-C16), 3.84−3.77 (1H, m, CH-C2), 3.80 (1H, 
qd, J = 7.0, 0.7 Hz, CH2-OEt), 3.80 (1H, qd, J = 7.0, 0.7 Hz, CH2-OEt), 3.69−3.64 (1H, m, 
CH-C3), 2.86−2.77 (1H, m, CH2-C5a), 2.75 (1H, br d, J = 14.0, CH2-C8a), 2.72−2.64 (2H, 
m, CH-C1, HO-C3), 2.35−2.15 (2H, m, CH2-C12), 2.10 (3H, s, CH3-OAc), 2.03−1.95 (1H, 
m, CH2-C4a), 1.97 (1H, dd, J = 14.0, 4.0 Hz, CH2-C8b), 1.94−1.86 (1H, m, CH2-C13a), 
1.86−1.74 (2H, m, CH2-C5b, CH-C14), 1.69 (3H, s, CH3-C19), 1.67−1.55 (2H, m, CH2-C4b, 
CH2-C13b), 1.24 (3H, dd, J = 7.0, 7.0 Hz, CH3-OEt); 
13C NMR (101 MHz, CDCl3) δ 170.8 
(C-OAc), 146.1 (C-C15), 144.8 (C-C11), 131.6 (C-C7), 129.2 (CH-C6), 119.5 (C-C10), 
113.4 (CH2-C17), 87.4 (CH-C2), 75.3 (CH-C9), 71.5 (CH-C3), 65.8 (CH2-C16), 62.9 
(CH2-OEt), 46.2 (CH-C1), 43.8 (CH-C14), 37.5 (CH2-C8), 32.4 (CH2-C4), 30.2 (CH2-C13), 
28.3 (CH3-C19), 25.0 (CH2-C12), 21.6 (CH2-C5), 21.1 (CH3-OAc), 15.9 (CH3-OEt); 
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[α]
D
23 +142 (c = 1.21, CHCl3); HRMS (ESI+) [M+Na]+ calcd. for C22H32O5Na 399.2142, 
found 399.2130, Δ 2.9 ppm.  
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2-[(1R,2S,3S,8R,10Z)-6-Ethoxy-10-methyl-15-oxatricyclo[6.6.1.0²,⁷]pentadeca-6,10-
dien-3-yl]prop-2-en-1-yl acetate (256) 
 
To a stirred solution of acetate 255 (270 mg, 0.717 mmol) in anhydrous dichloromethane 
(11 mL) at room temperature was added pyridine (0.23 mL, 2.9 mmol) and Dess–Martin 
periodinane (551 mg, 1.30 mmol). The resulting solution was stirred for 2 hours then diluted 
with diethyl ether (30 mL). The reaction was quenched by the addition of saturated aqueous 
solution of sodium thiosulfate (10 mL) and left for 5 minutes before the addition of saturated 
aqueous solution of sodium bicarbonate (5 mL). The resulting solution was stirred 
vigorously for 30 minutes. The aqueous phase was separated and extracted with diethyl ether 
(3 × 15 mL). The combined organic extracts were washed with brine (30 mL), dried (MgSO4) 
and concentrated under reduced pressure. The residue was purified by flash column 
chromatography on silica gel (petroleum ether-ethyl acetate, 4:1) to afford ketone 256 
(223 mg, 83%) as a colourless oil. 
Rf = 0.77 (petroleum ether-ethyl acetate, 1:1); νmax 2974, 2930, 2868, 1742, 1705, 1647, 901, 
845 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.45 (1H, br s, CH-C6), 5.10 (1H, br s, CH-C9), 
5.06 (1H, d, J = 1.4 Hz, CH2-C17a), 5.00 (1H, d, J = 1.4 Hz, CH2-C17b), 4.70 (1H, d, J = 
14.0 Hz, CH2-C16a), 4.66 (1H, d, J = 14.0 Hz, CH2-C16b), 3.97 (1H, d, J = 6.0 Hz, CH-C2), 
3.83 (2H, q, J = 7.0 Hz, CH2-OEt), 2.98 (1H, ddd, J = 13.0, 6.0, 3.9 Hz, CH2-C4a), 2.81 (1H, 
br s, CH-C1), 2.44−2.31 (2H, m, CH2-C4b, CH2-C12a), 2.28−2.16 (1H, m, CH2-C12b), 2.10 
(3H, s, CH3-OAc), 2.09−1.89 (5H, m, CH2-C5a, CH2-C8, CH2-C13a, CH-C14), 1.74 (3H, s, 
CH3-C19), 1.79−1.66 (2H, m, CH2-C5b, CH2-C13b), 1.24 (3H, t, J = 7.0 Hz, CH3-OEt). 
13C NMR (101 MHz, CDCl3) δ 171.0 (C-OAc), 146.0 (C-C15), 145.0 (C-C11), 134.8 
(C-C7), 127.1 (CH-C6), 119.5 (C-C10), 113.4 (CH2-C17), 88.7 (CH-C2), 80.3 (CH-C9), 
64.9 (CH2-C16), 63.3 (CH2-OEt), 46.7 (CH-C14), 41.5 (CH2-C4), 37.1 (CH2-C8), 29.3 
(CH2-C13), 29.3 (CH3-C19), 24.9 (CH2-C12), 24.1 (CH2-C5), 21.2 (CH3-OAc), 15.7 
(CH3-OEt). Peaks for C-C3 and CH-C1 were not observed; [α]D
31
 +108 (c = 0.980, CHCl3); 
HRMS (ESI+) [M+Na]+ calcd. for C22H30O5Na 397.1985, found 397.1979, Δ 1.7 ppm. Anal. 
calcd for C22H30O5: C, 70.56%; H, 8.08%. Found: C, 70.25%, H, 7.89%.        
 Experimental 
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2-[(1R,2S,3S,8R,10Z)-6-Ethoxy-10-methyl-15-oxatricyclo[6.6.1.0²,⁷]pentadeca-6,10-
dien-3-yl]prop-2-en-1-yl acetate (256) 
 
To a stirred solution of diol 253 (820 mg, 2.45 mmol), DMAP (299 mg, 2.45 mmol) and 
distilled triethylamine (0.68 mL, 4.9 mmol) in anhydrous dichloromethane (98 mL) at 0 °C 
was added distilled acetic anhydride (13.5 mL of a 0.2 M solution in dichloromethane, 2.70 
mmol). The resulting solution was warmed to room temperature and allowed to stir for 
45 minutes before being cooled to 0 °C. The reaction was quenched by the addition of 
saturated aqueous solution of ammonium chloride (75 mL) and diluted with diethyl ether 
(200 mL). The aqueous phase was separated and extracted with diethyl ether (3 × 40 mL). 
The combined organic extracts were washed with brine (75 mL), dried (MgSO4) and 
concentrated under reduced pressure to give crude acetate 255, which was used in the next 
step without further purification. 
To a stirred solution of acetate 255 in anhydrous dichloromethane (38 mL) at room 
temperature was added pyridine (0.79 mL, 9.8 mmol) and Dess–Martin periodinane (1.87 g, 
4.41 mmol) in one portion. The resulting solution was stirred for 2 hours then diluted with 
diethyl ether (80 mL). The reaction was quenched by the addition of saturated aqueous 
solution of sodium thiosulfate (40 mL) and left for 5 minutes before the addition of saturated 
aqueous solution of sodium bicarbonate (10 mL). The resulting solution was stirred 
vigorously for 30 minutes. The aqueous phase was separated and extracted with diethyl ether 
(3 × 20 mL). The combined organic extracts were washed with brine (50 mL), dried (MgSO4) 
and concentrated under reduced pressure. The residue was purified by flash column 
chromatography on silica gel (petroleum ether-ethyl acetate, 4:1) to afford ketone 256 
(905 mg, 98%) as a colourless oil. 
The NMR (1H and 13C), IR and mass spectrometry data were consistent with those reported 
for compound 256 previously (see p. 126). 
 
  
 Experimental 
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(1R,2R,6S,7S,8R,9R,12Z)-9-Hydroxy-6-(3-hydroxyprop-1-en-2-yl)-9,13-dimethyl-15-
oxatricyclo[6.6.1.0²,⁷]pentadec-12-en-3-one (224) 
 
To a stirred solution of MeMgCl (4.60 mL of a 3.0 M solution in THF, 13.8 mmol) in 
anhydrous THF (32 mL) at 0 °C was added a solution of ketone 256 (520 mg, 1.39 mmol) 
in anhydrous THF (64 mL) dropwise over 5 minutes. The resulting solution was stirred for 
30 minutes before being allowed to warm to room temperature for 1.5 hours. The reaction 
was quenched by slow transfer of the reaction mixture into a round bottom flask containing 
an aqueous solution of 1 M HCl (60 mL) over 30 minutes at room temperature. The resulting 
solution was stirred for 2 hours before being diluted by the addition of saturated aqueous 
solution of ammonium chloride (60 mL), water (60 mL) and ethyl acetate (120 mL). The 
aqueous phase was separated and extracted with ethyl acetate (3 × 40 mL). The combined 
organic extracts were washed with brine (60 mL), dried (MgSO4) and concentrated under 
reduced pressure. The residue was purified by flash column chromatography on silica gel 
(petroleum ether-ethyl acetate, gradient elution from 1:2 → 1:5) to afford diol 224 (388 mg, 
87%) as a colourless solid. 
Rf = 0.22 (petroleum ether-ethyl acetate, 1:2); m.p. 118−120 °C; νmax 3410, 2963, 2926, 
2853, 1703, 1530, 977, 899, 735 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.79 (1H, dd, J = 11.3, 
5.9 Hz, CH-C6), 5.25 (1H, d, J = 0.8 Hz, CH2-C17a), 5.06 (1H, d, J = 0.8 Hz, CH2-C17b), 
4.41 (ddd, J = 8.9, 3.2, 3.2 Hz, CH-C9), 4.16 (1H, d, J = 0.8 Hz, CH2-C16a), 4.14 (1H, d, 
J = 0.8 Hz, CH2-C16b), 3.86 (1H, d, J = 1.3 Hz, CH-C2), 3.06−2.85 (5H, m, CH-C1, 
CH2-C5a, CH2-C8a, CH-C10, HO-C16), 2.49−2.43 (2H, m, CH2-C12), 2.38 (1H, ddd, J = 
11.7, 11.7, 3.0 Hz, CH-C14), 2.09−1.94 (3H, m, CH2-C5b, CH2-C8b, CH2-C13a), 1.91 (3H, 
s, CH3-C19), 1.87−1.72 (3H, m, HO-C3, CH2-C4a, CH2-C13b), 1.70 (1H, ddd, J = 14.6, 
10.7, 6.0 Hz, CH2-C4b),  1.00 (3H, s, CH3-C18); 
13C NMR (101 MHz, CDCl3) δ 210.0 
(C-C11), 150.7 (C-C15), 135.9 (C-C7), 128.8 (CH-C6), 112.2 (CH2-C17), 91.5 (CH-C2), 
79.6 (CH-C9), 74.9 (C-C3), 65.3 (CH2-C16), 54.0 (CH-C10), 48.7 (CH-C1), 41.2 (CH-C14), 
38.8 (CH2-C12), 38.6 (CH2-C4), 35.6 (CH2-C8), 31.1 (CH2-C13), 28.9 (CH3-C18), 28.5 
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(CH3-C19), 26.6 (CH2-C5); [α]D
24
 +29.3 (c = 0.420, CHCl3); HRMS (ESI+) [M+Na]
+ calcd. 
for C19H28O4Na 343.1880, found 343.1870, Δ 2.7 ppm.  
 Experimental 
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(1R,6S,7R,8R,9R,12Z)-3-Ethoxy-6-(3-hydroxyprop-1-en-2-yl)-9,13-dimethyl-15-
oxatricyclo[6.6.1.0²,⁷]pentadeca-2,12-dien-9-ol (257) 
 
Rf = 0.53 (petroleum ether-ethyl acetate, 1:2); νmax 3381, 2969, 2924, 2857, 1711, 1645, 
1443, 910, 897 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.32 (1H, dd, J = 11.2, 5.4 Hz, CH-C6), 
5.17 (1H, br s, CH2-C17a), 4.94 (1H, br s, CH2-C17b), 4.87 (1H, ddd, J = 4.0, 1.8, 1.8 
Hz, CH-C9), 4.07 (1H, d, J = 13.4 Hz, CH2-C16a), 4.02 (1H, d, J = 13.4 Hz, CH2-C16b),  
3.86–3.74 (2H, m, CH2-OEt), 3.50 (1H, br d, J = 8.6 Hz, CH-C2), 2.99 (1H, br s, HO-C16), 
2.91 (1H, m, CH-C1), 2.67 (1H, br d, J = 14.0 Hz, CH2-C8a), 2.60 (1H, ddd, J = 12.5, 11.2, 
8.5 Hz, CH2-C5a), 2.26-2.21 (2H, m, CH2-C12), 1.99–1.79 (5H, m, CH2-C4a, CH2-C5b, 
CH2-C13a, CH-C14, HO-C3), 1.96 (1H, dd, J = 14.0, 4.0 Hz, CH2-C8b) 1.75–1.70 (1H, m, 
CH2-C13b), 1.69 (3H, s, CH3-C19), 1.47 (1H, dd, J = 13.5, 8.5 Hz, CH2-C4b), 1.37 (3H, s, 
CH3-C18), 1.23 (3H, t, J = 7.0 Hz, CH3-OEt); 
13C NMR (126 MHz, CDCl3) δ 157.0 (C-C15), 
145.0 (C-C11), 132.1 (C-C7), 128.7 (CH-C6), 120.1 (C-C10), 111.2 (CH2-C17), 91.3 
(CH-C2), 77.1 (CH-C9), 73.8 (C-C3), 66.1 (CH2-C16), 62.8 (CH2-OEt), 47.0 (CH-C1), 42.6 
(CH-C14), 39.7 (CH2-C4), 37.3 (CH2-C8), 31.6 (CH2-C12), 28.3 (CH3-C19), 27.9 
(CH3-C18), 24.9 (CH2-C13), 23.2 (CH2-C5), 15.8 (CH3-OEt); HRMS (ESI+) [M+Na]
+ 
calcd. for C21H32O4Na 371.2193, found 371.2175, Δ 4.8 ppm. 
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(1R,2R,3S,7S,11R,14Z,17R)-11,15-Dimethyl-8-methylidene-10,18-
dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadec-14-en-4-one (258) 
 
To a stirred solution of diol 224 (645 mg, 2.01 mmol) in anhydrous chloroform (101 mL) at 
0 °C was added 2,6-lutidine (1.20 mL, 10.4 mmol) followed by trifluoromethanesulfonic 
anhydride (16.1 mL of a 0.5 M solution in dichloromethane, 8.05 mmol) dropwise over 
5 minutes. The resulting solution was stirred for 1 hour before the reaction was quenched by 
the addition of a saturated aqueous solution of ammonium chloride (60 mL) and diluted with 
ethyl acetate (150 mL). The aqueous phase was separated and extracted with ethyl acetate 
(3 × 20 mL). The combined organic extracts were washed with an aqueous solution of 1 M 
HCl (2 × 50 mL), brine (75 mL), dried (MgSO4) and concentrated under reduced pressure. 
The residue was purified by flash column chromatography on silica gel (petroleum 
ether-ethyl acetate, 10:1) to afford tetracycle 258 (591 mg, 97%) as a colourless solid.  
Rf = 0.47 (petroleum ether-ethyl acetate, 4:1); m.p. 137−140 °C; νmax 2980, 2963, 2936, 
2917, 2869, 2850, 1708, 1639, 895, 730 cm−1; 1H NMR (400 MHz, C6D6) δ 5.39 (1H, dd, 
J = 10.5, 6.8 Hz, CH-C6), 5.26 (1H, ddd, J = 4.3, 2.9, 2.9 Hz, CH-C9), 4.77 (1H, br s, 
CH2-C17a), 4.56 (1H, br s, CH2-C17b), 4.05 (1H, d, J = 14.2 Hz, CH2-C16a), 3.86 (1H, d, 
J = 14.2 Hz, CH2-C16b), 3.62 (1H, d, J = 9.3 Hz, CH-C2), 2.86−2.75 (1H, m, CH2-C5a), 
2.66−2.61 (1H, m, CH2-C8a), 2.64 (1H, ddd, J = 12.0, 11.0, 9.3 Hz, CH-C1), 2.44 (1H, dd, 
J = 12.0, 2.9 Hz, CH-C10), 2.02−1.97 (2H, m, CH2-C12), 1.88 (1H, dd, J = 14.2, 8.7 Hz, 
CH2-C4a), 1.86−1.80 (1H, m, CH2-C5b), 1.74 (1H, dd, J = 14.2, 10.7 Hz, CH2-C4b), 1.64 
(1H, dd, J = 14.5, 4.3 Hz, CH2-C8b), 1.57 (3H, s, CH3-C19), 1.54−1.47 (1H, m, CH2-C13a), 
1.45 (3H, d, J = 0.7 Hz, CH3-C18), 1.44−1.39 (1H, m, CH-C14), 1.37−1.26 (1H, m, 
CH2-C13b); 
13C NMR (101 MHz, C6D6) δ 208.4 (C-C11), 149.9 (C-C15), 131.8 (CH-C6), 
129.2 (C-C7), 110.7 (CH2-C17), 92.4 (CH-C2), 76.9 (C-C3), 76.6 (CH-C9), 67.4 
(CH2-C16), 53.0 (CH-C10), 47.8 (CH-C1), 43.3 (CH-C14), 38.5 (CH2-C12), 37.2 (CH2-C8), 
36.6 (CH2-C4), 29.3 (CH3-C19), 27.2 (CH3-C18), 25.5 (CH2-C13), 23.4 (CH2-C5); 
[α]
D
23
 −26.6 (c = 0.630, CHCl3); HRMS (ESI+) [M+Na]+ calcd. for C19H26O3Na 325.1774, 
found 325.1768, Δ 1.9 ppm.  
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(1R,2R,3S,7R,8S,11R,14Z,17R)-8,11,15-Trimethyl-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷] 
octadec-14-en-4-one (221) 
 
To a stirred solution of tetracycle 258 (590 mg, 1.95 mmol) in ethyl acetate (49 mL) was 
added PtO2 (44 mg, 0.19 mmol) and the resulting suspension stirred under an atmosphere of 
hydrogen for 1.5 hours. The suspension was filtered over celite, washed with ethyl acetate 
and concentrated under reduced pressure. The residue was purified by flash column 
chromatography on silica gel (petroleum ether-ethyl acetate, 10:1) to afford ketone 221 
(536 mg, 90%) as a colourless solid.   
Rf = 0.41 (petroleum ether-ethyl acetate, 3:1); m.p. 113−115 °C; νmax 2961, 2924, 2874, 
1713, 851, 750 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.56−5.49 (1H, m, CH-C6), 4.94 (1H, 
ddd, J = 4.4, 3.0, 3.0 Hz, CH-C9), 3.80 (1H, dd, J = 13.4, 0.6 Hz, CH2-C16a), 3.76 (1H, d, 
J = 9.0 Hz, CH-C2), 3.46 (1H, dd, J = 13.4, 3.3 Hz, CH2-C16b), 2.85 (1H, ddd, J = 11.6, 
11.6, 9.0 Hz, CH-C1), 2.69–2.56 (3H, m, CH2-C5a, CH2-C8a, CH-C10), 2.50 (1H, dd, J = 
18.6, 6.9 Hz, CH2-C12a), 2.31 (1H, ddd, J = 18.6, 11.1, 7.9 Hz, CH2-C12b), 1.95–1.78 (4H, 
m, CH2-C4a, CH2-C5b, CH2-C8b, CH2-C13a), 1.76 (3H, s, CH3-C19), 1.76–1.66 (3H, m, 
CH2-C4b, CH2-13b, CH-C15), 1.37–1.24 (1H, m, CH-C14), 1.33 (3H, s, CH3-C18), 1.02 
(3H, d, J = 7.1 Hz, CH3-C17); 
13C NMR (101 MHz, CDCl3) δ 211.3 (C-C11), 131.7 
(CH-C6), 128.9 (C-C7), 90.8 (CH-C2), 77.1 (C-C3), 76.3 (CH-C9), 67.2 (CH2-C16), 53.2 
(CH-C10), 44.5 (CH-C14), 43.8 (CH-C1), 39.4 (CH2-C4), 39.3 (CH2-C12), 37.3 (CH-C15), 
37.0 (CH2-C8), 29.4 (CH3-C19), 26.3 (CH2-C13), 26.3 (CH3-C18), 23.2 (CH2-C5), 11.3 
(CH3-C17); [α]D
23
 −49.7 (c = 0.320, CHCl3); HRMS (ESI+) [M+Na]+ calcd. for C19H28O3Na 
327.1931, found 327.1921, Δ 2.9 ppm. 
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(1R,2R,3S,7R,8S,11R,14Z,17R)-8,11,15-Trimethyl-5-methylidene-10,18-
dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadec-14-en-4-one (260) 
 
To a solution of ketone 221 (64 mg, 0.20 mmol) in anhydrous DMF (2.1 mL) was added 
tert-butoxy bis(dimethylamino)methane (0.14 mL, 0.68 mmol) in one portion. The resulting 
solution was stirred at 100 °C in a sealed tube for 2 hours. The reaction mixture was cooled 
down to room temperature and diluted with ethyl acetate (15 mL) and water (5 mL). The 
organic phase was separated and washed with water (3 × 5 mL), 10 mol% aqueous solution 
of lithium chloride (5 mL), brine (5 mL), dried (MgSO4) and concentrated under reduced 
pressure. The residue was purified by flash column chromatography on silica gel (petroleum 
ether-ethyl acetate, gradient elution from 2:1 → 1:5) to afford enaminone 261 as a pale 
yellow solid, which was used in the next step without further purification. 
To a stirred solution of enaminone 261 in anhydrous dichloromethane (2.6 mL) at −78 °C 
was added DIBAL-H (0.30 mL of a 1.0 M solution in dichloromethane, 0.30 mmol) dropwise 
and stirred for 20 minutes. The resulting solution was warmed to room temperature and 
allowed to stir for a further 1 hour. A solution of iodomethane (0.13 mL, 2.1 mmol) in 
anhydrous dichloromethane (4.2 mL) was added and the resulting solution stirred for 1 hour. 
The reaction mixture was cooled to 0 °C before a saturated aqueous solution of potassium 
sodium tartrate (8 mL) and diethyl ether (10 mL) was added. The resulting solution was 
warmed to room temperature and stirred vigorously for 1 hour (two clear phases were 
obtained). The aqueous phase was separated and extracted with diethyl ether (3 × 5 mL). 
The combined organic extracts were washed with brine (10 mL), dried (MgSO4) and 
concentrated under reduced pressure. The residue was purified by flash column 
chromatography on silica gel (petroleum ether-ethyl acetate, 10:1) to afford enone 260 
(34.5 mg, 52%) as a colourless solid.  
Rf = 0.60 (petroleum ether-ethyl acetate, 3:1); m.p. 118−120 °C; νmax 2963, 2924, 2874, 
2851, 1699, 1624, 939, 923, 850, 824 cm−1; 1H NMR (400 MHz, CDCl3) δ 6.06 (1H, dd, J 
= 1.1, 1.1 Hz, CH2-C20a), 5.57−5.50 (1H, m, CH-C6), 5.23 (1H, br s, CH2-C20b), 5.01−4.96 
(1H, m, CH-C9), 3.81 (1H, br d, J = 9.0 Hz, CH-C2), 3.81 (1H, dd, J = 13.4, 1.5 Hz, 
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CH2-C16a), 3.46 (1H, dd, J = 13.4, 3.2 Hz, CH2-C16b), 2.84 (1H, ddd, J = 11.9, 11.5, 9.0 Hz, 
CH-C1), 2.75−2.52 (4H, m, CH2-C5a, CH2-C8a, CH-C10, CH2-C13a), 2.40 (1H, dd, J = 
14.9, 2.2 Hz, CH2-C13b), 1.91−1.76 (3H, m, CH2-C4a, CH2-C5b, CH-C15), 1.91 (1H, dd, 
J = 14.6, 4.4 Hz, CH2-C8b), 1.75 (3H, s, CH3-C19), 1.73−1.65 (1H, m, CH2-C4b), 1.52 (1H, 
dddd, J = 13.5, 11.5, 4.7, 2.2 Hz, CH-C14), 1.34 (3H, s, CH3-C18), 1.04 (3H, d, J = 7.1 Hz, 
CH3-C17); 
13C NMR (101 MHz, CDCl3) δ 199.6 (C-C11), 143.9 (C-C12), 131.8 (CH-C6), 
129.0 (C-C7), 120.8 (CH2-C20), 91.1 (CH-C2), 78.4 (CH-C9), 76.2 (C-C3), 67.1 
(CH2-C16), 52.4 (CH-C10), 43.7 (CH-C14), 43.3 (CH-C1), 39.4 (CH2-C4), 37.2 (CH2-C8), 
37.0 (CH-C15), 34.8 (CH2-C13), 29.6 (CH3-C19), 26.0 (CH3-C18), 23.2 (CH2-C5), 11.3 
(CH3-C17); [α]D
25
 +1.99 (c = 0.795, CHCl3); HRMS (ESI+) [M]
+ calcd. for C20H28O3Na 
339.1931, found 339.1931, Δ 0.0 ppm. 
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(1R,2R,3R,4S,7R,8S,11R,14Z,17R)-8,11,15-Trimethyl-5-methylidene-10,18-
dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadec-14-en-4-ol (262) 
 
To a solution of ketone 221 (12.3 mg, 40.0 μmol) in anhydrous DMF (0.4 mL) was added 
tert-butoxy bis(dimethylamino)methane (27 μL, 0.13 mmol) in one portion. The resulting 
solution was stirred at 100 °C in a sealed tube for 2 hours. The reaction mixture was cooled 
down to room temperature and diluted with ethyl acetate (5 mL) and water (2 mL). The 
organic phase was separated and washed with water (3 × 2 mL), 10 mol% aqueous solution 
of lithium chloride (3 mL), brine (3 mL), dried (MgSO4) and concentrated under reduced 
pressure. The residue was purified by flash column chromatography on silica gel (petroleum 
ether-ethyl acetate, gradient elution from 2:1 → 1:2) to afford enaminone 261 as a pale 
yellow solid, which was used in the next step without further purification. 
To a stirred solution of enaminone 261 in anhydrous dichloromethane (0.5 mL) at −78 °C 
was added DIBAL-H (0.05 mL of a 1.0 M solution in dichloromethane, 0.05 mmol) dropwise 
and stirred for 20 minutes. The resulting solution was warmed to room temperature and 
allowed to stir for a further 1 hour. A solution of iodomethane (30 μL, 0.48 mmol) in 
anhydrous dichloromethane (2.4 mL) was added and the resulting solution stirred for 1 hour. 
The reaction mixture was cooled to 0 °C before a saturated aqueous solution of potassium 
sodium tartrate (2 mL) and diethyl ether (3 mL) was added. The resulting solution was 
warmed to room temperature and stirred vigorously for 1 hour (two clear phases were 
obtained). The aqueous phase was separated and extracted with diethyl ether (3 × 2 mL). 
The combined organic extracts were washed with brine (3 mL), dried (MgSO4) and 
concentrated under reduced pressure to give crude enone 260, which was used in the next 
step without further purification. 
 Experimental 
 
 
136 
 
To a stirred solution of enone 260 in methanol (0.8 mL) at room temperature was added 
cerium (III) chloride heptahydrate (30 mg, 81 µmol). The resulting mixture was stirred for 
15 minutes before being cooled down to −78 °C. To this sodium borohydride (3 mg, 
0.08 mmol) was added in one portion and the resulting solution was stirred for 2.5 hours. 
The reaction mixture was warmed to room temperature and allowed to stir for a further 
1.5 hours. The reaction was quenched by the addition of a 50% aqueous solution of 
ammonium chloride (1 mL) and diluted with ethyl acetate (3 mL). The aqueous phase was 
separated and extracted with ethyl acetate (3 × 2 mL). The combined organic extracts were 
washed with brine (3 mL), dried (MgSO4) and concentrated under reduced pressure. The 
residue was purified by flash column chromatography on silica gel (petroleum ether-ethyl 
acetate, gradient elution from 10:1 → 4:1) to afford allylic alcohol 262 (6.3 mg, 49%) as a 
colourless solid. 
Rf = 0.43 (petroleum ether-ethyl acetate, 2:1); m.p. 134−136 °C; νmax 3402, 2961, 2928, 
2878, 2857, 1647, 905, 899, 729 cm−1: 1H NMR (400 MHz, CDCl3) δ 5.53−5.46 (1H, dd, J 
= 10.2, 6.6 Hz, CH-C6), 5.19 (1H, d, J = 2.1 Hz, CH2-C20a), 4.98 (1H, d, J = 2.1 Hz, 
CH2-C20b), 4.52 (1H, ddd, J = 5.0, 2.8, 2.5 Hz, CH-C9), 4.34−4.24 (1H, m, CH-C11), 3.96 
(1H, d, J = 8.9 Hz, CH-C2), 3.82 (1H, d, J = 13.2 Hz, CH2-C16a), 3.46 (1H, dd, J = 13.2, 
3.2 Hz, CH2-C16b), 2.67–2.57 (2H, m, CH2-C5a, CH2-C8a), 2.50 (1H, ddd, J = 10.8, 8.9, 
8.9 Hz, CH-C1), 2.38–2.31 (2H, m, CH2-C13), 1.94 (1H, dd, J = 14.4, 5.0 Hz, CH2-C8b), 
1.91–1.79 (3H, m, CH2-C4a, CH2-C5b, CH-C10), 1.78 (3H, s, CH3-C19), 1.76–1.61 (3H, m, 
CH2-C4b, CH-C14, CH-C15), 1.56 (1H, br s, HO-C11), 1.37 (3H, s, CH3-C18), 0.94 (3H, d, 
J = 7.0 Hz, CH3-C17); 
13C NMR (101 MHz, CDCl3) δ 149.6 (C-C12), 131.0 (CH-C6), 129.2 
(C-C7), 107.9 (CH2-C20), 91.4 (CH-C2), 82.9 (CH-C9), 76.2 (C-C3), 71.1 (CH-C11), 67.4 
(CH2-C16), 48.6 (CH-C10), 42.0 (CH-C1), 39.5 (CH-C14), 39.0 (CH2-C4), 38.1 (CH2-C8), 
36.6 (CH-C15), 34.1 (CH2-C13), 29.3 (CH3-C19), 26.0 (CH3-C18), 23.1 (CH2-C5), 10.8 
(CH3-C17); [α]D
26
 +59.5 (c = 0.305, CHCl3); HRMS (EI+) [M]
+ calcd. for C20H30O3 
318.2195, found 318.2208, Δ 4.1 ppm. 
  
 Experimental 
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(1R,2R,3S,5S,7R,8S,11R,14Z,17R)-5,8,11,15-Tetramethyl-10,18-
dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadec-14-en-4-one (263) and 
(1R,2R,3S,5R,7R,8S,11R,14Z,17R)-5,8,11,15-Tetramethyl-10,18-
dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadec-14-en-4-one (222)  
 
To a stirred solution of enone 260 (12 mg, 38 µmol) in anhydrous THF (0.8 mL) at −78 °C 
was added L-Selectride (57 μL of a 1.0 M solution in THF, 57 µmol) dropwise. The resulting 
solution was stirred for 1 hour before being warmed to 0 °C for 30 minutes. The reaction 
was quenched by the addition of water (0.5 mL) and warmed to room temperature before 
being diluted with ethyl acetate (2 mL). The aqueous phase was separated and extracted with 
ethyl acetate (3 × 1 mL). The combined organic extracts were washed with brine (2 mL), 
dried (MgSO4) and concentrated under reduced pressure. The residue was purified by flash 
column chromatography on silica gel (petroleum ether-ethyl acetate, 10:1) to afford 
diastereoisomeric ketones 263 (3.6 mg, 30%) and 222 (5.5 mg, 46%) as colourless solids.  
263: Rf = 0.63 (petroleum ether-ethyl acetate, 4:1); m.p. 109−111 °C; νmax 2963, 2924, 2874, 
1713, 922, 856, 806, 732 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.55−5.48 (1H, m, CH-C6), 
4.98 (1H, ddd, J = 4.4, 2.9, 2.9 Hz, CH-C9), 3.79 (1H, d, J = 13.3 Hz, CH2-C16a), 3.71 (1H, 
d, J = 9.1 Hz, CH-C2), 3.44 (1H, dd, J = 13.3, 3.3 Hz, CH2-C16b), 2.87 (1H, ddd, J = 
11.7, 9.2, 9.1 Hz, CH-C1), 2.70 (1H, dd, J = 11.7, 2.9 Hz, CH-C10), 2.69–2.56 (2H, m, 
CH2-C5a, CH2-C8a), 2.50 (1H, dq, J = 8.4, 7.1 Hz, CH-C12), 2.26 (1H, ddd, J = 13.3, 13.2, 
8.4 Hz, CH2-C13a), 1.92–1.78 (3H, m, CH2-C4a, CH2-C5b, CH2-C8b), 1.77 (3H, s, 
CH3-C19), 1.76–1.64 (2H, m, CH2-C4b, CH-C15), 1.40 (1H, dd, J = 13.3, 1.9 Hz, 
CH2-C13b), 1.33 (3H, s, CH3-C18), 1.29–1.19 (1H, m, CH-C14), 1.12 (3H, d, J = 7.1 Hz, 
CH3-C20), 1.00 (3H, d, J = 7.1 Hz, CH3-C17); 
13C NMR (101 MHz, CDCl3) δ 213.2 
(C-C11), 131.6 (CH-C6), 128.9 (C-C7), 90.3 (CH-C2), 76.6 (CH-C9), 76.2 (C-C3), 67.2 
(CH2-C16), 52.9 (CH-C10), 45.7 (CH-C1), 41.6 (CH-C14), 41.4 (CH-C12), 39.5 (CH2-C4), 
37.4 (CH-C15), 37.0 (CH2-C8), 35.2 (CH2-C13), 29.4 (CH3-C19), 26.3 (CH3-C18), 23.2 
(CH2-C5), 16.0 (CH3-C20), 11.3 (CH3-C17); [α]D
24
 −12.1 (c = 0.162, CHCl3); HRMS (ESI+) 
[M]+ calcd. for C20H30O3Na 341.2087, found 341.2078, Δ 2.8 ppm. 
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222: Rf = 0.51 (petroleum ether-ethyl acetate, 4:1); m.p. 139−141 °C; νmax 2963, 2928, 2874, 
1709, 914, 845, 806, 737 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.56−5.49 (1H, m, CH-C6), 
4.92 (1H, ddd, J = 4.6, 3.0, 3.0 Hz, CH-C9), 3.78 (1H, dd, J = 13.3, 1.2 Hz, CH2-C16a), 3.74 
(1H, br d, J = 9.1 Hz, CH-C2), 3.45 (1H, dd, J = 13.3, 3.3 Hz, CH2-C16b), 2.85 (1H, ddd, 
J = 12.2, 11.0, 9.1 Hz, CH-C1), 2.70 (1H, dd, J = 12.2, 3.0 Hz, CH-C10), 2.67−2.56 (2H, m, 
CH2-C5a, CH2-C8a), 2.35 (1H, dqd, J = 10.8, 7.3, 7.2 Hz, CH-C12), 1.89 (1H, dd, J = 14.6, 
4.7 Hz, CH2-C8b), 1.89−1.76 (3H, m, CH2-C4a, CH2-C5b, CH2-C13a), 1.76 (3H, s, 
CH3-C19), 1.74−1.67 (2H, m, CH2-C4b, CH-C15), 1.54 (1H, ddd, J = 12.8, 12.8, 10.8 Hz, 
CH2-C13b), 1.38−1.29 (1H, m, CH-C14), 1.33 (3H, s, CH3-C18), 1.16 (3H, d, J = 7.3 Hz, 
CH3-C20), 1.02 (3H, d, J = 7.1 Hz, CH3-C17); 
13C NMR (101 MHz, CDCl3) δ 214.9 
(C-C11), 131.6 (CH-C6), 128.9 (C-C7), 90.8 (CH-C2), 77.0 (CH-C9), 76.4 (C-C3), 67.3 
(CH2-C16), 50.6 (CH-C10), 45.2 (CH-C12), 44.3 (CH-C1), 44.0 (CH-C14), 39.4 (CH2-C4), 
37.2 (CH-C15), 37.0 (CH2-C8), 35.4 (CH2-C13), 29.3 (CH3-C19), 26.2 (CH3-C18), 23.2 
(CH2-C5), 18.8 (CH3-C20), 11.3 (CH3-C17); [α]D
24
 −61.1 (c = 0.195, CHCl3); HRMS (ESI+) 
[M]+ calcd. for C20H30O3Na 341.2087, found 341.2078, Δ 2.8 ppm. 
  
 Experimental 
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(1R,2R,3S,5S,7R,8S,11R,14Z,17R)-5,8,11,15-Tetramethyl-10,18-
dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadec-14-en-4-one (263) and 
(1R,2R,3S,5R,7R,8S,11R,14Z,17R)-5,8,11,15-Tetramethyl-10,18-
dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadec-14-en-4-one (222)  
 
To a solution of ketone 221 (56.5 mg, 0.186 mmol) in anhydrous DMF (1.9 mL) was added 
tert-butoxy bis(dimethylamino)methane (0.12 mL, 0.58 mmol) in one portion. The resulting 
solution was stirred at 100 °C in a sealed tube for 2 hours. The reaction mixture was cooled 
down to room temperature and diluted with ethyl acetate (12 mL) and water (5 mL). The 
organic phase was separated and washed with water (3 × 3 mL), 10 mol% aqueous solution 
of lithium chloride (5 mL), brine (5 mL), dried (MgSO4) and concentrated under reduced 
pressure. The residue was purified by flash column chromatography on silica gel (petroleum 
ether-ethyl acetate, gradient elution from 1:1 → 1:5) to afford enaminone 261 as a pale 
yellow solid, which was used in the next step without further purification. 
To a stirred solution of enaminone 261 in anhydrous dichloromethane (2.3 mL) at −78 °C 
was added DIBAL-H (0.22 mL of a 1.0 M solution in dichloromethane, 0.22 mmol) dropwise 
and stirred for 20 minutes. The resulting solution was warmed to room temperature and 
allowed to stir for a further 1 hour. A solution of iodomethane (0.12 mL, 1.9 mmol) in 
anhydrous dichloromethane (3.5 mL) was added and the resulting solution stirred for 1 hour. 
The reaction mixture was cooled to 0 °C before a saturated aqueous solution of potassium 
sodium tartrate (5 mL) and diethyl ether (5 mL) was added. The resulting solution was 
warmed to room temperature and stirred vigorously for 1 hour (two clear phases were 
obtained). The aqueous phase was separated and extracted with diethyl ether (3 × 3 mL). 
The combined organic extracts were washed with brine (5 mL), dried (MgSO4) and 
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concentrated under reduced pressure to give crude enone 260, which was used in the next 
step without further purification. 
To a stirred solution of (triphenylphosphine)copper hydride hexamer (0.47 mL of a 0.2 M 
solution in benzene, 0.094 mmol) in anhydrous and de-gassed toluene (3.3 mL) at −10 °C 
was added a solution of enone 260 in anhydrous and de-gassed toluene (6 mL) dropwise 
over 10 minutes. The resulting solution was stirred for 1 hour before being quenched by the 
addition of water (5 mL). The mixture was room temperature before being diluted with ethyl 
acetate (5 mL). The aqueous phase was separated and extracted with ethyl acetate 
(3 × 3 mL). The combined organic extracts were washed with brine (5 mL), dried (MgSO4) 
and concentrated under reduced pressure. The residue was purified by flash column 
chromatography on silica gel (petroleum ether-ethyl acetate, 10:1) to afford 
diastereoisomeric ketones 263 (15 mg, 25%) and 222 (22 mg, 37%) as colourless solids.  
The NMR (1H and 13C), IR and mass spectrometry data were consistent with those reported 
for compounds 263 and 222 previously (see p. 137). 
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(1R,2R,3S,5S,7R,8S,11R,14Z,17R)-5,8,11,15-Tetramethyl-10,18-
dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadec-14-en-4-one (263) and 
(1R,2R,3S,5R,7R,8S,11R,14Z,17R)-5,8,11,15-Tetramethyl-10,18-
dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadec-14-en-4-one (222)  
 
To a stirred solution of ketone 222 (39 mg, 0.12 mmol) in anhydrous methanol (2.5 mL) at 
room temperature was added potassium carbonate (20 mg, 0.15 mmol) and the resulting 
solution was stirred for 16 hours. The reaction mixture was diluted with a saturated aqueous 
solution of ammonium chloride (5 mL) and ethyl acetate (5 mL). The aqueous phase was 
separated and extracted with ethyl acetate (3 × 3 mL). The combined organic extracts were 
washed with brine (5 mL), dried (MgSO4) and concentrated under reduced pressure. The 
residue was purified by flash column chromatography on silica gel (petroleum ether-ethyl 
acetate, 10:1) to afford diastereoisomeric ketones 263 (15.9 mg, 41%) and 222 (23 mg, 59%) 
as colourless solids.  
The NMR (1H and 13C), IR and mass spectrometry data were consistent with those reported 
for compounds 263 and 222 previously (see p. 137). 
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(1R,2R,3S,5S,7R,8S,11R,14Z,17R)-5,8,11,15-Tetramethyl-10,18-
dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadec-14-en-4-one (263) and 
(1R,2R,3S,5R,7R,8S,11R,14Z,17R)-5,8,11,15-Tetramethyl-10,18-
dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadec-14-en-4-one (222)  
 
To a stirred solution of ketone 263 (12.6 mg, 39.6 μmol) in anhydrous methanol (0.8 mL) 
was added potassium carbonate (6.6 mg, 48 µmol) and the resulting solution was stirred at 
room temperature for 16 hours. The reaction mixture was diluted with a saturated aqueous 
solution of ammonium chloride (3 mL) and ethyl acetate (5 mL). The aqueous phase was 
separated and extracted with ethyl acetate (3 × 3 mL). The combined organic extracts were 
washed with brine (5 mL), dried (MgSO4) and concentrated under reduced pressure. The 
residue was purified by flash column chromatography on silica gel (petroleum ether-ethyl 
acetate, 10:1) to afford diastereoisomeric ketones 263 (4.5 mg, 36%) and 222 (6.2 mg, 49%) 
as colourless solids.  
The NMR (1H and 13C), IR and mass spectrometry data were consistent with those reported 
for compounds 263 and 222 previously (see p. 137). 
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(1R,2R,3S,5R,7R,8S,11R,14Z,17R)-5,8,11,15-Tetramethyl-10,18-
dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadec-14-en-4-one (222) 
 
To a stirred solution of ketone 221 (18.6 mg, 61.1 μmol) in anhydrous THF (1.2 mL) at 
−78 °C was added NaHMDS (0.12 mL of a 1.0 M solution in THF, 0.12 mmol) dropwise 
over 10 minutes. The resulting solution was stirred for 15 minutes before being warmed to 
–30 °C for 50 minutes. The reaction mixture afterwards was cooled down to −78 °C before 
a solution of methyl iodide (0.62 mL of a 0.5 M solution in THF, 0.31 mmol) was added 
dropwise over 5 minutes. The resulting solution was stirred for 1 hour before being warmed 
to −30 °C for 30 minutes. The reaction was quenched by the addition of water (2 mL) and 
diluted with ethyl acetate (5 mL). The aqueous phase was separated and extracted with ethyl 
acetate (3 × 2 mL). The combined organic extracts were washed with brine (5 mL), dried 
(MgSO4) and concentrated under reduced pressure. The residue was purified by flash column 
chromatography on silica gel (petroleum ether-ethyl acetate, 10:1) to afford ketone 222 
(1.5 mg, 8%) as a colourless solid.  
The NMR (1H and 13C), IR and mass spectrometry data were consistent with those reported 
for compound 222 previously (see p. 137). 
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11-Acetoxy-4-deoxyasbestinin D (18)[8]  
 
 
To a stirred solution of ketone 263 (23 mg, 72 µmol) in a mixture of methanol and 
dichloromethane (1:1, 1.4 mL) at 0 °C was added sodium borohydride (4.9 mg, 0.13 mmol) 
in one portion and the resulting solution was stirred for 1 hour. The reaction mixture was 
warmed to room temperature and allowed to stir for a further 30 minutes. The reaction was 
quenched by the addition of a water (3 mL) before being diluted with ethyl acetate (3 mL). 
The aqueous phase was separated and extracted with ethyl acetate (3 × 2 mL). The combined 
organic extracts were washed with brine (3 mL), dried (MgSO4) and concentrated under 
reduced pressure to give crude alcohol 265, which was used in the next step without further 
purification. 
To a stirred solution of alcohol 265, DMAP (8.8 mg, 72 µmol) and distilled triethylamine 
(20 μL, 0.14 mmol) in anhydrous dichloromethane (1.4 mL) at 0 °C was added distilled 
acetic anhydride (0.65 mL of a 0.2 M solution in dichloromethane, 0.13 mmol). The resulting 
solution was warmed to room temperature and stirred for 16 hours. The reaction was 
quenched by the addition of a saturated aqueous solution of ammonium chloride (3 mL) and 
diluted with diethyl ether (3 mL). The aqueous phase was separated and extracted with 
diethyl ether (3 × 2 mL). The combined organic extracts were washed with brine (3 mL), 
dried (MgSO4) and concentrated under reduced pressure. The residue was purified by flash 
column chromatography on silica gel (pentane-ethyl acetate, 10:1) to afford 
11-acetoxy-4-deoxyasbestinin D (18) (23.8 mg, 88%) as a colourless oil. 
Rf = 0.67 (petroleum ether-ethyl acetate, 4:1); νmax 2963, 2924, 2878, 1736, 910, 733 cm−1; 
1H NMR (400 MHz, CDCl3) δ 5.48 (1H, dddd, J = 9.8, 6.4, 1.4, 1.4 Hz, CH-C6), 5.31 (1H, 
dd, J = 5.2, 2.8 Hz, CH-C11), 4.10 (1H, ddd, J = 5.4, 2.8, 2.8 Hz, CH-C9), 3.88 (1H, dd, J = 
8.8 Hz, CH-C2), 3.86 (1H, dd, J = 13.2, 1.2 Hz, CH2-C16a), 3.48 (1H, dd, J = 13.2, 3.3 Hz, 
CH2-C16b), 2.61−2.52 (1H, m, CH2-C5a), 2.50 (1H, dd, J = 14.4, 2.8 Hz, CH2-C8a), 2.34 
(1H, ddd, J = 10.8, 10.8, 8.8 Hz, CH-C1), 2.10 (3H, s, CH3-OAc), 2.08−1.83 (5H, m, 
CH2-C5b, CH2-C8b, CH-C10, CH-C12, CH-C14), 1.77−1.73 (2H, m, CH2-C4), 1.75 (3H, s, 
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CH3-C19), 1.66−1.56 (1H, m, CH-C15), 1.53 (1H, ddd, J = 13.5, 13.5, 9.7 Hz, CH2-C13a), 
1.35 (3H, s, CH3-C18), 1.01 (1H, ddd, J = 13.5, 3.2, 1.5 Hz, CH2-C13b), 0.93 (3H, d, 
J = 7.2 Hz, CH3-C20), 0.92 (3H, d, J = 7.1 Hz, CH3-C17); 
13C NMR (101 MHz, CDCl3) 
δ 171.4 (C-OAc), 131.0 (CH-C6), 128.9 (C-C7), 92.4 (CH-C2), 81.2 (CH-C9), 76.6 (C-C3), 
73.7 (CH-C11), 68.1 (CH2-C16), 46.0 (CH-C10), 40.7 (CH-C1), 38.7 (CH2-C4), 38.2 
(CH-C14), 37.7 (CH2-C8), 37.5 (CH-C15), 31.7 (CH2-C13), 31.6 (CH-C12), 29.1 
(CH3-C19), 26.2 (CH3-C18), 23.6 (CH2-C5), 21.5 (CH3-OAc), 18.1 (CH3-C20), 11.1 
(CH3-C17); [α]D
26
 −13.5 (c = 0.445, CHCl3) {Lit.8 [α]D
29
 −2.29 (c = 1.31, CHCl3); HRMS 
(ESI+) [M]+ calcd. for C22H34O4Na 385.2349, found 385.2341, Δ 2.2 ppm. 
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(1R,2R,3R,4S,5S,7R,8S,11R,14Z,17R)-5,8,11,15-Tetramethyl-10,18-
dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadec-14-en-4-ol (265)  
 
 
Rf = 0.41 (petroleum ether-ethyl acetate, 2:1); m.p. 126−128 °C; νmax 3292, 2920, 2890, 
1721, 986, 733 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.49 (1H, dddd, J = 9.9, 6.2, 1.5, 1.5 Hz, 
CH-C6), 4.42 (1H, ddd, J = 5.0, 2.8, 2.8 Hz, CH-C9), 3.94 (1H, br d, J = 8.9 Hz, CH-C2), 
3.86 (1H, br d, J = 13.2 Hz, CH2-C16a), 3.86−3.82 (1H, m, CH-C11), 3.45 (1H, dd, J = 13.2, 
3.3 Hz, CH2-C16b), 2.69−2.57 (2H, m, CH2-C5a, CH2-C8a), 2.28 (1H, ddd, J = 10.9, 10.7, 
8.9 Hz, CH-C1), 2.07 (1H, dddd, J = 13.6, 10.9, 4.4, 3.5 Hz, CH-C14), 1.97 (1H, dd, J = 14.4, 
5.0 Hz, CH2-C8b), 1.92−1.79 (2H, m, CH2-C5b, CH-C12), 1.89 (1H, ddd, J = 10.7, 2.8, 
2.4 Hz, CH-C10), 1.78−1.72 (2H, m, CH2-C4), 1.77 (3H, s, CH3-C19), 1.64 (1H, br d, 
J = 3.0 Hz, HO-C11), 1.60−1.54 (1H, m, CH-C15), 1.52 (1H, ddd, J = 13.6, 13.5, 10.0 Hz, 
CH2-C13a), 1.35 (3H, s, CH3-C18), 1.08 (3H, d, J = 7.3 Hz, CH3-C20), 1.01 (1H, ddd, J = 
13.5, 3.5, 1.8 Hz, CH2-C13b), 0.90 (3H, d, J = 7.1 Hz, CH3-C17); 
13C NMR (101 MHz, 
CDCl3) δ 131.0 (CH-C6), 128.9 (C-C7), 92.7 (CH-C2), 81.9 (CH-C9), 76.4 (C-C3), 72.7 
(CH-C11), 68.1 (CH2-C16), 47.2 (CH-C10), 40.7 (CH-C1), 38.8 (CH2-C4), 37.9 (CH-C14), 
37.8 (CH2-C8), 37.7 (CH-C15), 32.3 (CH-C12), 31.8 (CH2-C13), 29.3 (CH3-C19), 26.1 
(CH3-C18), 23.6 (CH2-C5), 18.5 (CH3-C20), 11.0 (CH3-C17); [α]D
17
 +6.7 (c = 0.86, CHCl3); 
HRMS (EI+) [M]+ calcd. for C20H32O3Na 343.2244, found 343.2249, Δ 1.6 ppm. 
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4-Deoxyasbestinin C (19)[8]  
 
 
To a stirred solution of alcohol 265 (18 mg, 56 µmol), DMAP (8.2 mg, 67 µmol) and distilled 
N,N-diisopropylethylamine (0.23 mL, 0.13 mmol)  in anhydrous dichloromethane (1.2 mL) 
at 0 °C was added butyric anhydride (0.34 mL of a 0.5 M solution in dichloromethane, 
0.17 mmol). The resulting solution was warmed to room temperature and stirred for 
16 hours. The reaction was quenched by the addition of a saturated aqueous solution of 
ammonium chloride (5 mL) and diluted with diethyl ether (3 mL). The aqueous phase was 
separated and extracted with diethyl ether (3 × 3 mL). The combined organic extracts were 
washed with brine (5 mL), dried (MgSO4) and concentrated under reduced pressure. The 
residue was purified by flash column chromatography on silica gel (pentane-ethyl acetate, 
10:1) to afford 4-deoxyasbestinin C (19) (16.5 mg, 75%) as a colourless oil. 
Rf = 0.81 (petroleum ether-ethyl acetate, 3:1); νmax 2963, 2932, 2874, 1732 cm−1; 1H NMR 
(400 MHz, CDCl3) δ5.51−5.44 (1H, m, CH-C6), 5.33 (1H, dd, J = 5.1, 2.8 Hz, CH-C11), 
4.08 (1H, ddd, J = 5.0, 2.8, 2.8 Hz, CH-C9), 3.88 (1H, d, J = 8.9 Hz, CH-C2), 3.86 (1H, d, 
J = 13.3 Hz, CH2-C16a), 3.48 (1H, dd, J = 13.3, 3.3 Hz, CH2-C16b), 2.63−2.50 (2H, m, 
CH2-C5a, CH2-C8a), 2.41–2.26 (3H, m, CH-C1, CH2-C22), 2.10–2.01 (1H, m, CH-C12), 
1.98 (1H, ddd, J = 10.7, 2.8, 2.8 Hz, CH-C10), 1.95 (1H, dd, J = 14.5, 5.0 Hz, CH2-C8b), 
1.93−1.84 (2H, m, CH2-C5b, CH-C14), 1.77–1.48 (5H, m, CH2-C4, CH-C15, CH2-C23), 
1.76 (3H, s, CH3-C19), 1.52 (1H, ddd, J = 13.5, 13.5, 9.7 Hz, CH2-C13a), 1.35 (3H, s, 
CH3-C18), 1.01 (1H, ddd, J = 13.5, 3.2, 1.5 Hz, CH2-C13b), 0.98 (3H, t, J = 7.4 Hz, 
CH3-C24), 0.92 (3H, d, J = 7.3 Hz, CH3-C20), 0.92 (3H, d, J = 7.0 Hz, CH3-C17); 
13C NMR 
(101 MHz, CDCl3) δ174.0 (C-C21), 131.1 (CH-C6), 128.9 (C-C7), 92.3 (CH-C2), 81.3 
(CH-C9), 76.5 (C-C3), 73.4 (CH-C11), 68.1 (CH2-C16), 45.9 (CH-C10), 40.8 (CH-C1), 38.9 
(CH2-C4), 38.3 (CH-C14), 37.6 (CH2-C8), 37.6 (CH-C15), 36.9 (CH2-C22), 31.8 
(CH2-C13), 31.6 (CH-C12), 29.2 (CH3-C19), 26.3 (CH3-C18), 23.4 (CH2-C5), 18.7 
(CH2-C23), 18.2 (CH3-C20), 13.9 (CH3-C24), 11.1 (CH3-C17); [α]D
20
 16.8 (c = 0.375, 
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CHCl3) {Lit.
8 [α]
D
29 −1.2 (c = 0.84, CHCl3); HRMS (ESI+) [M]+ calcd. for C24H38O4Na 
413.2662, found 413.2646, Δ 3.8 ppm.  
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(1R,2R,3S,4S,5S,7R,8S,11R,14S,16R,18R)-5,8,11,16-Tetramethyl-10,15,19-
trioxapentacyclo[9.8.0.0²,⁷.0³,¹8.014,¹6]nonadecan-4-yl acetate (269) and 
(1R,2R,3S,4S,5S,7R,8S,11R,14R,16S,18R)-5,8,11,16-Tetramethyl-10,15,19-
trioxapentacyclo[9.8.0.0²,⁷.0³,¹8.014,¹6]nonadecan-4-yl acetate (270)  
 
 
 
Epoxidation of 11-Acetoxy-4-deoxyasbestinin D (18) with m-CPBA 
To a stirred solution of 11-acetoxy-4-deoxyasbestinin D (18) (22 mg, 61 µmol) in anhydrous 
dichloromethane (1.2 mL) at 0 °C was added m-CPBA (0.24 mL of a 0.5 M solution in 
dichloromethane, 0.12 mmol). The resulting solution was stirred for 2.5 hours. The reaction 
was quenched by the addition of a saturated aqueous solution of sodium thiosulfate (3 mL) 
before being warmed to room temperature and diluted with ethyl acetate (5 mL). The 
aqueous phase was separated and extracted with ethyl acetate (3 × 3 mL). The combined 
organic extracts were washed with brine (5 mL), dried (MgSO4) and concentrated under 
reduced pressure. The residue was purified by flash column chromatography on silica gel 
(petroleum ether-ethyl acetate, gradient elution from 10:1 → 1:1) to afford diastereoisomeric 
epoxides 269 (13.6 mg, 59%) and 270 (5.3 mg, 23%) as colourless solids.  
Epoxidation of 11-Acetoxy-4-deoxyasbestinin D (18) using Shi’s Asymmetric Protocol 
(Unnatural Enatiomer) 
To a stirred solution of 11-acetoxy-4-deoxyasbestinin D (18) (16 mg, 44 µmol), unnatural 
Shi ketone (3.8 mg, 15 µmol) in a mixture of acetonitrile and dimethoxyethane (1:2, 0.9 mL) 
was added buffer (0.48 mL of a 0.05 M solution of Na2B4O7•10H2O in 4 × 10-4 M aqueous 
Na2(EDTA), 0.024 mmol) followed by tetrabutylammonium hydrogen sulfate (5.0 μL of a 
0.4 M solution in water, 2.0 μmol). The resulting solution was cooled to 0 °C before Oxone™ 
(1.4 mL of a 0.07 M solution in 4 × 10-4 M aqueous Na2(EDTA), 0.098 mmol) and potassium 
carbonate (0.70 mL of a 0.4 M solution in water, 0.28 mmol) were added simultaneously. 
The reaction mixture was stirred for 1 hour before being diluted with water (5 mL) and ethyl 
acetate (10 mL). The aqueous phase was separated and extracted with ethyl acetate 
(3 × 5 mL). The combined organic extracts were washed with brine (10 mL), dried (MgSO4) 
 Experimental 
 
 
150 
 
and concentrated under reduced pressure. The residue was purified by flash column 
chromatography on silica gel (pentane-ethyl acetate, gradient elution from 10:1 → 2:1) to 
afford diastereoisomeric epoxides 269 (12.5 mg, 75%) and 270 (1.0 mg, 6%) as colourless 
solids.  
Epoxidation of 11-Acetoxy-4-deoxyasbestinin D (18) using Shi’s Asymmetric Protocol 
(Natural Enatiomer) 
To a stirred solution of 11-acetoxy-4-deoxyasbestinin D (18) (27.5 mg, 75.9 μmol), natural 
Shi ketone (5.9 mg, 0.023 mmol) in a mixture of acetonitrile and dimethoxyethane (1:2, 
1.2 mL) was added buffer (1.2 mL of a 0.05 M solution of Na2B4O7•10H2O in 4 × 10-4 M 
aqueous Na2(EDTA), 0.060 mmol) followed by tetrabutylammonium hydrogen sulfate 
(7.5 μL of a 0.4 M solution in water, 3.0 μmol). The resulting solution was cooled to 0 °C 
before Oxone™ (1.9 mL of a 0.4 M solution in 4 × 10-4 M aqueous Na2(EDTA), 0.76 mmol) 
and potassium carbonate (1.1 mL of a 0.4 M solution in water, 0.44 mmol) were added 
simultaneously. The reaction mixture was stirred for 1 hour before being diluted with water 
(5 mL) and ethyl acetate (10 mL). The aqueous phase was separated and extracted with ethyl 
acetate (3 × 5 mL). The combined organic extracts were washed with brine (10 mL), dried 
(MgSO4) and concentrated under reduced pressure. The residue was purified by flash column 
chromatography on silica gel (pentane-ethyl acetate, gradient elution from 10:1 → 2:1) to 
afford diastereoisomeric epoxides 269 (3.6 mg, 13%) and 270 (20.4 mg, 71%) as colourless 
solids.  
269: Rf = 0.10 (petroleum ether-ethyl acetate, 2:1); m.p. 156−158 °C; νmax 2959, 2928, 2878, 
1736, 733 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.41 (1H, dd, J = 6.3, 1.8 Hz, CH-C11), 4.26 
(1H, dd, J = 11.7, 4.8 Hz, CH-C9), 3.88 (1H, d, J = 10.1 Hz, CH-C2), 3.83 (1H, d, J = 
13.1 Hz, CH2-C16a), 3.60 (1H, dd, J = 13.1, 2.2 Hz, CH2-C16b), 2.80 (1H, ddd, J = 10.1, 
9.6, 9.4 Hz, CH-C1), 2.74 (1H, dd, J = 9.6, 3.1 Hz, CH-C6), 2.20−2.11 (1H, m, CH-C12), 
2.08 (3H, s, CH3-OAc), 2.03−1.96 (1H, m, CH2-C5a), 2.02 (1H, dd, J = 13.6, 4.8 Hz, 
CH2-C8a), 1.91−1.74 (3H, m, CH2-C4a, CH-C10, CH-C14), 1.71−1.48 (5H, m, CH2-C4b, 
CH2-C5b, CH2-C8b, CH2-C13a, CH-C15), 1.34 (3H, s, CH3-C18), 1.34 (3H, s, CH3-C19), 
1.05 (1H, dd, J = 13.5, 2.2 Hz, CH2-C13b), 0.98 (3H, d, J = 7.1 Hz, CH3-C17), 0.92 (3H, d, 
J = 7.2 Hz, CH3-C20); 
13C NMR (101 MHz, CDCl3) δ 171.1 (C-OAc), 94.4 (CH-C2), 79.3 
(C-C3), 78.5 (CH-C9), 72.8 (CH-C11), 70.3 (CH2-C16), 66.4 (CH-C6), 59.5 (C-C7), 50.0 
(CH-C10), 43.4 (CH2-C8), 39.6 (CH-C1), 37.6 (CH-C14), 36.4 (CH-C15), 34.3 (CH2-C4), 
32.0 (CH2-C13), 31.3 (CH-C12), 27.8 (CH3-C18 or CH3-C19), 22.5 (CH3-C18 or CH3-C19), 
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21.8 (CH2-C5), 21.5 (CH3-OAc), 16.7 (CH3-C20), 11.2 (CH3-C17); [α]D
19
 −37.7 (c = 0.247, 
CHCl3); HRMS (ESI+) [M]
+ calcd. for C22H34O5Na 401.2298, found 401.2304, Δ 1.4 ppm. 
270: Rf = 0.18 (petroleum ether-ethyl acetate, 2:1); m.p. 167−169 °C ;νmax 2963, 2928, 2874, 
1736, 991, 930, 872, 733, 702 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.30 (1H, dd, J = 5.1, 
3.2 Hz, CH-C11), 4.06 (1H, ddd, J = 3.2, 3.2, 3.2 Hz, CH-C9), 3.88 (1H, br d, J = 8.8 Hz, 
CH-C2), 3.85 (1H, br d, J = 13.2 Hz, CH2-C16a), 3.50 (1H, dd, J = 13.2, 3.5 Hz, CH2-C16b), 
2.70 (1H, dd, J = 10.9, 3.8 Hz, CH-C6), 2.37 (1H, ddd, J = 10.8, 3.2, 3.2 Hz, CH-C10), 2.31 
(1H, ddd, J = 10.8, 10.8, 8.8 Hz, CH-C1), 2.12 (3H, s, CH3-OAc), 2.07−1.83 (7H, m, 
CH2-C4a, CH2-C5, CH2-C8, CH-C12, CH-C14), 1.72−1.61 (2H, m, CH2-C4b, CH-C15), 
1.55 (1H, ddd, J = 13.5, 13.5, 9.7 Hz, CH2-C13a), 1.43 (3H, s, CH3-C19), 1.35 (3H, s, 
CH3-C18), 1.07 (1H, ddd, J = 13.5, 3.2, 1.6 Hz, CH2-C13b), 0.95 (3H, d, J = 7.6 Hz, 
CH3-C20), 0.93 (3H, d, J = 7.4 Hz, CH3-C17); 
13C NMR (101 MHz, CDCl3) δ 171.4 
(C-OAc), 92.1 (CH-C2), 80.7 (CH-C9), 76.0 (C-C3), 73.7 (CH-C11), 67.8 (CH2-C16), 67.0 
(CH-C6), 59.2 (C-C7), 44.6 (CH-C10), 40.8 (CH2-C8), 39.9 (CH-C1), 38.1 (CH-C14), 37.5 
(CH-C15), 33.7 (CH2-C4), 31.8 (CH2-C13), 31.6 (CH-C12), 28.7 (CH3-C19), 25.5 
(CH3-C18), 23.9 (CH2-C5), 21.4 (CH3-OAc), 18.2 (CH3-C20), 11.0 (CH3-C17); [α]D
17
 +6.74 
(c = 0.860, CHCl3); HRMS (ESI+) [M]
+ calcd. for C22H34O5Na 401.2298, found 401.2286, 
Δ 3.1 ppm. 
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Asbestinin 20 (14)[10] and (1R,2R,3S,4S,5S,7R,8S,11R,14S,15R,17R)-14,15-Dihydroxy-
5,8,11,15-tetramethyl-10,18-dioxatetracyclo[9.7.0.02,7.03,17]octadecan‐4‐yl acetate (275)  
 
 
To a stirred solution of epoxide 269 (20 mg, 53 µmol) in a mixture of THF and water (1:1, 
1.1 mL) at room temperature was added potassium bisulfate (289 mg, 2.12 mmol) followed 
by scandium triflate (54 mg, 0.11 mmol). The resulting solution was stirred for 2 hours 
before being quenched by the addition of saturated aqueous solution of sodium carbonate 
(3 mL) and diluted with ethyl acetate (5 mL). The aqueous phase was separated and extracted 
with ethyl acetate (3 × 3 mL). The combined organic extracts were washed with brine 
(5 mL), dried (MgSO4) and concentrated under reduced pressure. The residue was purified 
by flash column chromatography on silica gel (pentane-ethyl acetate, gradient elution from 
5:1 → 1:5) to afford asbestinin 20 (14) (2 mg, 10%) and syn-diol 275 (16 mg, 80%) as 
colourless solids.  
14: Rf = 0.40 (petroleum ether-ethyl acetate, 1:2); m.p. 185−187 °C; νmax 3433, 2959, 2924, 
2874, 1736 cm−1; 1H NMR (500 MHz, CDCl3) δ 5.37−5.33 (1H, m, CH2-C19a), 5.36 (1H, 
dd, J = 5.3, 2.2 Hz, CH-C11), 5.05 (1H, br s, CH2-C19b), 4.27 (1H, br s, CH-C6), 4.17 (1H, 
ddd, J = 4.5, 4.5, 1.8 Hz, CH-C9), 3.85 (1H, d, J = 8.7 Hz, CH-C2), 3.76 (1H, d, J = 13.0 Hz, 
CH2-C16a), 3.45 (1H, dd, J = 13.0, 2.9 Hz, CH2-C16b), 2.51−2.42 (1H, m, CH-C1), 
2.32−2.16 (4H, m, CH2-C5, CH2-C8a, CH-C10), 2.16−2.07 (1H, m, CH-C12), 2.09 (3H, s, 
CH3-OAc), 1.91−1.78 (3H, m, CH2-C4a, CH2-C8b, CH-C14), 1.61−1.55 (1H, m, CH-C15), 
1.50 (1H, ddd, J = 13.5, 13.5, 9.4 Hz, CH2-C13a), 1.48 (1H, d, J = 3.1 Hz, HO-C6), 
1.40−1.30 (1H, m, CH2-C4b), 1.30 (3H, s, CH3-C18), 1.02 (1H, dd, J = 13.5, 2.4 Hz, 
CH2-C13b), 0.93 (3H, d, J = 7.2 Hz, CH3-C20), 0.90 (3H, d, J = 7.1 Hz, CH3-C17); 
13C NMR 
(126 MHz, CDCl3) δ 171.5 (C-OAc), 148.5 (C-C7), 115.0 (CH2-C19), 94.3 (CH-C2), 83.1 
(CH-C9), 76.8 (C-C3), 76.2 (CH-C6), 74.0 (CH-C11), 67.7 (CH2-C16), 46.3 (CH-C10), 39.3 
(CH2-C8), 39.0 (CH-C1), 38.2 (CH-C14), 36.9 (CH-C15), 31.7 (CH2-C13), 31.5 (CH-C12), 
29.2 (CH2-C4), 27.4 (CH2-C5), 23.6 (CH3-C18), 21.5 (CH3-OAc), 17.7 (CH3-C20), 11.1 
(CH3-C17); [α]D
16
 −14.4 (c = 0.250, CHCl3) {Lit.10 [α]D
25
 −16.7 (c = 5.20, CHCl3); HRMS 
(ESI+) [M]+ calcd. for C22H34O5Na 401.2298, found 401.2283, Δ 3.8 ppm. 
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275: Rf = 0.13 (petroleum ether-ethyl acetate, 1:2); m.p. 209−211 °C; νmax 3431, 2963, 2922, 
2876, 1734, 991, 974, 930, 918, 731 cm−1; 1H NMR (500 MHz, CDCl3) δ 5.39 (1H, dd, J = 
5.7, 2.0 Hz, CH-C11), 4.22 (1H, dd, J = 12.4, 3.9 Hz, CH-C9), 3.83−3.77 (2H, m, CH-C2, 
CH2-C16a), 3.47 (1H, dd, J = 13.1, 2.7 Hz, CH2-C16b), 2.56 (1H, ddd, J = 9.4, 9.4, 9.4 Hz, 
CH-C1), 2.22−1.99 (4H, m, CH2-C4a, CH-C6, CH2-C8a, CH-C12), 2.08 (3H, s, CH3-OAc), 
1.96−1.74 (5H, m, CH2-C4b, CH2-C5, CH-C10, CH-C14), 1.65−1.57 (1H, m, HO-C7, 
CH-C15), 1.52−1.43 (2H, m, CH2-C8b, CH2-C13a), 1.37 (1H, br s, HO-C6), 1.30 (3H, s, 
CH3-C18), 1.30 (3H, s, CH3-C19), 1.03 (1H, dd, J = 13.4, 2.7 Hz, CH2-C13b), 0.92 (3H, d, 
J = 7.2 Hz, CH3-C17), 0.92 (3H, d, J = 7.2 Hz, CH3-C20); 
13C NMR (126 MHz, CDCl3) 
δ 171.5 (C-OAc), 93.4 (CH-C2), 79.3 (CH-C9), 77.5 (C-C3), 75.5 (C-C7), 73.5 (CH-C11), 
68.0 (CH2-C16), 48.5 (CH-C10), 38.3(CH-C14), 37.6 (CH-C1), 37.6 (CH-C15), 31.5 
(CH-C12), 31.4 (CH2-C13), 22.4 (CH3-C18), 21.6 (CH3-OAc), 17.4 (CH3-C20), 11.1 
(CH3-C17). Peaks for CH2-C4, CH2-C5, CH-C6, CH2-C8 and CH3-C19 were not observed; 
[α]D
20
 −8.89 (c = 0.450, CHCl3); HRMS (ESI+) [M]+ calcd. for C22H36O6Na 419.2404, found 
419.2387, Δ 4.0 ppm.  
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6-epi-Asbestinin 20 (16)[11] and Diols (276)  
 
 
To a stirred solution of epoxide 270 (13 mg, 0.034 mmol) in THF (0.65 mL) and water 
(30 μL) at room temperature was added potassium bisulfate (185 mg, 1.36 mmol) followed 
by scandium triflate (33 mg, 0.068 mmol). The resulting solution was stirred for 1.5 hours 
before being quenched by the addition of saturated aqueous solution of sodium carbonate 
(0.5 mL) and diluted with ethyl acetate (3 mL). The aqueous phase was separated and 
extracted with ethyl acetate (3 × 2 mL). The combined organic extracts were washed with 
brine (3 mL), dried (MgSO4) and concentrated under reduced pressure. The residue was 
purified by flash column chromatography on silica gel (pentane-ethyl acetate, gradient 
elution from 1:1 → 1:3) to afford 6-epi-asbestinin 20 (16) (3.2 mg, 25%) as a colourless 
solid and a diastereomeric mixture (ratio and relative stereochemistry not determined) of 
diols 276 (7.8 mg, 60%) as a colourless oil.  
16: Rf = 0.21 (petroleum ether-ethyl acetate, 1:2); m.p. 212−214 °C; νmax 3429, 2957, 2926, 
2876, 1736, 968 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.35 (1H, dd, J = 5.4, 2.5 Hz, CH-C11), 
5.22 (1H, br s, CH2-C19a), 5.08 (1H, br s, CH2-C19b), 4.14 (1H, ddd, J = 4.7, 2.5, 2.5 Hz, 
CH-C9), 4.03 (1H, dd, J = 11.7, 4.0 Hz, CH-C6), 3.85 (1H, d, J = 8.5 Hz, CH-C2), 3.76 (1H, 
d, J = 13.0 Hz, CH2-C16a), 3.42 (1H, dd, J = 13.0, 3.2 Hz, CH2-C16b), 2.74 (1H, dd, J = 
14.0, 4.7 Hz, CH2-C8a), 2.30 (1H, ddd, J = 10.5, 10.5, 8.5 Hz, CH-C1), 2.19 (1H, ddd, J = 
10.5, 2.5, 2.5 Hz, CH-C10), 2.13−2.02 (2H, m, CH2-C5a, CH-C12), 2.11 (3H, s, CH3-OAc), 
1.97 (1H, dd, J = 14.0, 2.5 Hz, CH2-C8b), 1.87 (1H, dddd, J = 13.5, 10.5, 4.5, 3.1 Hz, 
CH-C14), 1.76−1.65 (1H, m, CH2-C5b), 1.63−1.35 (5H, m, CH2-C4, HO-C6, CH2-C13a, 
CH-C15), 1.32 (3H, s, CH3-C18), 1.01 (1H, dd, J = 13.5, 3.1 Hz, CH2-C13b), 0.93 (3H, d, 
J = 7.2 Hz, CH3-C20), 0.86 (3H, d, J = 7.1 Hz, CH3-C17); 
13C NMR (101 MHz, CDCl3) 
δ 171.3 (C-OAc), 147.6 (C-C7), 119.6 (CH2-C19), 93.9 (CH-C2), 82.0 (CH-C9), 79.1 
(CH-C6), 76.0 (C-C3), 74.0 (CH-C11), 67.4 (CH2-C16), 45.8 (CH-C10), 39.1 (CH-C1), 37.9 
(CH-C14), 36.8 (CH-C15), 35.4 (CH2-C8), 31.6 (CH2-C4), 31.6 (CH2-C13), 31.4 (CH-C12), 
27.8 (CH2-C5), 23.5 (CH3-C18), 21.3 (CH3-OAc), 17.7 (CH3-C20), 10.9 (CH3-C17); 
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[α]D
20 −51.2 (c = 0.285, CHCl3) {Lit.11 [α]D
20
 −30 (c = 0.50, CHCl3); HRMS (ESI+) [M]+ 
calcd. for C22H34O5Na 401.2298, found 401.2284, Δ 3.6 ppm.  
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Asbestinin 20 (14)  
 
To a stirred solution of epoxide 269 (18 mg, 48 µmol) in anhydrous dichloromethane 
(1.0 mL) at 0 °C was added 2,6-lutidine (28 μl, 0.24 mmol) followed by 
tert-butyldimethylsilyl trifluoromethanesulfonate (0.16 mL of a 0.5 M solution in THF, 
80 µmol). The reaction mixture was stirred for 3 hours before the reaction was quenched by 
the addition of a saturated aqueous solution of ammonium chloride (3 mL) and diluted with 
ethyl acetate (5 mL). The aqueous phase was separated and extracted with ethyl acetate 
(3 × 3 mL). The combined organic extracts were washed with brine (5 mL), dried (MgSO4) 
and concentrated under reduced pressure to give crude TBS-protected allylic alcohol 279, 
which was used in the next step without further purification. 
To a stirred solution of TBS-protected allylic alcohol 279 in THF (1.0 mL) at room 
temperature was added tetra-N-butylammonium fluoride (0.19 mL of a 1.0 M solution in 
THF, 0.19 mmol) in one portion. The reaction mixture was left to stir for 16 hours before 
being diluted with diethyl ether (5 mL) and water (3 mL). The aqueous phase was separated 
and extracted with diethyl ether (3 × 3 mL). The combined organic extracts were washed 
with brine (5 mL), dried (MgSO4) and concentrated under reduced pressure. The residue was 
purified by flash column chromatography on silica gel (hexane-ethyl acetate, gradient 
elution from 2:1 → 1:1) to afford asbestinin 20 (14) (7.0 mg, 39%) as a colourless solid.  
The NMR (1H and 13C), IR and mass spectrometry data were consistent with those reported 
for compound 14 previously (see p. 152). 
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6-epi-Asbestinin 20 (16)  
 
To a stirred solution of epoxide 270 (20 mg, 53 µmol) in anhydrous dichloromethane 
(1.1 mL) at 0 °C was added 2,6-lutidine (30 μl, 0.27 mmol) followed by 
tert-butyldimethylsilyl trifluoromethanesulfonate (0.16 mL of a 0.5 M solution in THF, 
80 µmol). The reaction mixture was stirred for 3 hours before the reaction was quenched by 
the addition of a saturated aqueous solution of ammonium chloride (3 mL) and diluted with 
ethyl acetate (5 mL). The aqueous phase was separated and extracted with ethyl acetate 
(3 × 3 mL). The combined organic extracts were washed with brine (5 mL), dried (MgSO4) 
and concentrated under reduced pressure to give crude TBS-protected allylic alcohol 280, 
which was used in the next step without further purification. 
 To a stirred solution of TBS-protected allylic alcohol 280 in THF (1.1 mL) at room 
temperature was added tetra-N-butylammonium fluoride (0.2 mL of a 1.0 M solution in THF, 
0.2 mmol) in one portion. The reaction mixture was left to stir for 16 hours before being 
diluted with diethyl ether (5 mL) and water (3 mL). The aqueous phase was separated and 
extracted with diethyl ether (3 × 3 mL). The combined organic extracts were washed with 
brine (5 mL), dried (MgSO4) and concentrated under reduced pressure. The residue was 
purified by flash column chromatography on silica gel (pentane-ethyl acetate, gradient 
elution from 1:1 → 1:2) to afford 6-epi-asbestinin 20 (16) (12.8 mg, 64%) as a colourless 
solid.  
The NMR (1H and 13C), IR and mass spectrometry data were consistent with those reported 
for compound 16 previously (see p. 154). 
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Asbestinin 20 (14)  
 
 
 
To a solution of epoxide 269 (8.6 mg, 23 µmol) in anhydrous dichloroethane (0.9 mL) was 
added Au/TiO2 (2.3 mg) in one portion. The resulting suspension was stirred at 80 °C in a 
sealed vial for 2 days. The reaction mixture was cooled down to room temperature and 
diluted with dichloromethane (3 mL) and filtered through a pad of celite, washed with 
dichloromethane (3 mL) and concentrated under reduced pressure. The residue was purified 
by flash column chromatography on silica gel (pentane-ethyl acetate, gradient elution from 
1:1 → 1:3) to afford asbestinin 20 (14) (3.0 mg, 35%) as a colourless solid.  
The NMR (1H and 13C), IR and mass spectrometry data were consistent with those reported 
for compound 14 previously (see p. 152). 
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Asbestinin 10 (15)[9] 
 
 
To a stirred solution of allylic alcohols 14 and 16 (1:2 mixture, 16 mg, 42 µmol) in anhydrous 
dichloromethane (1.0 mL) at room temperature was added anhydrous pyridine (14 μL, 
0.17 mmol) followed by Dess–Martin periodinane (32 mg, 75 µmol) in one portion. The 
reaction mixture was stirred for 2 hours before being diluted with ethyl acetate (5 mL). The 
reaction was quenched by the addition of saturated aqueous solution of sodium thiosulfate 
(3 mL) and left for 5 minutes before the addition of saturated aqueous solution of sodium 
bicarbonate (1 mL). The resulting solution was stirred vigorously for 30 minutes. The 
aqueous phase was separated and extracted with ethyl acetate (3 × 3 mL). The combined 
organic extracts were washed with brine (5 mL), dried (MgSO4) and concentrated under 
reduced pressure. The residue was purified by flash column chromatography on silica gel 
(pentane-diethyl ether, 10:1) to afford asbestinin 10 (15) (12 mg, 75%) as a colourless oil. 
Rf = 0.23 (petroleum ether-ethyl acetate, 2:1); νmax 2961, 2928, 2874, 1736, 1686, 1458, 
1371, 1300, 1234, 1107, 1074, 1013, 916 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.28–5.26 
(1H, m, CH2-C19a), 5.26 (1H, dd, J = 5.0, 2.8 Hz, CH-C11), 5.18 (1H, br s, CH2-C19b), 
4.04 (1H, dd, J = 6.7, 4.1 Hz, CH-C9), 3.77 (1H, d, J = 9.4 Hz, CH-C2), 3.75 (1H, d, J = 
13.0 Hz, CH2-C16a), 3.49 (1H, dd, J = 13.0, 3.0 Hz, CH2-C16b), 3.36 (1H, ddd, J = 13.2, 
6.8, 1.5 Hz, CH2-C8a), 2.81 (1H, ddd, J = 15.5, 8.01, 2.1 Hz, CH2-C5a), 2.49 (1H, ddd, J = 
15.5, 12.5, 2.0 Hz, CH2-C5b), 2.41 (1H, ddd, J = 11.2, 10.8, 9.4 Hz, CH-C1), 2.30 (1H, ddd, 
J = 14.9, 12.5, 2.1 Hz, CH2-C4a), 2.15 (1H, br d, J = 13.2 Hz, CH2-C8b), 2.10–1.98 (2H, m, 
CH-C10, CH-C12), 2.09 (3H, s, CH3-OAc), 1.89 (1H, dddd, J = 14.0, 10.8, 4.0, 3.6 Hz, 
CH-C14), 1.67 (1H, ddd, J = 14.9, 8.1, 2.0 Hz, CH2-C4b), 1.63–1.51 (2H, m, CH2-C13a, 
CH-C15), 1.28 (3H, s, CH3-C18), 1.05 (1H, ddd, J = 13.6, 3.6, 1.9 Hz, CH2-C13b), 0.94 (3H, 
d, J = 7.2 Hz, CH3-C20), 0.93 (3H, d, J = 7.1 Hz, CH3-C17); 
1H NMR (400 MHz, C6D6) 
δ 5.23 (1H, dd, J = 5.0, 2.9 Hz, CH-C11), 4.79 (1H, br s, CH2-C19a), 4.77 (1H, br s, 
CH2-C19b), 4.07 (1H, dd, J = 6.7, 4.0 Hz, CH-C9), 3.77 (1H, d, J = 9.4 Hz, CH-C2), 
3.49−3.42 (2H, m, CH2-C8a, CH2-C16a), 3.33 (1H, dd, J = 13.0, 3.0 Hz, CH2-C16b), 
2.63−2.48 (2H, m, CH2-C5), 2.39–2.24 (2H, m, CH-C1, CH2-C4a), 1.82–1.71 (4H, m, 
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CH2_C4b, CH2-C8b, CH-C10, CH-C14), 1.70 (3H, s, CH3-OAc), 1.66–1.57 (1H, m, 
CH-C12), 1.29–1.18 (2H, m, CH2-C13a, CH-C15), 1.28 (3H, s, CH3-C18), 0.88 (3H, d, J = 
7.1 Hz, CH3-C20), 0.88 (3H, d, J = 7.1 Hz, CH3-C17), 0.75 (1H, ddd, J = 13.5, 3.7, 2.0 Hz, 
CH2-C13b); 
13C NMR (101 MHz, CDCl3) δ 206.5 (C-C6), 171.1 (C-OAc), 146.7 (C-C7), 
114.1 (CH2-C19), 93.3 (CH-C2), 80.0 (CH-C9), 73.1 (CH-C11), 68.2 (CH2-C16), 48.0 
(CH-C10), 41.6 (CH2-C8), 40.2 (CH-C1), 37.6 (CH2-C5), 37.4 (CH-C14), 36.7 (CH-C15), 
35.9 (CH2-C4), 31.7 (CH2-C13), 31.2 (CH-C12), 24.1 (CH3-C18), 21.2 (CH3-OAc), 18.1 
(CH3-C20), 11.0 (CH3-C17), Peak for at C-C3 was not observed;  
13C NMR (101 MHz, 
C6D6) δ 203.0 (C-C6), 169.1 (C-OAc), 146.8 (C-C7), 111.6 (CH2-C19), 92.5 (CH-C2), 79.2 
(CH-C9), 76.4 (C-C3), 71.8 (CH-C11), 66.7 (CH2-C16), 47.1 (CH-C10), 40.6 (CH2-C8), 
39.1 (CH-C1), 36.7 (CH2-C5), 36.6 (CH-C14), 36.0 (CH-C15), 35.1 (CH2-C4), 30.7 
(CH2-C13), 30.3 (CH-C12), 23.0 (CH3-C18), 19.4 (CH3-OAc), 17.1 (CH3-C20), 10.1 
(CH3-C17); [α]D
23
 −78 (c = 0.13, CHCl3) {Lit.9 [α]D
25 −81.5 (c = 0.760, CHCl3); HRMS (ESI+) 
[M+Na]+ calcd. for C22H32O5Na 399.2142, found 399.2131, Δ 2.8 ppm. 
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Asbestinin 20 (14) and 6-epi-Asbestinin 20 (16)  
 
To a stirred solution of enone 15 (10 mg, 27 µmol) in a mixture of methanol and 
dichloromethane (1:1, 0.6 mL) at room temperature was added cerium (III) chloride 
heptahydrate (20 mg, 53 µmol). The reaction mixture was stirred for 15 minutes before being 
cooled down to −78 °C. To this, sodium borohydride (2.0 mg, 53 µmol) was added in one 
portion and the resulting solution was stirred for 2 hours. The reaction mixture was warmed 
to room temperature and allowed to stir for a further 20 minutes. The reaction was quenched 
by the addition of a 50% aqueous solution of ammonium chloride (2 mL) and diluted with 
ethyl acetate (5 mL). The aqueous phase was separated and extracted with ethyl acetate 
(3 × 2 mL). The combined organic extracts were washed with brine (3 mL), dried (MgSO4) 
and concentrated under reduced pressure. The residue was purified by flash column 
chromatography on silica gel (pentane-diethyl ether, gradient elution from 1:2 → 1:5) to 
afford asbestinin 20 (14) (6.4 mg, 64%) and 6-epi-asbestinin 20 (16) (2.0 mg, 20%) as 
colourless solids. 
The NMR (1H and 13C), IR and mass spectrometry data were consistent with those reported 
for compounds 14 and 16 previously (see p. 152 and 154). 
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(1R,2R,3S,4S,5S,7R,8S,11R,14S,16R,18R)‐5,8,11,16‐Tetramethyl‐10,15,19‐
trioxapentacyclo[9.8.0.02,7.03,18.014,16]nonadecan‐4‐yl butanoate (284)   
 
 
To a stirred solution of 4-deoxyasbestinin C (19) (20 mg, 51 µmol), unnatural Shi ketone 
(4.0 mg, 15 µmol) in a mixture of acetonitrile and dimethoxyethane (1:2, 1.2 mL) was added 
buffer (0.52 mL of a 0.05 M solution of Na2B4O7•10H2O in 4 × 10-4 M aqueous Na2(EDTA), 
26 µmol) followed by tetrabutylammonium hydrogen sulfate (5.0 μL of a 0.4 M solution in 
water, 2.0 μmol). The resulting solution was cooled to 0 °C before Oxone™ (1.3 mL of a 
0.4 M solution in 4 × 10-4 M aqueous Na2(EDTA), 0.52 mmol) and potassium carbonate 
(0.75 mL of a 0.4 M solution in water, 0.30 mmol) were added simultaneously. The reaction 
mixture was stirred for 1 hour before being diluted with water (5 mL) and ethyl acetate 
(10 mL). The aqueous phase was separated and extracted with ethyl acetate (3 × 5 mL). The 
combined organic extracts were washed with brine (10 mL), dried (MgSO4) and 
concentrated under reduced pressure. The residue was purified by flash column 
chromatography on silica gel (pentane-ethyl acetate, gradient elution from 10:1 → 2:1) to 
afford epoxide 284 (15.2 mg, 73%) as a colourless solid.  
Rf = 0.38 (petroleum ether-ethyl acetate, 2:1); m.p. 123−125 °C; νmax 2961, 2924, 2878, 
1732, 839, 729 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.44 (1H, dd, J = 6.3, 1.9 Hz, CH-C11), 
4.24 (1H,br dd, J = 11.7, 5.2 Hz, CH-C9), 3.89 (1H, d, J = 10.1 Hz, CH-C2), 3.83 (1H, dd, 
J = 13.2, 1.3 Hz, CH2-C16a), 3.60 (1H, dd, J = 13.2, 2.2 Hz, CH2-C16b), 2.81–2.71 (2H, m, 
CH-C1, CH-C6), 2.31 (2H, t, J = 7.5 Hz, CH2-C22), 2.21–2.12 (1H, m, CH-C12), 2.03 (1H, 
dd, J = 13.8, 5.2 Hz, CH2-C8a), 2.03–1.96 (1H, m, CH2-C5a), 1.89–1.76 (2H, m, CH2-C4a, 
CH-C10, CH-C14), 1.73–1.63 (3H, m, CH2-C5b, CH2-C23), 1.61–1.47 (4H, m, CH2-C4b, 
CH2-C8b, CH2-C13a, CH-C15), 1.33 (3H, s, CH3-C18), 1.33 (3H, s, CH3-C19), 1.04 (1H, 
dd, J = 13.4, 2.8 Hz, CH2-C13b), 0.98 (3H, d, J = 7.1 Hz, CH3-C17), 0.97 (3H, t, J = 7.4 Hz, 
CH3-C24), 0.91 (3H, d, J = 7.3 Hz, CH3-C20); 
13C NMR (101 MHz, CDCl3) δ 173.7 
(C-C21), 94.2 (CH-C2), 78.4 (CH-C9), 79.3 (C-C3), 72.5 (CH-C11), 70.3 (CH2-C16), 66.4 
(CH-C6), 59.5 (C-C7), 50.0 (CH-C10), 43.4 (CH2-C8), 39.6 (CH-C1), 37.7 (CH-C14), 36.9 
(CH2-C22), 36.4 (CH-C15), 34.5 (CH2-C4), 32.1 (CH2-C13), 31.4 (CH-C12), 27.8 
 Experimental 
 
 
163 
 
(CH3-C19), 22.5 (CH3-C18), 21.8 (CH2-C5), 18.6 (CH2-C23), 17.0 (CH3-C20), 13.9 
(CH3-C24), 11.3 (CH3-C17); [α]D
15 –21.1 (c = 0.845, CHCl3); HRMS (ESI+) [M]+ calcd. for 
C24H38O5Na 426.2604, found 429.2611, Δ 1.9 ppm. 
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(1R,2R,3S,4S,5S,7R,8S,11R,14S,15R,17R)-14,15-Dihydroxy-5,8,11,15-tetramethyl-
10,18-dioxatetracyclo[9.7.0.02,7.03,17]octadecan‐4‐yl acetate (275) and 
(1R,2R,3S,4S,5S,7R,8S,11R,14R,15S,17R)-14,15-Dihydroxy-5,8,11,15-tetramethyl-
10,18-dioxatetracyclo[9.7.0.02,7.03,17]octadecan‐4‐yl acetate (287)  
 
To a stirred of 11-acetoxy-4-deoxyasbestinin D (18) (16.6 mg, 45.8 μmol) in a mixture of 
THF and water (1:1, 1.2 mL) at 0 °C was added N-methylmorpholine oxide (54 mg, 0.46 
mmol) followed by osmium tetroxide (15 μL of a 4% wt solution in water, 2.4 μmol). The 
reaction mixture was left to stir for 1.5 hours before the reaction was quenched by the 
addition of a saturated aqueous solution of sodium thiosulfate (2 mL). The resulting 
suspension was vigorously stirred for 1 hour before being diluted with ethyl acetate (5 mL). 
The aqueous phase was separated and extracted with ethyl acetate (3 × 2 mL). The combined 
organic extracts were washed with brine (4 mL), dried (MgSO4) and concentrated under 
reduced pressure. The residue was purified by flash column chromatography on silica gel 
(pentane-ethyl acetate, gradient elution from 1:2 → 1:5) to afford diols 275 and 287 (5.7:1, 
10.2 mg, 56%) as a colourless solid.1 
 
 
 
 
 
 
 
 
 
                                                 
1 Diols were later found to be separable by flash column chromatography on silica gel 
(dichloromethane-methanol, gradient elution from 19:1 → 5.1) 
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7-epi-Asbestinin 21 (223) and Asbestinin 21 (288)[10] 
 
To a stirred solution of diols 275 and 287 (10.2 mg, 25.7 μmol) in anhydrous 
dichloromethane (1.0 mL) at room temperature was added pyridine (80 μL, 0.10 mmol) and 
Dess–Martin periodinane (20 mg, 47 µmol). The resulting solution was stirred for 2 hours 
then diluted with diethyl ether (3 mL). The reaction was quenched by the addition of 
saturated aqueous solution of sodium thiosulfate (2 mL) and left for 5 minutes before the 
addition of saturated aqueous solution of sodium bicarbonate (0.5 mL). The resulting 
solution was stirred vigorously for 30 minutes. The aqueous phase was separated and 
extracted with diethyl ether (3 × 2 mL). The combined organic extracts were washed with 
brine (3 mL), dried (MgSO4) and concentrated under reduced pressure. The residue was 
purified by flash column chromatography on silica gel (pentane-ethyl acetate, gradient 
elution from 1:1 → 1:3) to afford 7-epi-asbestinin 21 (223) (6.8 mg, 67%) as a colourless oil 
and asbestinin 21 (288) (1.4 mg, 14%) as a colourless solid. 
223: Rf = 0.49 (petroleum ether-ethyl acetate, 1:3); νmax 3451, 2963, 2932, 2876, 1736, 1690, 
997, 963, 918, 873, 731 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.23 (1H, dd, J = 5.1, 2.6 Hz, 
CH-C11), 3.92 (1H, ddd, J = 6.1, 4.1, 1.8 Hz, CH-C9), 3.78 (1H, br d, J = 13.1 Hz, 
CH2-C16a), 3.77 (1H, d, J = 9.7 Hz, CH-C2), 3.55 (1H, dd, J = 13.1, 2.8 Hz, CH2-C16b), 
3.32−3.21 (1H, m, CH2-C5a), 2.83 (1H, ddd, J = 10.4, 9.7, 9.5 Hz, CH-C1), 2.52–2.46 (1H, 
m, CH-C10), 2.46 (1H, dd, J = 14.5, 6.1 Hz, CH2-C8a), 2.41−2.30 (1H, m, CH2-C4a), 
2.12−1.98 (2H, m, CH2-C5b, CH-C12), 2.07 (3H, s, CH3-OAc), 1.93–1.79 (4H, m, 
CH2-C4b, HO-C7, CH2-C8b, CH-C14), 1.63–1.51 (2H, m, CH2-C13a, CH-C15), 1.38 (3H, 
s, CH3-C19), 1.32 (3H, s, CH3-C18), 1.03 (1H, dd, J = 13.5, 2.0 Hz, CH2-C13b), 0.99 (3H, 
d, J = 7.1 Hz, CH3-C17), 0.92 (3H, d, J = 7.2 Hz, CH3-C20); 
13C NMR (101 MHz, CDCl3) 
δ 214.2 (C-C6), 171.4 (C-OAc), 93.7 (CH-C2), 79.8 (C-C7), 78.9 (CH-C9), 76.7 (C-C3), 
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73.8 (CH-C11), 69.1 (CH2-C16), 47.1 (CH-C10), 47.0 (CH2-C8), 40.1 (CH-C1), 37.5 
(CH-C14), 37.1 (CH2-C4), 37.0 (CH-C15), 32.8 (CH2-C5), 32.1 (CH2-C13), 31.3 (CH-C12), 
28.4 (CH3-C19), 25.7 (CH3-C18), 21.4 (CH3-OAc), 18.0 (CH3-C20), 11.2 (CH3-C17); 
[α]D
20 −25.6 (c = 0.245, CHCl3); HRMS (ESI+) [M]+ calcd. for C22H34O6Na 417.2248, found 
417.2235, Δ 3.1 ppm.  
288: Rf = 0.44 (petroleum ether-ethyl acetate, 1:2); νmax 3439, 2964, 2926, 1736, 1686, cm−1; 
1H NMR (500 MHz, CDCl3) δ 5.34 (1H, dd, J = 5.6, 2.3 Hz, CH-C11), 4.39 (1H, s, HO-C7), 
4.28 (1H, dd, J = 11.5, 3.4 Hz, CH-C9), 3.82 (1H, d, J = 8.8 Hz, CH-C2), 3.78 (1H, br d, J = 
13.0 Hz, CH2-C16a), 3.49 (1H, dd, J = 13.0, 2.8 Hz, CH2-C16b), 2.75 (1H, ddd, J = 14.6, 
14.6, 3.9 Hz, CH2-C5a), 2.67−2.61 (1H, m, CH2-C5b), 2.57 (1H, ddd, J = 10.0, 10.0, 8.8 Hz, 
CH-C1), 2.30 (1H, ddd, J = 14.6, 14.6, 3.4 Hz, CH2-C4a), 2.26−2.18 (1H, m, CH2-C8a), 
2.12–2.03 (2H, m, CH2-C8b, CH-C12), 2.05 (3H, s, CH3-OAc), 1.93–1.85 (2H, m, CH-C10, 
CH-C14), 1.64–1.45 (3H, m, CH2-C4b, CH2-C13a, CH-C15), 1.33 (3H, s, CH3-C18), 1.30 
(3H, s, CH3-C19),  1.04 (1H, dd, J = 13.6, 2.6 Hz, CH2-C13b), 0.94 (3H, d, J = 7.1 Hz, 
CH3-C17), 0.90 (3H, d, J = 7.3 Hz, CH3-C20); 
13C NMR (126 MHz, CDCl3) δ 210.9 (C-C6), 
171.0 (C-OAc), 93.7 (CH-C2), 78.4 (CH-C9), 77.2 (C-C3), 76.4 (C-C7), 72.9 (CH-C11), 
68.3 (CH2-C16), 49.4 (CH2-C8), 47.7 (CH-C10), 38.1 (CH-C1), 38.1 (CH-C14), 36.5 
(CH-C15), 36.2 (CH2-C5), 34.1 (CH2-C4), 31.6 (CH2-C13), 31.6 (CH-C12), 27.8 
(CH3-C19), 22.6 (CH3-C18), 21.6 (CH3-OAc), 17.4 (CH3-C20), 11.1 (CH3-C17); [α]D
21 −7.2 
(c = 0.10, CHCl3) {Lit.
10 [α]D
24
 −27.1 (c = 1.80, CHCl3); HRMS (ESI+) [M]+ calcd. for 
C22H34O6Na 417.2248, found 417.2233, Δ 3.5 ppm.  
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7-epi-Asbestinin 21 (223) 
 
To a stirred solution of diol 275 (10.5 mg, 26.4 μmol) in anhydrous dichloromethane 
(0.5 mL) at room temperature was added pyridine (8.4 μL, 0.10 mmol) and Dess–Martin 
periodinane (20 mg, 48 μmol). The resulting solution was stirred for 2 hours then diluted 
with diethyl ether (5 mL). The reaction was quenched by the addition of saturated aqueous 
solution of sodium thiosulfate (2 mL) and left for 5 minutes before the addition of saturated 
aqueous solution of sodium bicarbonate (0.5 mL). The resulting solution was stirred 
vigorously for 30 minutes. The aqueous phase was separated and extracted with diethyl ether 
(3 × 1 mL). The combined organic extracts were washed with brine (3 mL), dried (MgSO4) 
and concentrated under reduced pressure. The residue was purified by flash column 
chromatography on silica gel (pentane-ethyl acetate, 1:2) to afford 7-epi-asbestinin 21 (223) 
(9.1 mg, 87%) as a colourless oil. 
The NMR (1H and 13C), IR and mass spectrometry data were consistent with those reported 
for compound 223 previously (see p. 165). 
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(1R,2R,3S,4S,5S,7R,8S,11R,14S,15R,17R)-14,15-Dihydroxy-5,8,11,15-tetramethyl-
10,18-dioxatetracyclo[9.7.0.02,7.03,17]octadecan‐4‐yl acetate (275), 
(1R,2R,3S,4S,5S,7R,8S,11R,14R,15S,17R)-14,15-Dihydroxy-5,8,11,15-tetramethyl-
10,18-dioxatetracyclo[9.7.0.02,7.03,17]octadecan‐4‐yl acetate (287) and 
7-epi-Asbestinin 21 (223)  
 
Dihydroxylation of 11-Acetoxy-4-deoxyasbestinin D (18) with the Osmium Complex of 
(DHQ)2PHAL (AD-mix-α) 
To a stirred solution of (DHQ)2PHAL (9.1 mg, 12 µmol), potassium osmate (2.9 mg, 
7.9 μmol), potassium ferricyanate (642 mg, 1.95 mmol) and potassium carbonate (270 mg, 
1.95 mmol) in a mixture of t-BuOH and water (1:1, 0.8 mL) at 0 °C was added 
11-acetoxy-4-deoxyasbestinin D (18) (18 mg, 50 µmol) in t-BuOH (0.3 mL) in one portion. 
The reaction mixture was warmed to room temperature over 2 hours before being left to stir 
for 16 hours. The reaction was quenched by the addition of saturated aqueous solution of 
sodium metabisulfite (3 mL) and left for 30 minutes before being diluted with ethyl acetate 
(5 mL). The aqueous phase was separated and extracted with ethyl acetate (3 × 3 mL). The 
combined organic extracts were washed with brine (5 mL), dried (MgSO4) and concentrated 
under reduced pressure. The residue was purified by flash column chromatography on silica 
gel (pentane-ethyl acetate, gradient elution from 1:2 → 1:5) to afford a diastereoisomeric 
mixture of diols 275 and 287 (>12:1, 4.6 mg, 23%) as a colourless solid and 
7-epi-asbestinin 21 (223) (9.1 mg, 46%) as a colourless oil. 
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Dihydroxylation of 11-Acetoxy-4-deoxyasbestinin D (18) with the Osmium Complex of 
(DHQD)2PHAL (AD-mix-β) 
To a stirred solution of (DHQD)2PHAL (23 mg, 30 µmol), potassium osmate (7.4 mg, 
20 µmol), potassium ferricyanate (1.64 g, 4.98 mmol) and potassium carbonate (690 mg, 
4.99 mmol) in a mixture of t-BuOH and water (1:1, 1.1 mL) at 0 °C was added 
11-acetoxy-4-deoxyasbestinin D (18) (18 mg, 50 µmol) in t-BuOH (0.3 mL) in one portion. 
The reaction mixture was warmed to room temperature over 2 hours before being left to stir 
for 16 hours. The reaction was quenched by the addition of saturated aqueous solution of 
sodium metabisulfite (3 mL) and left for 30 minutes before being diluted with ethyl acetate 
(5 mL). The aqueous phase was separated and extracted with ethyl acetate (3 × 3 mL). The 
combined organic extracts were washed with brine (5 mL), dried (MgSO4) and concentrated 
under reduced pressure. The residue was purified by flash column chromatography on silica 
gel (pentane-ethyl acetate, gradient elution from 1:2 → 1:5) to afford a diastereoisomeric 
mixture of diols 275 and 287 (8.0:1, 14.7 mg, 75%) as a colourless solid and 
7-epi-asbestinin 21 (223) (1.9 mg, 10%) as a colourless oil. 
The NMR (1H and 13C), IR and mass spectrometry data were consistent with those reported 
for compounds 275 and 223 previously (see p. 152 and 165). 
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Asbestinin 23 (266)[10] and 7-epi-Asbestinin 23 (289)  
 
 
 
To a stirred solution of 11-acetoxy-4-deoxyasbestinin D (18) (26 mg, 72 µmol) in anhydrous 
THF (1.4 mL) at 0 °C was added BH3•THF (0.2 mL of a 1.0 M solution in THF, 0.2 mmol). 
The resulting solution was stirred for 2.5 hours before the reaction was quenched by the 
addition of a water (2 mL) and sodium perborate tetrahydrate (84 mg, 0.55 mmol). The 
reaction mixture was warmed to room temperature and left to stir for 16 hours before being 
diluted with diethyl ether (5 mL). The aqueous phase was separated and extracted with 
diethyl ether (3 × 2 mL). The combined organic extracts were washed with brine (5 mL), 
dried (MgSO4) and concentrated under reduced pressure to give crude alcohols 290 and 291, 
which was used in the next step without further purification. 
To a stirred solution of alcohols 290 and 291 in anhydrous dichloromethane (1.4 mL) at 
room temperature was added pyridine (0.30 mL, 0.36 mmol) and Dess–Martin periodinane 
(73 mg, 0.17 mmol) in one portion. The resulting solution was stirred for 2 hours before 
being diluted with diethyl ether (5 mL). The reaction was quenched by the addition of 
saturated aqueous solution of sodium thiosulfate (2 mL) and left for 5 minutes before the 
addition of saturated aqueous solution of sodium bicarbonate (0.5 mL). The resulting 
solution was stirred vigorously for 30 minutes. The aqueous phase was separated and 
extracted with diethyl ether (3 × 3 mL). The combined organic extracts were washed with 
brine (5 mL), dried (MgSO4) and concentrated under reduced pressure. The residue was 
purified by flash column chromatography on silica gel (pentane-ethyl acetate, gradient 
elution from 10:1 → 2:1) to afford 7-epi-asbestinin 23 (289) (13.4 mg, 49%) and 
asbestinin 23 (266) (5.3 mg, 20%) as colourless oils.  
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289: Rf = 0.44 (petroleum ether-ethyl acetate, 1:1); νmax 2961, 2932, 2872, 1734, 1694, 993, 
951, 936, 733 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.27 (1H, dd, J = 5.0, 2.7 Hz, CH-C11), 
3.98 (1H, ddd, J = 6.5, 6.5, 3.3 Hz, CH-C9), 3.77 (1H, br d, J = 13.2 Hz, CH2-C16a), 3.74 
(1H, d, J = 9.4 Hz, CH-C2), 3.49 (1H, dd, J = 13.2, 3.0 Hz, CH2-C16b), 2.87–2.76 (1H, m, 
CH-C7), 2.57–2.44 (2H, m, CH2-C8), 2.42 (1H, ddd, J = 10.6, 10.4, 9.4 Hz, CH-C1), 2.26 
(1H, ddd, J = 14.8, 10.7, 4.1 Hz, CH2-C4a), 2.07 (3H, s, CH3-OAc), 2.06–1.92 (4H, m, 
CH2-C5, CH-C10, CH-C12), 1.85 (1H, dddd, J = 13.7, 10.8, 4.1, 3.7 Hz, CH-C14), 1.73 
(1H, ddd, J = 14.8, 7.3, 3.6 Hz, CH2-C4b), 1.65–1.58 (1H, m, CH-C15), 1.51 (1H, ddd, J = 
13.7, 13.4, 9.7 Hz, CH2-C13a), 1.33 (3H, s, CH3-C18), 1.06 (3H, d, J = 6.9 Hz, CH3-C19), 
1.01 (1H, ddd, J = 13.4, 3.7, 1.8 Hz, CH2-C13b), 0.95 (3H, d, J = 7.1 Hz, CH3-C17), 0.90 
(3H, d, J = 7.2 Hz, CH3-C20); 
13C NMR (101 MHz, CDCl3) δ 215.2 (C-C6), 171.2 (C-OAc), 
92.9 (CH-C2), 79.3 (CH-C9), 73.1 (CH-C11), 68.0 (CH2-C16), 49.9 (CH-C10), 44.3 
(CH-C7), 42.8 (CH2-C5), 38.8 (CH2-C8), 38.3 (CH-C1), 37.9 (CH-C14), 36.7 (CH-C15), 
34.6 (CH2-C4), 31.3 (CH2-C13), 31.2 (CH-C12), 24.1 (CH3-C18), 21.3 (CH3-OAc), 18.0 
(CH3-C19), 17.9 (CH3-C20), 11.0 (CH3-C17). Peak for C-C3 was obscured by solvent 
(~77.0 ppm);  [α]D
20
 −23.6 (c = 0.250, CHCl3); HRMS (ESI+) [M]+ calcd. for C22H34O5Na 
401.2284, found 401.2298, Δ 3.6 ppm.  
266: Rf = 0.39 (petroleum ether-ethyl acetate, 1:1); νmax 2959, 2928, 2872, 1736, 1697 cm−1; 
1H NMR (400 MHz, CDCl3) δ 5.25 (1H, dd, J = 5.0, 2.8 Hz, CH-C11), 3.94−3.90 (1H, m, 
CH-C9), 3.80 (1H, d, J = 9.5 Hz, CH-C2), 3.78 (1H, br d, J = 13.0 Hz, CH2-C16a), 3.53 (1H, 
dd, J = 13.0, 2.9 Hz, CH2-C16b), 2.78 (1H, dqd, J = 13.4, 6.7, 1.9 Hz, CH-C7), 2.61−2.53 
(2H, m, CH-C1, CH2-C5a), 2.48 (1H, ddd, J = 13.4, 12.4, 6.0 Hz, CH2-C8a), 2.40−2.32 (1H, 
m, CH2-C5b), 2.29−2.22 (1H, m, CH2-C4a), 2.08 (3H, s, CH3-OAc), 2.07−2.01 (2H, m, 
CH-C10, CH-C12), 1.96−1.87 (1H, m, CH-C14), 1.73 (1H, dd, J = 14.7, 8.0 Hz, CH2-C4b), 
1.65−1.55 (3H, m, CH2-C8b, CH2-C13a, CH-C15), 1.30 (3H, s, CH3-C18), 1.07 (1H, ddd, 
J = 13.6, 3.5, 1.7 Hz, CH2-C13b), 1.02 (3H, d, J = 6.7 Hz, CH3-C19), 0.98 (3H, d, J = 7.1 Hz, 
CH3-C17), 0.94 (3H, d, J = 7.2 Hz, CH3-C20); 
13C NMR (101 MHz, CDCl3) δ 171.2 
(C-OAc), 93.5 (CH-C2), 79.8 (CH-C9), 77.1 (C-C3), 73.3 (CH-C11), 68.5 (CH2-C16), 48.5 
(CH-C10), 43.1 (CH2-C8), 40.9 (CH-C1), 39.5 (CH2-C5), 37.6 (CH-C7), 37.4 (CH-C14), 
36.9 (CH-C15), 35.6 (CH2-C4), 32.0 (CH2-C13), 31.3 (CH-C12), 24.5 (CH3-C18), 21.4 
(CH3-OAc), 18.2 (CH3-C20), 17.7 (CH3-C19), 11.2 (CH3-C17). Peak for C-C6 was not 
observed; [α]D
20
 −38.3 (c = 0.235, CHCl3) {Lit.10 [α]D
24
 −22.0 (c = 2.30, CHCl3); HRMS 
(ESI+) [M]+ calcd. for C22H34O5Na 401.2298, found 401.2298, Δ 2.7 ppm. 
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(1R,2R,3S,4S,5S,7R,8S,11R,14S,15R,17R)‐14-Hydroxy-5,8,11,15‐tetramethyl‐10,18‐
dioxatetracyclo[9.7.0.02,7.03,17]octadecan‐4‐yl acetate (290)  
 
To a stirred solution of 7-epi-asbestinin 23 (289) (12.3 mg, 32.5 μmol) in anhydrous THF 
(0.6 mL) at −78 °C was added L-selectride (0.04 mL of a 1.0 M solution in THF, 0.04 mmol) 
dropwise and the resulting solution was stirred for 1 hour. The reaction was quenched by the 
addition of a water (2 mL) and warmed to room temperature before being diluted with ethyl 
acetate (3 mL). The aqueous phase was separated and extracted with ethyl acetate 
(3 × 2 mL). The combined organic extracts were washed with brine (3 mL), dried (MgSO4) 
and concentrated under reduced pressure. The residue was purified by flash column 
chromatography on silica gel (pentane-ethyl acetate, gradient elution from 2:1 → 1:2) to 
afford alcohol 290 (7.9 mg, 64%) as a colourless solid. 
Rf = 0.29 (petroleum ether-ethyl acetate, 1:1); m.p. 206−208 °C; νmax 3451, 2963, 2874, 
1736, 1462, 1371, 1236, 1109, 1074, 1016, 974, 731 cm−1; 1H NMR (500 MHz, CDCl3) 
δ 5.39 (1H, dd, J = 5.7, 1.6 Hz, CH-C11), 4.09 (1H, app dd, J = 12.1, 3.7 Hz, CH-C9), 3.85 
(1H, d, J = 8.5 Hz, CH-C2), 3.82−3.74 (2H, m, CH-C6, CH2-C16a), 3.48 (1H, dd, J = 12.9, 
2.3 Hz, CH2-C16b), 2.59 (1H, ddd, J = 9.9, 9.9, 8.5 Hz, CH-C1), 2.15−1.98 (4H, m, 
CH2-C4a, CH2-C5a, CH2-C8a, CH-C12), 2.09 (3H, s, CH3-OAc), 1.93−1.85 (1H, m, 
CH-C14), 1.84−1.79 (1H, m, CH2-C4b), 1.77 (1H, dd, J = 9.4, 1.6 Hz, CH-C10), 1.72−1.65 
(1H, m, CH-C7), 1.64−1.57 (1H, m, CH-C15), 1.48 (1H, ddd, J = 13.5, 13.5, 9.2 Hz, 
CH2-C13a), 1.33 (3H, s, CH3-C18), 1.27−1.16 (1H, m, CH2-C5b), 1.05−0.98 (5H, m, 
CH2-C8b, CH2-C13b, CH3-C19), 0.93 (3H, d, J = 7.2 Hz, CH3-C17), 0.92 (3H, d, J = 7.2 Hz, 
CH3-C20); 
13C NMR (126 MHz, CDCl3) δ 171.5 (C-OAc), 94.9 (CH-C2), 82.1 (CH-C9), 
77.8 (C-C3), 73.9 (CH-C6), 73.6 (CH-C11), 68.1 (CH2-C16), 48.3 (CH-C10), 38.4 
(CH-C14), 37.9 (CH-C1), 37.5 (CH2-C8), 37.3 (CH-C7), 36.5 (CH-C15), 31.6 (CH2-C13), 
31.5 (CH-C12), 29.9 (CH2-C4), 28.2 (CH2-C5), 22.9 (CH3-C19), 22.7 (CH3-C18), 21.6 
(CH3-OAc), 17.2 (CH3-C20), 11.1 (CH3-C17); [α]D
23 +12.4 (c = 0.210, CHCl3); HRMS 
(ESI+) [M]+ calcd. for C22H36O5Na 403.2455, found 403.2446, Δ 2.1 ppm. 
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(1ʹR,2R,2ʹR,3ʹS,4ʹS,5ʹS,7ʹR,8ʹS,11ʹR,14ʹS,17ʹR)‐14ʹ-Hydroxy-5ʹ,8ʹ,11ʹ‐trimethyl‐
10ʹ,18ʹ‐dioxaspiro[oxirane-2,15ʹ-tetracyclo[9.7.0.02,7.03,17]octadecan]‐4ʹ‐yl acetate 
(292)  
 
To a suspension of 4 Å powdered molecular sieves (5 mg) in anhydrous CH2Cl2 (0.2 mL) at 
−15 °C were added distilled titanium tetraisopropoxide (10 μL of a 0.11 M solution in 
CH2Cl2, 1.1 μmol), distilled (+)-diethyl tartrate (10 μL of a 0.16 M solution in CH2Cl2, 
1.6 μmol) and tert-butylhydroperoxide (0.10 mL of a 0.42 M solution in CH2Cl2, 42 µmol) 
in one portion. The resulting suspension was stirred for 1 hour before a solution of 
asbestinin 20 (14) (8.0 mg, 21 µmol) in anhydrous CH2Cl2 (0.2 mL) was added dropwise 
over 15 minutes and left to stir for 2 hours. The reaction was quenched by the addition of 
50% aqueous solution of NaHCO3 (0.5 mL) before the reaction mixture was warmed to room 
temperature and diluted with diethyl ether (5 mL) and water (3 mL). The aqueous phase was 
separated and extracted with diethyl ether (3 × 2 mL). The combined organic extracts were 
washed with brine (5 mL), dried (MgSO4) and concentrated under reduced pressure. The 
residue was purified by flash column chromatography on silica gel (pentane-diethyl ether, 
gradient elution from 1:2 → 1:5) to afford epoxide 292 (6.2 mg, 75%) as a colourless solid. 
Rf = 0.17 (petroleum ether-ethyl acetate, 1:2); m.p. 228−230 °C; νmax 3452, 2961, 2930, 
2874, 1736, 916, 729 cm−1; 1H NMR (500 MHz, CDCl3) δ 5.35 (1H, dd, J = 5.7, 2.2 Hz), 
4.31−4.26 (1H, m), 3.89 (1H, d, J = CH-C2), 3.80 (1H, d, J = 13.0 Hz), 3.49 (1H, dd, J = 
13.0 Hz), 2.63 (1H, d, J = 5.0 Hz), 2.59−2.50 (1H, m), 2.23−2.06 (3H, m), 2.09 (3H, s), 
1.97−1.87 (4H, m), 1.80−1.71 (2H, m), 1.66−1.59 (1H, m), 1.53−1.42 (2H, m), 1.35 (3H, s), 
1.05 (1H, dd, J = 13.4, 2.6 Hz), 0.94 (3H, d, J = 7.1 Hz), 0.92 (3H, d, J = 7.3 Hz); 13C NMR 
(126 MHz, CDCl3) δ 171.3, 94.1, 79.5, 73.3, 68.0, 48.0, 38.3, 38.3, 36.6, 31.6, 31.5, 27.6, 
22.9, 21.5, 17.4, 11.1;2 [α]D
21 −38.6 (c = 0.110, CHCl3); HRMS (ESI+) [M]+ calcd. for 
C22H34O6Na 417.2238, found 417.2248, Δ 2.1 ppm.  
                                                 
2 Full assignment of compound 292 was not possible; this is likely caused by conformational change in oxonene 
ring broadening the peaks. Structure of compound 292 was confirmed by single crystal X-ray analysis. 
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(1R,6S,7R,8R,12Z)‐6‐{3‐[(tert‐Butyldimethylsilyl)oxy]prop‐1‐en‐2‐yl}‐3‐ethoxy‐13‐
methyl‐15‐oxatricyclo[6.6.1.02,7]pentadeca‐3,12‐dien‐9‐one (300) 
 
To a stirred solution of ketone 256 (676 mg, 1.80 mmol) in anhydrous methanol (36 mL) at 
room temperature was added potassium carbonate (302 mg, 2.18 mmol) in one portion. The 
resulting solution was stirred for 1.5 hours before the reaction was quenched by the addition 
of saturated aqueous solution of ammonium chloride (20 mL) and diluted with ethyl acetate 
(30 mL). The aqueous phase was separated and extracted with ethyl acetate (3 × 10 mL). 
The combined organic extracts were washed with brine (20 mL), dried (MgSO4) and 
concentrated under reduced pressure to give crude alcohol 298, which was used in the next 
step without further purification. 
To a stirred solution of alcohol 298 in anhydrous dichloromethane (36 mL) at room 
temperature was added imidazole (248 mg, 3.64 mmol) and tert-butyldimethylsilyl chloride 
(494 mg, 3.28 mmol) in one portion. The resulting solution was stirred for 2 hours before 
the reaction was quenched by the addition of water (20 mL) and diluted with diethyl ether 
(50 mL). The aqueous phase was separated and extracted with diethyl ether (3 × 15 mL). 
The combined organic extracts were washed with brine (40 mL), dried (MgSO4) and 
concentrated under reduced pressure. The residue was purified by flash column 
chromatography on silica gel (pentane-ethyl acetate, gradient elution from 30:1 → 15:1) to 
afford ketone 299 which underwent isomerisation to give ketone 300 (663 mg, 82%) as a 
colourless oil.  
Rf = 0.83 (petroleum ether-ethyl acetate, 9:1); νmax 2951, 2928, 2857, 1705, 1668, 906, 835, 
775 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.50 (1H, dd, J = 11.4, 5.7 Hz, CH-C6), 5.15 (1H, 
d, J = 1.6 Hz, CH2-C17a), 4.94 (1H, d, J = 1.6 Hz, CH2-C17b), 4.58 (1H, br d, J = 5.6 Hz, 
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CH-C12), 4.32–4.27 (1H, m, CH-C9), 4.12 (1H, br s, CH-C2), 4.09 (2H, br s, CH2-C16), 
3.72–3.59 (2H, m, CH2-OEt), 3.28 (1H, dddd, J = 12.2, 12.2, 12.2, 6.2 Hz, CH2-C5a), 2.97 
(1H, app dd, J = 11.9, 7.1 Hz, CH-C1), 2.88 (1H, br d, J = 14.4 Hz, CH2-C8a), 2.81 (1H, 
ddd, J = 12.7, 6.1, 2.7 Hz, CH2-C4a), 2.45–2.35 (2H, m, CH2-C4b, CH-C10), 2.26–2.01 (5H, 
m, CH2-C5b, CH2-C8b, CH2-C13, CH-C14), 1.78 (3H, s, CH3-C19), 1.25 (3H, t, J = 7.0 Hz, 
CH3-OEt), 0.90 (9H, s, CH3-
tBu OTBS), 0.05 (3H, s, CH3-OTBS), 0.04 (3H, s, CH3-OTBS); 
13C NMR (101 MHz, CDCl3) δ 213.7 (C-C3), 154.3 (C-C11 or C-C15), 150.4 (C-C11 or 
C-C15), 134.9 (C-C7), 126.8 (CH-C6), 110.1 (CH2-C17), 92.8 (CH-C12), 88.8 (CH-C2), 
86.4 (CH-C9), 64.9 (CH2-C16), 62.1 (CH2-OEt), 43.3 (CH-C1), 42.6 (CH2-C4), 41.9 (CH-
C10), 38.3 (CH-C14), 36.6 (CH2-C8), 30.6 (CH2-C13), 27.1 (CH3-C19), 26.5 (CH2-C5), 
26.1 (CH3-
tBu OTBS), 18.6 (C-tBu OTBS), 14.7 (CH3-OEt), –5.3 (CH3-OTBS), –5.3 
(CH3-OTBS); [α]D
19 +12.3 (c = 1.08, CHCl3); HRMS (ESI+) [M]+ calcd. for C26H42O4SiNa 
469.2745, found 469.2736, Δ 1.8 ppm. 
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(1R,6S,7R,8R,12Z)‐3‐Ethoxy‐6‐(3‐hydroxyprop‐1‐en‐2‐yl)‐13‐methyl‐15‐
oxatricyclo[6.6.1.02,7]pentadeca‐3,12‐dien‐9‐one (301) 
 
To a stirred solution of ketone 300 (20.0 mg, 0.381 mmol) in anhydrous THF (0.5 mL) at 
room temperature was added tetra-N-butylammonium fluoride (0.18 ml of a 1.0 M solution 
in THF, 0.18 mmol) in one portion. The resulting solution was stirred for 1 hour before the 
reaction mixture was diluted with water (3 mL) and diethyl ether (5 mL). The aqueous phase 
was separated and extracted with diethyl ether (3 × 3 mL). The combined organic extracts 
were washed with brine (5 mL), dried (MgSO4) and concentrated under reduced pressure. 
The residue was purified by flash column chromatography on silica gel 
(pentane-ethyl acetate, gradient elution from 2:1 → 1:1) to afford alcohol 301 (14 mg, 94%) 
as a colourless oil.  
Rf = 0.54 (petroleum ether-ethyl acetate, 1:1); νmax 3464, 2974, 2918, 2886, 1701, 1670, 907, 
731 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.50 (1H, dd, J = 11.4, 5.7 Hz, CH-C6), 5.15 (1H, 
d, J = 1.2 Hz, CH2-C17a), 5.01 (1H, br s, CH2-C17b), 4.60 (1H, dd, J = 5.7, 1.8 Hz, CH-C12), 
4.32 (1H, ddd, J = 8.5, 4.1, 2.8 Hz, CH-C9), 4.15 (1H, br s, CH-C2), 4.11 (2H, br s, 
CH2-C16), 3.73–3.60 (2H, m, CH2-OEt), 3.35−3.25 (1H, m, CH2-C5a), 2.98 (1H, app dd, 
J = 12.0, 7.1 Hz, CH-C1), 2.90 (1H, br d, J = 14.5 Hz, CH2-C8a), 2.82 (1H, ddd, J = 12.9, 
6.2, 2.7 Hz, CH2-C4a), 2.47–2.37 (2H, m, CH2-C4b, CH-C10), 2.28–2.19 (2H, m, 
CH2-C13a, CH-C14), 2.13–2.02 (2H, m, CH2-C5b, CH2-C13b), 2.05 (1H, dd, J = 14.5, 4.1 
Hz, CH2-C8b), 1.79 (3H, s, CH3-C19), 1.59 (1H, br s, HO-C16), 1.25 (3H, t, J = 7.0 Hz, 
CH3-OEt); 
13C NMR (101 MHz, CDCl3) δ 214.2 (C-C3), 154.2 (C-C11 or C-C15), 150.8 
(C-C11 or C-C15), 134.9 (C-C7), 126.8 (CH-C6), 111.9 (CH2-C17), 92.6 (CH-C12), 88.8 
(CH-C2), 86.4 (CH-C9), 64.7 (CH2-C16), 62.2 (CH2-OEt), 43.4 (CH-C1), 42.7 (CH2-C4), 
41.8 (CH-C10), 38.8 (CH-C14), 36.5 (CH2-C8), 30.3 (CH2-C13), 27.2 (CH3-C19), 26.4 
(CH2-C5), 14.7 (CH3-OEt); [α]D
20 –15.0 (c = 0.420, CHCl3); HRMS (ESI+) [M]+ calcd. for 
C20H28O4Na 355.1867, found 355.1880, Δ 3.5 ppm. 
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(1R,6S,7R,8R,12Z)‐6‐{3‐[(4‐Methoxyphenyl)methoxy]prop‐1‐en‐2‐yl}‐13‐methyl‐15‐
oxatricyclo[6.6.1.02,7]pentadec‐12‐ene‐3,9‐dione (303) and 
(1R,6S,7R,8R,12Z)-6-(3-Hydroxyprop‐1‐en‐2‐yl)‐13‐methyl‐15‐
oxatricyclo[6.6.1.02,7]pentadec‐12‐ene‐3,9‐dione (304) 
 
To a stirred solution of alcohol 298 (21 mg, 63 µmol) in anhydrous dichloromethane 
(1.3 mL) at room temperature was added 4-methoxybenzyl-2,2,2-trichloroacetimidate 
(18 μL, 88 µmol) and CSA (1.4 mg, 6.0 μmol) in one portion. The reaction mixture was left 
to stir for 16 hours before the reaction was quenched by the addition of saturated aqueous 
solution of ammonium chloride (3 mL) and diluted with diethyl ether (5 mL). The aqueous 
phase was separated and extracted with diethyl ether (3 × 3 mL). The combined organic 
extracts were washed with brine (5 mL), dried (MgSO4) and concentrated under reduced 
pressure. The residue was purified by flash column chromatography on silica gel 
(petroleum ether-ethyl acetate, gradient elution from 15:1 → 2:1) to afford diones 303 
(13 mg, 49%) as a colourless wax and 304 (4 mg, 21%) as a colourless solid. 
303: Rf = 0.44 (petroleum ether-ethyl acetate, 2:1); νmax 3373, 3321, 3242, 3184, 2955, 2924, 
2855, 1694, 1612, 1512, 831, 735 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.31–7.24 (2H, m, 
2 × CH-Ar PMB), 6.91–6.86 (2H, m, 2 × CH-Ar PMB), 5.53 (1H, dd, J = 11.3, 5.8 Hz, 
CH-C6), 5.20 (1H, d, J = 1.1 Hz, CH2-C17a), 5.09 (1H, br s, CH2-C17b), 4.52 (1H, ddd, J = 
8.7, 4.7, 2.8 Hz, CH-C9), 4.46 (1H, d, J = 11.5 Hz, CH2-PMBa), 4.41 (1H, d, J = 11.5 Hz, 
CH2-PMBb), 4.18 (1H, br s, CH-C2), 4.00 (1H, d, J = 12.6 Hz, CH2-C16a), 3.92 (1H, d, J = 
12.6 Hz, CH2-C16b), 3.81 (3H, s, CH3-OMe PMB), 3.18–3.04 (1H, m, CH2-C5a), 2.86–2.78 
(1H, m, CH2-C8a), 2.81 (1H, ddd, J = 12.6, 5.7, 3.3 Hz, CH2-C4a), 2.64 (1H, dd, J = 8.5, 7.5 
Hz, CH-C10), 2.46–2.34 (4H, m, CH2-C4b, CH2-C12, CH-C14), 2.14–2.03 (2H, m, 
CH2-C5b, CH2-C13a), 1.88–1.81 (1H, m, CH2-C8b), 1.83 (3H, s, CH3-C19), 1.82–1.70 (1H, 
m, CH2-C13b); 
13C NMR (101 MHz, CDCl3) δ 213.0 (C-C3), 209.5 (C-C11), 159.4 
(C-Ar PMB), 147.0 (C-C15), 134.1 (C-C7), 130.3 (C-Ar PMB), 129.5 (2 × CH-Ar PMB), 
127.4 (CH-C6), 114.4 (CH2-C17), 114.0 (2 × CH-Ar PMB), 89.4 (CH-C2), 82.3 (CH-C9), 
72.2 (CH2-PMB), 71.8 (CH2-C16), 55.4 (CH3-OMe PMB), 52.6 (CH-C10), 46.4 (CH-C1), 
 Experimental 
 
 
178 
 
42.3 (CH2-C4), 40.5 (CH-C14), 38.8 (CH2-C12), 35.5 (CH2-C8), 30.5 (CH2-C13), 27.1 
(CH3-C19), 26.4 (CH2-C5); [α]D
19
 +1.6 (c = 0.25, CHCl3); HRMS (ESI+) [M]
+ calcd. for 
C26H32O5Na 447.2133, found 447.2142, Δ 2.1 ppm. 
304: Rf = 0.23 (petroleum ether-ethyl acetate, 1:1); m.p. 90–92 °C; νmax 3321, 2922, 2868, 
1699, 1643, 908, 735 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.54 (1H, dd, J = 11.2, 5.8 Hz, 
CH-C6), 5.20 (1H, d, J = 0.9 Hz, CH2-C17a), 5.06 (1H, br s, CH2-C17b), 4.56 (1H, ddd, J = 
8.0, 4.9, 2.8 Hz, CH-C9), 4.20–4.12 (3H, m, CH-C2, CH2-C16), 3.31 (1H, dd, J = 12.0, 7.6 
Hz, CH-C1), 3.16 (1H, m, CH2-C5a), 2.85–2.78 (1H, m, CH2-C8a), 2.83 (1H, ddd, J = 12.6, 
5.5, 3.6 Hz, CH2-C4a), 2.66 (1H, dd, J = 7.9, 7.9 Hz, CH-C10), 2.49–2.44 (2H, m, CH2-C12), 
2.43–2.34 (2H, m, CH2-C4b, CH-C14), 2.13–2.04 (2H, m, CH2-C5b, CH2-C13a), 1.86 (1H, 
dd, J = 14.8, 4.9 Hz, CH2-C8b), 1.85–1.80 (1H, m, CH2-C13b), 1.83 (3H, s, CH3-C19), 1.70 
(1H, br s, HO-C16); 13C NMR (101 MHz, CDCl3) δ 213.6 (C-C3), 209.2 (C-C11), 149.6 
(C-C15), 134.1 (C-C7), 127.4 (CH-C6), 113.0 (CH2-C17), 89.4 (CH-C2), 82.1 (CH-C9), 
64.7 (CH2-C16), 52.7 (CH-C10), 46.5 (CH-C1), 42.3 (CH2-C4), 41.1 (CH-C14), 38.7 
(CH2-C12), 35.5 (CH2-C8), 30.3 (CH2-C13), 27.0 (CH3-C19), 26.2 (CH2-C5); [α]D 
20 –32.3 
(c = 0.420, CHCl3); HRMS (ESI+) [M]
+ calcd. for C18H24O4Na 327.1560, found 327.1567, 
Δ 2.1 ppm
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Appendix 1: Comparison of 13C NMR Data for Isolated and Synthetic Asbestinin 21 (288) 
and Synthetic 7-epi-Asbestinin 21 (223)3 
 
 
                                                 
3 Chemical shifts in ppm relative to CDCl3 (77.0) on the δ scale 
Carbon Asbestinin 21 
(isolated)[10] 
Asbestinin 21 
(synthetic) 
7-epi-Asbestinin 21 
1 38.0 37.9 40.0 
2 93.6 93.5 93.6 
3 77.2 77.0 76.6 
4 34.0 33.9 36.9 
5 36.2 36.1 32.7 
6 210.8 210.6 214.1 
7 76.3 76.2 79.6 
8 49.3 49.2 46.9 
9 78.2 78.2 78.8 
10 47.7 47.5 46.9 
11 72.8 72.7 73.6 
12 31.5 31.4 31.2 
13 31.5 31.4 32.0 
14 38.0 37.9 37.3 
15 36.5 36.4 36.9 
16 68.2 68.1 68.9 
17 10.9 10.9 11.0 
18 22.5 22.5 25.5 
19 27.7 27.7 28.2 
20 17.3 17.2 17.8 
21 170.8 170.9 171.2 
22 21.3 21.4 21.2 
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Appendix 2: 1H and 13C NMR Spectra of Compound 258 
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Appendix 3: 1H and 13C NMR Spectra of Compound 221 
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Appendix 4: 1H and 13C NMR Spectra of Compound 260 
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Appendix 5: 1H and 13C NMR Spectra of Compound 262 
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Appendix 6: 1H and 13C NMR Spectra of Compound 263 
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Appendix 7: 1H and 13C NMR Spectra of Compound 222 
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Appendix 8: 1H and 13C NMR Spectra of Compound 265 
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Appendix 9: 1H and 13C NMR Spectra of 11-Acetoxy-4-deoxyasbestinin D (18) 
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Appendix 10: 1H and 13C NMR Spectra of 4-Deoxyasbestinin C (19) 
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Appendix 11: 1H and 13C NMR Spectra of Compound 269 
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Appendix 12: 1H and 13C NMR Spectra of Compound 270 
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Appendix 13: 1H,13C, HSQC and HMBC NMR Spectra of Compound 275 
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Appendix 14: 1H,13C and HMBC NMR Spectra of Asbestinin 20 (14) 
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Appendix 15: 1H and 13C NMR Spectra of 6-epi-Asbestinin 20 (16) 
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Appendix 16: 1H and 13C NMR Spectra of Asbestinin 10 (15) (CDCl3) 
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Appendix 17: 1H and 13C NMR Spectra of Asbestinin 10 (15) (C6D6) 
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Appendix 18: 1H and 13C NMR Spectra of Compound 284 
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Appendix 19: 1H, 13C, HSQC and HMBC NMR Spectra of Asbestinin 21 (288) 
 
 
 Appendix 
 
 
208 
 
 
 
  
 Appendix 
 
 
209 
 
Appendix 20: 1H and 13C NMR Spectra of 7-epi-Asbestinin 21 (223) 
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Appendix 21: 1H, 13C and HMBC NMR Spectra of Asbestinin 23 (266) 
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Appendix 22: 1H and 13C NMR Spectra of 7-epi-Asbestinin 23 (289) 
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Appendix 23: 1H and 13C NMR Spectra of Compound 290 
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Appendix 24: 1H and 13C NMR Spectra of Compound 292 
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Appendix 25: X-ray Crystallography Data of Compound 262 
 
Empirical Formula    C20H30O3 
Formula Weight    318.44 
Temperature     100 K 
Crystal System    Monoclinic 
Space Group     C2 
Unit Cell Dimensions    a = 36.3802(11) Å α = 90 o 
      b = 9.4047(3) Å β = 123.178(1) o 
      c = 24.8585(7) Å γ = 90 o 
Volume     711.6(4) Å3 
Z      16 
Density     1.188 Mg m-3 
Radiation Type    Cu Kα, λ = 1.54178 Å 
Absorption Coefficient   0.61 mm-1 
F(000)      2784 
Crystal Size     0.27 × 0.24 × 0.11 mm 
Theta range for Data Collection  2.5−74.4 o 
Index Ranges     −45 ≤ h ≤37; −11 ≤ k ≤ 11; −28 ≤ l ≤ 31 
Number of Reflections Collected  30711 
Number of Independent Reflections  13848 
Absorption Correction Type   Multi-scan SADABS2016/2 
Max. and Min. Transmission   0.754 and 0.638  
Goodness-of-fit on F2    1.06 
Final R Indexes [I>=2σ (1)]   R1 = 0.043  
      wR2 = 0.113 
Largest Diff. Peak/hole   0.36 and −0.19 e Å-3 
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 Appendix 26: X-ray Crystallography Data of Compound 222 
 
Empirical Formula    C20H30O3 
Formula Weight    318.44 
Temperature     150 K 
Crystal System    Triclinic 
Space Group     P1 
Unit Cell Dimensions    a = 6.6385(6) Å α = 117.319(3) o 
      b = 8.6617(7) Å β = 93.106(4) o 
      c = 9.0518(7) Å γ = 108.575(4) o 
Volume     425.75(6) Å3 
Z      1 
Density     1.242 Mg m-3 
Radiation Type    Cu Kα, λ = 1.54178 Å 
Absorption Coefficient   0.64 mm-1 
F(000)      174 
Crystal Size     0.35 × 0.2 × 0.16 mm 
Theta range for Data Collection  5.7−68.1 o 
Index Ranges     −7 ≤ h ≤6; −10 ≤ k ≤ 10; −10 ≤ l ≤ 10 
Number of Reflections Collected  8144 
Number of Independent Reflections  2672 
Absorption Correction Type   Multi-scan SADABS2016/2 
Max. and Min. Transmission   0.753 and 0.545 
Goodness-of-fit on F2    1.03 
Final R Indexes [I>=2σ (1)]   R1 = 0.037  
      wR2 = 0.095 
Largest Diff. Peak/hole   0.21 and −0.19 e Å-3  
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 Appendix 27: X-ray Crystallography Data of Compound 269 
 
 
 
 
Empirical Formula    C22H34O5 
Formula Weight    378.49 
Temperature     150 K 
Crystal System    Monoclinic 
Space Group     P2 
Unit Cell Dimensions    a = 9.6204(7) Å α = 90 o 
      b = 10.7595(7) Å β = 102.681(2) o 
      c = 10.2026(7) Å γ = 90 o 
Volume     1030.32(12) Å3 
Z      2 
Density     1.220 Mg m-3 
Radiation Type    Mo Kα, λ = 0.71073 Å 
Absorption Coefficient   0.09 mm-1 
F(000)      412 
Crystal Size     0.34 × 0.17 × 0.13 mm 
Theta range for Data Collection  2.9−28.3 o 
Index Ranges     −12 ≤ h ≤12; −14 ≤ k ≤ 14; −13 ≤ l ≤ 11 
Number of Reflections Collected  9383 
Number of Independent Reflections  4898 
Absorption Correction Type   Multi-scan SADABS2016/2 
Max. and Min. Transmission   0.746 and 0.652 
Goodness-of-fit on F2    1.04 
Final R Indexes [I>=2σ (1)]   R1 = 0.046  
      wR2 = 0.123 
Largest Diff. Peak/hole   0.34 and −0.18 e Å-3 
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 Appendix 28: X-ray Crystallography Data of Compound 270 
 
Empirical Formula    C22H34O5 
Formula Weight    378.49 
Temperature     150 K 
Crystal System    Orthorhombic 
Space Group     P212121 
Unit Cell Dimensions    a = 10.5369(5) Å α = 90 o 
      b = 11.2074(5) Å β = 90 o 
      c = 69.861(3) Å γ = 90 o 
Volume     8249.9(7) Å3 
Z      16 
Density     1.219 Mg m-3 
Radiation Type    Cu Kα, λ = 1.54178 Å 
Absorption Coefficient   0.68 mm-1 
F(000)      3296 
Crystal Size     0.37 × 0.16 × 0.04 mm 
Theta range for Data Collection  2.5−68.2 o 
Index Ranges     −12 ≤ h ≤12; −13 ≤ k ≤ 11; −84 ≤ l ≤ 83 
Number of Reflections Collected  48330 
Number of Independent Reflections  15077 
Absorption Correction Type   Multi-scan SADABS2016/2 
Max. and Min. Transmission   0.753 and 0.634 
Goodness-of-fit on F2    1.02 
Final R Indexes [I>=2σ (1)]   R1 = 0.036  
      wR2 = 0.093 
Largest Diff. Peak/hole   0.16 and −0.20 e Å-3 
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Appendix 29: X-ray Crystallography Data of Compound 14  
 
Empirical Formula    C22H34O5 
Formula Weight    378.49 
Temperature     150 K 
Crystal System    Orthorhombic 
Space Group     P212121 
Unit Cell Dimensions    a = 10.7567(5) Å α = 90 o 
      b = 10.9673(5) Å β = 90 o 
      c = 34.4321(17) Å γ = 90 o 
Volume     4062.0(3) Å3 
Z      8 
Density     1.238 Mg m-3 
Radiation Type    Mo Kα, λ = 0.71073 Å 
Absorption Coefficient   0.09 mm-1 
F(000)      1648 
Crystal Size     0.22 × 0.15 × 0.09 mm 
Theta range for Data Collection  2.4−26.2 o 
Index Ranges     −13 ≤ h ≤12; −13 ≤ k ≤ 13; −41 ≤ l ≤ 43 
Number of Reflections Collected  23463 
Number of Independent Reflections  8267 
Absorption Correction Type   Multi-scan SADABS2016/2 
Max. and Min. Transmission   0.745 and 0.646 
Goodness-of-fit on F2    1.05 
Final R Indexes [I>=2σ (1)]   R1 = 0.040  
      wR2 = 0.086 
Largest Diff. Peak/hole   0.23 and −0.16 e Å-3 
  
 Appendix 
 
 
220 
 
 Appendix 30: X-ray Crystallography Data of Compound 275 
 
 
 
 
Empirical Formula    C22H36O6 
Formula Weight    396.51 
Temperature     295 K 
Crystal System    Tetragonal 
Space Group     P43212 
Unit Cell Dimensions    a = 10.9573(8) Å α = 90 o 
      c = 36.631(3) Å γ = 90 o 
Volume     4398.0(7) Å3 
Z      8 
Density     1.198 Mg m-3 
Radiation Type    Cu Kα, λ = 1.54178 Å 
Absorption Coefficient   0.70 mm-1 
F(000)      1728 
Crystal Size     0.36 × 0.24 × 0.08 mm 
Theta range for Data Collection  3.6−78.5 o 
Index Ranges     −13 ≤ h ≤13; −12 ≤ k ≤ 13; −46 ≤ l ≤ 44 
Number of Reflections Collected  38626 
Number of Independent Reflections  4675 
Absorption Correction Type   Multi-scan SADABS2016/2 
Max. and Min. Transmission   0.754 and 0.589 
Goodness-of-fit on F2    1.05 
Final R Indexes [I>=2σ (1)]   R1 = 0.045  
      wR2 = 0.132 
Largest Diff. Peak/hole   0.24 and −0.19 e Å-3 
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Appendix 31: X-ray Crystallography Data of Compound 16 
 
Empirical Formula    C22H34O5 
Formula Weight    378.49 
Temperature     150 K 
Crystal System    Orthorhombic 
Space Group     P212121 
Unit Cell Dimensions    a = 10.0317(6) Å α = 90 o 
b = 11.2228(6) Å α = 90 o 
      c = 18.7242(10) Å γ = 90 o 
Volume     2108.0(2) Å3 
Z      4 
Density     1.193 Mg m-3 
Radiation Type    Mo Kα, λ = 0.71073 Å 
Absorption Coefficient   0.08 mm-1 
F(000)      824 
Crystal Size     0.40 × 0.28 × 0.15 mm 
Theta range for Data Collection  2.3−28.3 o 
Index Ranges     −13 ≤ h ≤13; −10 ≤ k ≤ 14; −24 ≤ l ≤ 24 
Number of Reflections Collected  14198 
Number of Independent Reflections  5181 
Absorption Correction Type   Multi-scan SADABS2016/2 
Max. and Min. Transmission   0.746 and 0.635 
Goodness-of-fit on F2    1.05 
Final R Indexes [I>=2σ (1)]   R1 = 0.039  
      wR2 = 0.105 
Largest Diff. Peak/hole   0.27 and −0.21 e Å-3 
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Appendix 32: X-ray Crystallography Data of Compound 290 
 
Empirical Formula    C22H36O5 
Formula Weight    380.51 
Temperature     150 K 
Crystal System    Orthorhombic 
Space Group     P212121 
Unit Cell Dimensions    a = 11.5008(7) Å α = 90 o 
b = 12.9803(11) Å α = 90 o 
      c = 14.0765(10) Å γ = 90 o 
Volume     2101.4(3) Å3 
Z      4 
Density     1.203 Mg m-3 
Radiation Type    Mo Kα, λ = 0.71073 Å 
Absorption Coefficient   0.08 mm-1 
F(000)      832 
Crystal Size     0.33 × 0.13 × 0.06 mm 
Theta range for Data Collection  2.3−28.2 o 
Index Ranges     −15 ≤ h ≤13; −12 ≤ k ≤ 17; −18 ≤ l ≤ 18 
Number of Reflections Collected  15988 
Number of Independent Reflections  5198 
Absorption Correction Type   Multi-scan SADABS2016/2 
Max. and Min. Transmission   0.746 and 0.650 
Goodness-of-fit on F2    1.02 
Final R Indexes [I>=2σ (1)]   R1 = 0.048  
      wR2 = 0.118 
Largest Diff. Peak/hole   0.27 and −0.25 e Å-3 
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Appendix 33: X-ray Crystallography Data of Compound 292 
 
Empirical Formula    C22H34O6 
Formula Weight    394.49 
Temperature     150 K 
Crystal System    Orthorhombic 
Space Group     P212121 
Unit Cell Dimensions    a = 9.7898(5) Å α = 90 o 
b = 11.4929(5) Å α = 90 o 
      c = 18.8684(13) Å γ = 90 o 
Volume     2122.9(2) Å3 
Z      4 
Density     1.234 Mg m-3 
Radiation Type    Mo Kα, λ = 0.71073 Å 
Absorption Coefficient   0.09 mm-1 
F(000)      856 
Crystal Size     0.18 × 0.16 × 0.07 mm 
Theta range for Data Collection  2.3−25.7 o 
Index Ranges     −11 ≤ h ≤11; −13 ≤ k ≤ 13; −23 ≤ l ≤ 12 
Number of Reflections Collected  8967 
Number of Independent Reflections  3866 
Absorption Correction Type   Multi-scan SADABS2016/2 
Max. and Min. Transmission   0.745 and 0.633 
Goodness-of-fit on F2    1.04 
Final R Indexes [I>=2σ (1)]   R1 = 0.040  
      wR2 = 0.089 
Largest Diff. Peak/hole   0.20 and −0.17 e Å-3 
 
 
